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CHAPTER 1: INTRODUCTION
Background and Significance
Shifting Demographics
Over the past 100 years, advances in healthcare and reductions in family sizes have
resulted in an aging population. Worldwide, aging trends are expected to accelerate in coming
decades. The worldwide population of older adults is projected to double by 2050, while overall
population growth will increase by only 34% during this period (He, Goodkind, & Kowal, 2016).
Economically developed countries in Europe and the United States have already begun to
gradually experience this demographic shift; countries in Latin America and Asia will face rapid
demographic shifts in the next 30 years (He et al., 2016).
In the United States, the large generation of people born between the 1940’s and mid
1960’s known as the “Baby Boomers” are becoming older. Individuals in the Baby Boomer
generation are expected to live longer than their ancestors. These two factors will result in the
number of Americans aged 65 and older doubling over the next 20 years to about 72 million
people (Alzheimer’s Association & Centers for Disease Control and Prevention [AA & CDC],
2013). In addition to the increase in the absolute number of older adults, Senior Citizens are also
beginning to represent a larger proportion of the United States population. Although they
represented only 9% of the population in 1960, older adults will account for 20% of the United
States population by 2030 (AA & CDC, 2013; Mather, Jacobsen, & Pollard, 2015). As older
adults have greater heath care needs, these demographic shifts present a challenge for the health
care system.
While these “golden years” of life hold the opportunity for increased leisure and the
enjoyment of the fruits of a life well lived, advanced age corresponds with an increased risk of
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developing Alzheimer Disease (AD; Katz et al., 2012). AD is very common in older adults.
One in ten people over the age of 65 has AD, and the risk increases with advancing age (AA,
2017). As a result of the aging population, the number of Americans with AD is expected to
triple to 14 million people by 2050 (Mather et al., 2015).
Alzheimer Disease
AD is a chronic, progressive, and irreversible neurological disease. AD has an insidious
onset; it results in the gradual loss of cognitive and functional abilities. At first, it may be
difficult to distinguish typical age-related changessuch as occasional memory lapses, episodes
of confusion, visual changes, or moodinessfrom signs of AD (AA, 2017). In AD, problems
with memory loss, problem solving, confusion, interpretation of spatial-visual information,
communication, judgement, or mood disrupt daily life (AA, 2017). These problems worsen over
time, and result in an inability to care for oneself, immobility, and death.
Despite the investment of billions of public and private research dollars over the past
several decades, no cure for AD has been identified. The clearest risk factors for AD are nonmodifiable genetic mutations, but even genetically-susceptible individuals have great
heterogeneity in neuropathology and cognitive performance in older age (Wirth, Villeneuve, La
Joie, Marks, & Jagust, 2014). Drugs have been investigated which may someday be used for
prevention of AD by individuals who have genetic risks for developing AD-related neural
pathologies, but more testing is needed to determine the safety and efficacy of these therapies
(Rafii & Aisen, 2015).
Evidence for the prevention of AD is largely inconclusive, although some risk factors
have been identified which may have an additive effect on the development of AD. Modifiable
risk factors for AD may include cardiovascular disease, cerebrovascular lesions, diabetes
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mellitus, hypertension, obesity, high cholesterol, smoking, alcoholism, high saturated fat diet,
and depression (Solomon et al., 2014). Activities that have demonstrated a protective effect
against AD include high levels of education, social engagement, mentally stimulating activities,
a heart-healthy diet, physical exercise, adequate intake of vitamins A, B complex, C, D, and E,
and medication such as anti-hypertensives, statins, hormone replacement therapy, and
nonsteroidal anti-inflammatory drugs (Solomon et al., 2014). These risk and protective factors
suggest an interaction between the pathophysiological processes of AD and other common
chronic conditions.
In addition to its impact on individuals, AD also has an enormous impact on family
members. As the disease advances, sufferers have an increased need for care and supervision
(Okura et al., 2011). Over 15 million Americans are unpaid caregivers for individuals with AD,
and their work is valued at over $230 billion annually (AA, 2017). Informal caregivers are at a
high risk for caregiver burnout, depression, anxiety, immune dysfunction, stroke, increased pain
symptoms, and premature death (Fonareva & Oken, 2014; Hong, Han, Reistetter, & Simpson,
2016; Ivey, Allen, Liu, Parmelee & Zarit, 2017; Perkins et al., 2013; Sallim, Sayampanathan,
Cuttilan, & Ho, 2015). These overburdened caregivers have more frequent doctor appointments,
hospitalizations, and medication use resulting in an estimated $10.9 billion in excess healthcare
cost (Zhu et al., 2015).
Because of the long-term course of AD, these individuals may need care for many years.
As AD symptoms worsen over time, the needs for care become more intense. Family caregivers
may be supplemented by professional services such as adult day services or hired in-home
caregivers. When the care needs or expenses become too great, individuals are moved into
residential institutions such as assisted living facilities or nursing homes.
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The cost of residential long-term care services is high. Assisted living costs over $43,000
per year, and care provided in nursing homes costs $82,000-$92,000 per year (Genworth, 2016).
As half of all older adults receiving Medicare benefits have less than $64,000 in savings, these
costs are unaffordable for most individuals (MetLife, 2012). When financial assets are depleted,
Medicaid pays for long-term care (Centers for Medicare & Medicaid [CMS], 2017). The
majority of long-term care residents, about 62%, are using the Medicaid program (Rudowitz &
Garfield, 2018). The Medicare program is strained by these costs. Expenditures have increased
6.0% annually in 2006 to 2017 mostly due to the increasing enrollment of older adults with
complex healthcare needs (Holahan & McMorrow, 2019). Given the enormous costs of longterm care, there is a clear financial incentive to help individuals remain in their homes for as long
as possible.
The total costs of AD and dementia care paid in 2017 was estimated at $259 billion (AA,
2017). AD is one of the most expensive medical conditions to the general public (Hurd,
Martorell, Delavande, Mullen, & Langa, 2013). Sources of payments for AD related care
include Medicare (51%), Medicaid (17%), out of pocket (22%; including personal savings,
pensions, and Social Security), and other sources such as private insurance and unpaid care
(11%; AA, 2017). Public sources of funding for care In addition to the high personal costs
incurred as a result of AD, this disease represents a high cost burden on society as a whole.
Agitation
Beyond the physical and cognitive effects of AD, behavioral symptoms are also common.
Behavioral or neuropsychiatric symptoms including agitation, anxiety, apathy, delusions,
depression, disinhibition, elation, hallucinations, irritability, sleep disorders, or social withdrawal
are common with AD (Cummings et al., 1994; McKhann et al., 2011).

As with other
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manifestations of AD, behavioral symptoms worsen with disease progression. In the early stages
of AD, the prevalence of at least one behavioral symptom ranges from 12.8-66.0% (Köhler et al.,
2016).

Incidence of these symptoms increases over the course of the disease. Cumulative

prevalence rates for at least one neuropsychiatric symptom range between 49 and 95% in
individuals with advanced AD (Borsje, Wetzels, Lucassen, Pot, & Koopmans, 2015).
Of the many neuropsychiatric symptoms in AD, agitated behavioral symptoms are
especially important. Agitation is a broad construct encompassing inappropriate verbalizations
or physical movements that are unrelated to needs or represent an excessive response to needs
(Cummings et al., 2015; Cohen-Mansfield & Billig, 1986).

Agitation can include both

aggressive and nonaggressive behaviors (Cohen-Mansfield & Billig, 1986).

Examples of

agitated behaviors include pacing or wandering, inappropriate dress or disrobing, screaming,
repeated questions, and hitting (Cohen-Mansfield, 1991). Although sometimes discussed as
distinct phenomena, aggression, fighting, irritability, resistance to care, restlessness, wandering
are closely related concepts which can be considered expressions of agitation when they occur in
person with dementia and cause excess disability (Cummings et al., 2015; Fauth & Gibbons,
2014; Hurley et al., 1999; Kong, 2005).
Agitation occurs in over 71% of individuals with AD.

Individuals with AD often

experience distress over these symptoms, and quality of life is diminished with increasing levels
of agitation (Hongisto et al., 2015). Agitated behavioral symptoms increase the need for care
and supervision of individuals with AD (Okura et al., 2011). Caregivers report that agitation is
the most difficult symptom of AD to manage (Chiao, Wu, & Hsiao, 2015). Caregiver distress
and burnout related to agitated behavioral symptoms results in early institutionalization of
persons with AD, and may increase the risk of elder abuse (Cooper et al., 2010; Gaugler,

6
Krichbaum, & Wyman, 2009; Pérez-Rojo, Izal, Montorio, & Penhale, 2009; VandeWeerd et al.,
2013).
Despite these dismal consequences of agitation, treating agitation is challenging. A
variety of promising social and environmental interventions have demonstrated no significant
improvement in agitated behavior. Staffing ratios, aromatherapy, and light therapy do not appear
to improve agitated behavioral symptoms (Livingston et al., 2014; Livingston et al., 2017;
Zuidema et al., 2009).
A few interventions have been identified which may reduce agitation in some situations.
Environmental and behavioral interventions which have demonstrated moderate improvements
to agitated behavioral symptoms include music therapy, staff communication training and
sensory interventions (Deudon et al., 2009; Livingston et al., 2014). Physical exercise has many
benefits for persons with dementia including reduced agitation, improved cognitive performance,
and improved mood (Brett, Traynor, & Stapley, 2016). However, many older adults including
persons with AD have impaired mobility and are unable to access these benefits, and
interventions to train staff to encourage exercise and social interactions are not effective in
reducing agitation (Ballard et al., 2015).
Pharmacological interventions are sometimes used to reduce agitated behavioral
symptoms in persons with AD. Although antipsychotic medications are sometimes effective in
temporarily reducing certain agitated behaviors, their use is not routinely recommended as these
drugs carry a high risk of side effects for older adults. Adverse side effects may include blood
clots, cerebrovascular events, drowsiness, tremors or movement difficulties, functional and
cognitive decline, and death (Foebel et al., 2016; Schneider, Dagerman, & Insel).
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While some interventions have demonstrated modest improvements in agitated
behavioral symptoms, effects of these interventions in the clinical setting are highly variable. To
improve the effectiveness of current interventions and identify further interventions to improve
agitated behavioral symptoms in persons with AD, a complete understanding of the causes of
agitation is needed. A causal model of agitation will help organize and understand antecedent
factors to allow more specific and effective interventions to be identified and developed.
Statement of Problem
AD is debilitating, costly, and widespread. Difficulties related to AD are projected to
worsen in the future due to shifting demographics and lack of treatments. Given that the current
state of the science of AD care offers no cure for the disease, mitigation of symptoms provides
the best opportunity for intervention to improve quality of life and functional status for
individuals with AD. Because agitated behavioral symptoms are the most detrimental and costly
symptoms associated with AD (through high prevalence, reduced quality of life for individuals,
increased caregiver burnout, increased risk of elder abuse, and increased risk of costly
institutionalization), the management of symptoms of agitation is the most urgent research
priority. At the present time, the nonpharmacological and pharmacological interventions to
address agitated behavioral symptoms have been shown to be ineffective or risky. Furthermore,
since most previous research investigates the direct effects of individual factors on agitation, it is
unclear how the constellation of symptoms and environmental factors experienced by those with
AD may contribute to the worsening or improvement of agitation. A holistic framework for
understanding the causes and consequences of agitation is needed. Therefore, this dissertation
proposes to identify factors that worsen or improve agitation, and how the resulting level of
agitation impacts functional status.
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Relevance to Nursing Knowledge
The phenomenon of agitated behavioral symptoms in persons with AD lends itself to
study by nursing as it fits squarely within the Fawcett’s definition of concepts of interest to
nursing’s metaparadigm including health, human beings, the environment and nursing (Fawcett
& DeSanto-Madeya, 2013). Health is the most important metaparadigm concept within the
phenomenon of functional performance in older adults with cognitive decline. It is the departure
from normal cognitive health that defines conditions like AD, and the performance of functional
roles that demonstrates a state of overall health. While studying this phenomenon, the nursing
perspective emphasizes the view that persons with AD are human beings first and sufferers of a
condition second. The environment is important to the study of agitated behavioral symptoms as
it can either trigger symptoms or help reduce symptoms. Finally, the concept of nursing is
important to the study this phenomenon because nurses and other caregivers are in a position to
prevent and manage agitated behavioral symptoms in persons with AD.
Epistemology refers to the nature of knowledge and how knowledge can be known
(Rodgers, 2005). In nursing, epistemology denotes knowledge that is accepted by members of
the nursing discipline, the types and patterns of knowledge within nursing, and the evaluation
criteria used by the discipline to accept or reject new knowledge claims (Schultz, 1988). The
nature of knowledge that can be described about the phenomenon of agitated behavioral
symptoms in persons with AD will be different depending on the disciplinary perspective from
which the phenomenon is studied. Since this phenomenon is so closely related to the concepts of
interest to the nursing discipline, there is an opportunity for nursing knowledge to be gained from
the study of this topic.
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One type of nursing knowledge is empirical knowledge. Empirical knowledge is gained
by making systematic observations through research (Schultz, 1988).

The credibility of

empirical knowledge in research is dependent on adherence to widely-accepted research methods
and the minimization of bias (Schultz, 1988). New claims of empirical knowledge related to the
study of agitated behavioral symptoms in persons with AD which arise from the proposed
research will be evaluated for credibility and utility to nursing on the basis of rigor of research
methods, minimization of bias, and assessment of how these new claims fit into the extant body
of literature surrounding the topic. Each additional claim of empirical knowledge can contribute
to conceptual nursing knowledge through reflection and synthesis of multiple claims to identify
patterns.
Conceptual nursing knowledge is a type of knowledge that extends beyond that which is
known through personal experience; conceptual knowledge describes the patterns shared through
multiple patient experiences or situations and explores these patterns through theories or models
(Schultz, 1988). Conceptual knowledge is evaluated based on the degree to which theories or
models are useful in describing patterns of experience with coherence and logical arguments
(Schultz, 1988). Research to better understand the phenomenon of agitated behavior in persons
with AD will contribute to conceptual knowledge in nursing by clarifying the relationship
between the empirical observations of agitated behavioral symptoms in persons with AD to
antecedents and consequences of these symptoms. These patterns in behavior will be framed
within a model based on the nursing Theory of Unpleasant Symptoms (TOUS). The degree to
which the model accurately and completely describes the observed phenomenon will validate the
legitimacy of the TOUS. If the model accurately reflects the phenomenon, it will be a useful tool
which can be applied to different nursing practice situations to improve the care of patients.
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Statement of Purpose
The purpose of this dissertation is to test a model of the predictors and outcomes of
agitated behavioral symptoms among persons with AD. The model will be structured by the
theoretical concepts and relationships predicted in the Theory of Unpleasant Symptoms (Lenz,
Supp, Gift, Pugh, & Milligan, 1995; Lenz, Pugh, Milligan, Gift, & Suppe, 1997). This nursing
theory focuses on the antecedents and consequences of symptoms within a comprehensive
framework. Antecedent factors are divided into three categories: situational, psychological, and
physical factors. Examples of situational factors include environmental influences like physical
surroundings and interpersonal factors such as social engagement and the influence of
caregivers. Psychological factors include anxiety and depression. Physical factors include sleep,
pain, hearing loss, and disease states such as AD with its resulting decline in cognitive capacity.
Symptom consequences are conceptualized as performance-based outcomes such as functional
ability, performance of activities of daily living, and quality of life. The TOUS provides a clear
framework for understanding symptoms and proposes theoretical relationships between
variables. However the TOUS has not been used to describe agitated behavioral symptoms and
has never been applied to a population of persons with AD.
Specific Aims and Hypotheses
Aim 1:
Describe the phenomenon of agitated behavioral symptoms in persons with AD within the
Theory of Unpleasant Symptoms.
Hypothesis:

The Theory of Unpleasant Symptoms (TOUS) will adequately describe the

antecedents and consequences of agitated behavioral symptoms in persons with AD.
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Aim 2:
Determine the effect of situational (physical and social environment), psychological (anxiety,
and depression), and physiological factors (comorbidities, pain, nutritional status, hearing,
cognitive impairment, and fatigue) on agitated behavioral symptoms in persons with AD.
Hypotheses:
(1) Supportive and stimulating physical and social environments will have a negative direct
effect on agitation.
(2) Comorbid psychological states will have a positive direct effect on agitation.
(3) Comorbid physical conditions, pain, inadequate nutritional status, hearing loss, cognitive
impairment, and fatigue will have a direct positive effect on agitation.
Aim 3:
Determine the effect of situational, psychological, and physical antecedent factors and agitation
on performance outcomes (functional status and quality of life) in persons with AD.
Hypotheses:
(1) Supportive and stimulating physical and social environments will have an indirect
positive effect on functional status and quality of life through reduced agitation.
(2) Comorbid psychological states will have an indirect negative effect on functional status
and quality of life through increased agitation.
(3) Comorbid physical conditions, pain, nutritional status, hearing loss, cognitive
impairment, and fatigue will have an indirect negative effect on functional status through
increased agitation.
(4) Agitation will have a negative direct effect on functional status and quality of life.
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Summary
As the population ages, problems related to AD will become increasingly burdensome in
the coming years. Agitated behavioral symptoms in persons with AD are of chief concern
because they are challenging to manage, have detrimental effects on individuals, and lead to
costly consequences. A complete understanding of the antecedent factors is needed to identify
future interventions to improve functional outcomes and quality of life for persons with AD.
While previous work has been done to study simple relationships between isolated antecedents
or consequences of agitation, this proposed research will build upon previous work by
identifying the relative and combined impact of each antecedent variable on agitation, and
determine how some of these factors may work together to exert a synergistic negative effect on
functional performance. This knowledge will be used to identify opportunities for high impact
interventions for future investigations.
The empirical and conceptual nursing knowledge gained through the study of this
phenomenon will contribute to nursing science. Donaldson (2003) explains that nursing science
is the science of human health within defined thematic and person-based health domains. In
contrast, Schoenhofer (1993) proposes that the most straightforward definition of nursing
research is a research question which is framed within a nursing theory. By either definition, the
study of agitated behavioral symptoms of older adults with AD framed within the nursing TOUS
will generate a type of unique nursing knowledge which supports the discipline of nursing and
informs nursing practice.
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CHAPTER 2: LITERATURE REVIEW AND THEORETICAL FRAMEWORK
The following review will discuss the state of the science related to AD and agitated
behaviors among persons with AD including risk factors and associated outcomes. A discussion
of gaps in the literature and conceptual challenges will follow. Finally, the application of the
Theory of Unpleasant Symptoms framework to guide research related to agitated behavioral
symptoms in persons with AD will be explained.
Alzheimer Disease Overview
Healthy individuals may experience changes in thinking as they age.

Although

crystallized intelligence (knowledge) and personality remain stable throughout the lifespan, fluid
intelligence, working memory, and response time generally decline in healthy adults as they age
(Blazer, Yaffe, & Karlawish, 2015; Bender & Raz, 2012; Harris, Brett, Johnson & Deary, 2016;
Yuan, Voelkle, & Raz, 2018). Occasionally, marked changes in thinking become pathological in
older adults. Symptoms of neuropathological changes, including a general loss of cognitive
ability and memory impairment, are known as dementia. Although dementia symptoms may
arise because of several different etiologies, the most common cause of dementia symptoms is
AD. The 2011 National Institute on Aging-Alzheimer Association criteria define possible or
probable AD as a persistent decline in cognitive function over time that interferes with usual
activities, and includes impairments in learning, judgment, visuospatial abilities, language, or
changes in personality (McKhann et al., 2011). A summary of neuropathological features of AD
and possible etiologies of AD are reviewed in the following.
Neuropathology of Alzheimer Disease
For over 100 years, AD has been recognized as a neurological disease primarily affecting
older adults. Although many scientific advances have been made in the past century, many
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details about the neuropathological processes that result in AD have remained elusive. Much of
what is known about the neurological disease states which result in the clinical expression of AD
symptoms was learned from the postmortem analysis of the brain tissue of affected individuals.
The microscopic and macroscopic pathologies identified in these early studies have allowed
scientists to validate the correlations between postmortem pathologies and AD with living
individuals with AD using MRI.
On the microscopic level, brain tissue of individuals with AD shows amyloid plaques and
neurofibrillary tangles which define AD. Amyloid plaques are accumulations of pieces of the
amyloid precursor protein called amyloid-β (Aβ; Okura et al., 2011). Aβ proteins are found in
the cortices and cerebral blood vessels of individuals with AD (Serrano-Pozo et al., 2011). In
early stages of AD, Aβ plaques tend to accumulate in the neocortex (Thal, Rüb, Orantes &
Braak, 2002).

As AD progresses, Aβ plaques spread to cover the deeper allocortical and

subcortical regions (Jucker, Mathias, & Walker, 2011). While Aβ is present even in the brains of
healthy individuals, a type of Aβ that is prone to causing plaque buildup is present in excessive
quantities in persons with AD (Puzzo et al., 2011; Shen & Kelleher, 2007).
Neurofibrillary tangles (NFT) composed of abnormally phosphorylated and misfolded tau
proteins are considered a hallmark of AD (Perl, 2010). The quantity and distribution of NFT
increases as AD progresses, and corresponds with increased dementia symptoms (Bierer et al.,
1995). Neurons and synapses are lost in parallel to the formation of NFT, but it is unclear how
the two phenomena are related (Serrano-Pozo, Frosch, Masliah, & Hyman, 2011).
Neuropathological changes with NFT in AD follow a very predictable pattern over time.
Eva and Heiko Braak (1991) categorized these changes into six stages commonly referred to as
Braak stages. The beginning stages are defined by diffuse NFT in the transentorhinal cortex
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within the temporal lobe (Braak & Braak, 1991). In the middle stages, NFT expand to involve
the limbic system, including the amygdala, hippocampus, thalamus, hypothalamus, basal ganglia,
and cingulate gyrus (Braak & Braak, 1991). The final stages are characterized by widespread
neurodegenerative changes related to continued accumulation of NFT, and NFT continue to
spread throughout the neocortex (Braak & Braak, 1991).

In its 1997 histopathological

diagnositic criteria for AD, the National Institute on Aging (NIA) use the Braak stages as the
basis for definitive diagnosis of AD, with greater diagnostic certainty at higher Braak stages
(Coleman & Dickson, 1997).
The systematic neurodegeneration of specific brain regions correspond to predictable
symptoms in individuals suffering from AD. Before any clinical symptoms of AD are apparent,
the disease process has already begun as neurofibrillary tangles begin to appear in the
transentorhinal cortex (Braak & Braak, 1991). As pathologies accumulate and spread to the
entorhinal cortex, episodic memory becomes slightly impaired because the entorhinal cortex is
no longer able to effectively facilitate communication between the hippocampus and the
neocortex (Tward et al., 2017; Maass, Berron, Libby, Ranganath, & Düzel 2015).
Neurofibrillary tangles become more severe and then spread to the limbic system (including the
prefrontal and occipitotemporal corticies); dementia syndrome results with impairments of
executive function and spatial visualization respectively (Serrano-Pozo et al., 2011; Tam &
Pasternak, 2017). In the final stages of AD, neuronal death continues in brain regions previously
affected, while pathologies continue to fan out in the frontal, superolateral, and occipaital
directions, eventually consuming most of the neocortex and resulting in moderated or severe
cognitive decline and motor and sensory impairment (Braak, Alafuzoff, Arzeberger,
Kretzschmar & Tredici, 2006; Serrano-Pozo et al., 2011).
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In addition to understanding the individual regions of the brain affected by AD,
understanding how multiple regions function together in networks is critical to gaining insight
into the neurological mechanisms behind neuropsychiatric clinical symptoms (Van Dam,
Vermeiren, Dekker, Naudé, & De Deyn, 2016). Catani, Dell’Acqua and De Schotten (2013)
propose that the limbic system can be divided into three functionally related networks. Memory
and spatial orientation are functions of the hippocampal-diencephalic and parahippocampalretrosplenial network (Catani et al., 2013). The default mode network facilitates attention,
introspection and knowledge of self (Catani et al., 2013). Emotion, language, and behavioral
inhibition are functions of the temporo-amygdala-orbitofrontal network (Catani et al., 2013).
This network model of neurological functioning explains why multiple brain regions are
associated with the neuropsychiatric symptoms of AD. Of the three networks, the temporoamygdala-orbitofrontal network is most affected in later stages of AD. The temporo-amygdalaorbitofrontal network is also most closely associated with agitated behavioral symptoms (Van
Dam et al., 2016). Physically agitated symptoms and aggression are associated with NFT in the
orbitofrontal cortex, medial temporal cortex, hippocampus, frontolimbic regions, amygdala, and
posterior cingulate (Lai, Chen, Hope, & Esiri, 2010; Poulin, Dautoff, Morris, Barrett, &
Dickerson, 2011; Tekin et al., 2001; Trzepacz et al., 2013). While the Braak progression of AD
pathology would suggest that neuropsychiatric symptoms such as agitation are a late-stage
manifestation of AD, their appearance in early AD is associated with a rapid decline in cognition
and may serve as a marker of rapid NFT proliferation (Gallagher, Fischer, & Iaboni, 2017). An
understanding of the neuropathological networks underlying agitation in AD may help identify
symptom clusters for targeted interventions.
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Proposed Etiologies of AD
There is still much debate about the causes of AD. One possible explanation is known as
the Amyloid Cascade Hypothesis. In this theory, neuropathological changes in AD begin with
abnormal deposits of Aβ (either through excessive production or inefficient removal), and the
presence of the Aβ damage neurons, result in NFT, and cause AD (Van Dam et al., 2016). This
theory is supported by observations that the presenilin 1 and 2 genes code for a protein involved
in processing the amyloid precursor protein, and individuals with this gene are predisposed to
inherited AD (Hardy & Selkoe, 2002).

The amyloid hypothesis is further supported by

observations that NFT can occur independently of Aβ (as seen in individuals with frontotemporal
lobar degeneration with parkinsonism), but Aβ deposits are always accompanied by NFT (Van
Dam et al., 2016; Hutton et al., 1998). Therefore, NFT cannot cause the amyloid cascade in AD,
but there is a possibility that Aβ may cause NFT.
Neuroinflammation is another proposed etiology of AD. The immune cells of the brain
(astrocytes and microglia) are responsible for synaptic remodeling, pH balance, blood flow,
metabolism, and phagocytosis of damaged tissue (Heneka et al., 2015; Hong et al., 2014; ReedGeaghan, Savage, Hise, & Landreth, 2009). Chronic neuroinflammation may be triggered by
Aβ, genetic mutations, peripheral inflammation, obesity, or mechanical trauma of the brain (Van
Dam et al., 2016).

The chronic neuroinflammation activates a cascade of inflammatory

molecules causing oxidative stress, scarring, and neuronal damage over time (Heneka et al.,
2015). As chronic neuroinflammation has been implicated as a causative mechanism in other
psychiatric disorders (Najjar, Pearlman, Alper, Najjar, & Devinsky, 2013) and it is also observed
in AD, it is possible that neuroinflammation has a role in the development of AD pathologies.
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A wide range of other theories about the pathogenesis have also been proposed. Kozlov,
Afonin, Evsyukov, and Bondarenko (2017) and Area-Gomez and Schon (2017) hypothesize that
AD progression is the result of mitochondrial dysfunction and resulting metabolic failures. In
recognizing the similarities between the systematic spreading of pathologies in AD and in
Creutzfeldt-Jakob disease, others view AD as a type of prion disease (Bastian, 2017). The
inflammatory phenomena in AD have lead others to propose that AD may be caused by
underlying systemic infections such as Bordetella pertussis, Herpes Simplex Virus, or even
chronic gingivitis (Harris & Harris, 2015; Rubin & Glazer, 2017; Singhrao, Harding, Poole,
Kesavalu, & Crean, 2015).

Still others implicate metals like lead or aluminum from

environmental exposure or endogenous iron dysregulation are key to the pathogenesis of AD
(Lee & Freeman, 2014; Lidsky 2014; Peters, Connor, & Meadowcroft, 2015). The lack of
consensus and wide variety of theoretical etiologies illustrate the complex nature of AD, and
suggest that much further research is needed to unify the variety of possible etiologies of AD.
State of the Science: Agitation in Alzheimer Disease
While impairments in thinking and memory are early symptoms of AD, changes in
behavior related to AD are common symptoms as well. Behavioral changes may include apathy,
social withdrawal, or agitation (McKhann et al., 2011). Because it is particularly challenging to
manage, an increased understanding of agitated behavioral symptoms are a research priority.
Agitation is defined by Cohen‐Mansfield and Billig (1986) as a wide range of
inappropriate verbalizations or motor activities that are not explained by obvious needs.
Agitation is expressed with aggressive and non-aggressive verbalizations and physical behaviors
(Cohen-Mansfield & Billig, 1986). Agitation is a very common symptom in AD; it occurs in
over 71% of individuals with AD (Hendriks, Smalbrugge, Galindo-Garre, Hertogh, & van der
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Steen, 2015; Van der Mussele et al., 2015). Up to 85% of individuals with dementia in long term
care facilities demonstrate at least one agitated behavioral symptom, the most common of which
is general restlessness (Zuidema, Derksen, Verhey, & Koopsman, 2007).

The physical

aggression component of agitation becomes more common as dementia impairment increases
(Zuidema, de Jonghe, Verhey, & Koopmans, 2009).
Risk Factors for Agitation
Although symptoms of agitation are common in AD, they are not continually experienced
by all persons with AD. Symptoms may arise from an unidentified unmet need or without any
known cause. By understanding the ways in which situational, psychological, cognitive, and
physiological factors coincide with agitated behavior, patterns of agitation become clear and
interventions become possible.
Situational factors. Environmental surroundings may contribute to agitated behavior in
persons with AD. Excessive noise is considered to be an environmental stressor which may lead
to agitation (Ragneskog, Gerdner, Josefsson, & Kihlgren, 1998). While features of the built
environmental surroundings such as light, sound, and number of residents in a nursing home
have not consistently demonstrated a relationship to agitation, other features of the environment
such as social factors may have an effect (Cohen-Mansfield et al., 2012; Zuidema et al., 2009).
Other disruptive situational stressors include activities of daily living or social
engagements (Corcoran & Gitlin, 1992). Individuals with cognitive decline may be less capable
of handling external stressors, and changes to routine, excess stimulation, or changes to physical
surroundings can cause agitation (Smith, Hall, Gerdner, & Buckwalter, 2006). Either excessive
stimulation (Livingston et al., 2014) or a lack of stimulation and boredom (Kolanowski et al.,
2017) can lead to agitation.
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Interpersonal factors such as social engagement and communication impact agitation.
The presence of familiar family members may be comforting to persons with dementia and
reduce agitated behavioral symptoms (Digby, Lee, & Williams, 2017). Cohen-Mansfield and
colleagues (2012) found that engagement with any other person was associated with reduced
agitation. Non-therapeutic interpersonal relations between caregivers and patients can result in
increased agitation (Ragneskog et al., 1998). Furthermore, when patients become agitated it can
cause psychological symptoms in caregivers, resulting in negative communication styles which
exacerbate agitation in patients (de Vugt et al., 2004).
Social engagement may also have an indirect effect on agitation.

Socialization is

important for the wellbeing of older adults, and also for their cognitive health.

Social

environment might play a role in agitated behavior through its effect on cognitive function
because social engagement is protective against cognitive decline (Freeman, Spirgiene, MartinKhan, & Hirdes, 2017).

Similarly, associations between increased social isolation and

diminished cognition were demonstrated in a longitudinal study by Bennett, Schneider, Tang,
Arnold, and Wilson (2006).
Psychological factors.

Psychological disturbances may co-occur with agitated

behavioral symptoms in persons with AD. Anxiety is experienced by 18-24% of persons with
AD (Borsje et al., 2015). Anxiety has been found to be more common in persons with AD who
also have agitated behavioral symptoms, with about one third of those who have frequent
agitation also reporting anxiety (Van der Mussele et al., 2015).
Depression is common among individuals with AD; it has been reported in 10 to 42
percent of with persons with AD (Borsje et al., 2015). However, depression is more commonly
diagnosed in individuals with vascular dementia than AD (Byers, Yaffe, Covinsky, Friedman, &
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Bruce, 2010). While the clinical diagnosis of depression is difficult in persons with dementia or
AD, these individuals demonstrate significant correlations between higher levels of depressive
symptoms and higher levels of agitation (Chen, Lin, Chen, & Liu, 2014; Volicer, Frijters, & Van
der Steen, 2012).
Cognitive function.

In persons with AD, cognitive function is inversely related to

agitated behavioral symptoms. Steinberg et at. (2006) found agitation was related to advanced
dementia severity, and agitation was more common with dementia due to AD.

Lovheim,

Sandman, Karlsson, and Gustafson (2008) found that the prevalence of agitation was the greatest
in those with moderate dementia, conflicting with the findings of Steinberg et al. (2006). In a
study of adults with only mild cognitive impairment or early AD, Apostolova (2014) found
agitation was most common with the amnesic types of cognitive deficits.
Other cross sectional studies report evidence supporting the inverse correlation between
cognitive function and agitated behavioral symptoms. In nursing home residents, frequency of
agitated behavioral symptoms increased with severity of cognitive impairment related to AD
(Ryu, Katona, Rive, & Livingston, 2005; Veldwijk-Rouwenhorst et al., 2017). Agitation is
present, but with low prevalence of 15% in persons with mild cognitive impairment, around 33%
with mild dementia, and 45-71% of those with moderate to severe dementia symptoms
(Livingston et al., 2017). In a model of antecedents of agitation, Chen and colleagues (2014)
found that impaired cognitive function had a direct effect on agitation, as well as an indirect
effect on agitation through decreased functional ability and resulting depression.
These findings are echoed with longitudinal studies.

Worsening of both cognitive

performance and agitated behavioral symptoms over time is seen in populations of nursing home
residents (Wetzels, Zuidema, Jansen, Verhey, & Koopmans, 2010), and among community-

22
dwelling individuals with dementia (Borsje et al., 2015). Other neuropsychological symptoms
are common with dementia and worsen over time with agitation, including delusions, aberrant
motor behavior and apathy (Borsje et al., 2015). It is possible that there is an interaction between
neuropathology, agitation, and other neuropsychological symptoms in AD.
The correlation between agitated behavioral symptoms and cognitive decline has been
well reported. However the mechanisms through which cognitive impairment and agitation are
related remain unknown. It is unclear the extent to which worsening agitated behaviors are a
result of increasing neurodegeneration, or if agitation is the result of other changes that are
consequences of diminished cognitive performance.

It is clear that as agitated behavioral

symptoms become more frequent and severe; the consequences for individuals with AD become
more pronounced as well.
Physical factors.
dysfunction.

Agitation is an expected response to physical discomfort or

Agitated behavioral symptoms are seen with a range of physical complaints.

Steinberg et at. (2006) found agitation was correlated with medical comorbidity severity. Even
relatively minor physical discomforts such as deviations in indoor air temperature are associated
with increased frequency of agitated behavioral symptoms (Tartarini, Cooper, Fleming, &
Batterham). Non-modifiable physical traits such as male gender, younger age of diagnosis, and
apolipoprotein E ε4 (APOE-ε4) genotype are associated with higher risk of agitation
(Kolanowski et al., 2017; Schutte, Reed, DeCrane & Ersig, 2011). Other physical risk factors for
agitation include functional ability, sleep, pain, nutrition, and hearing ability which are examined
below.
Sleep. Sleep disturbances are more common in persons with AD than in non-demented
older adults (Tractenberg, Singer, & Kaye, 2005). Van der Mussele and colleagues (2015) found
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that persons with AD exhibited more frequent and severe neuropsychiatric and behavioral
symptoms including disinhibition, impaired emotional control, restlessness, delusions,
hallucinations, psychosis, activity disturbances, aggressiveness, diurnal rhythm disturbances, and
anxiety with the presence of agitation in than in those without significant agitation. However, in
individuals with only mild cognitive impairment, only diurnal rhythm disturbances were related
to severity of agitation (Van der Mussele et al., 2015). This finding suggests the possibility that
sleep disturbances are a risk factor for agitation early in the AD trajectory.
Pain. Individuals with AD may have challenges in expressing themselves, and may not
communicate their experience of pain effectively. Their expression of pain may be demonstrated
as agitated behaviors. Volicer and collegues (2012) found that agitated behavioral symptoms
and pain scores in persons with AD are correlated. Pain was found to explain much of the
variance in agitated behavioral symptoms in persons with dementia when factors such as
dementia severity and functional disability were controlled (Pelletier & Landreville, 2007). Pain
may increase agitation directly and indirectly through reduced functional ability and increased
depression (Chen et al., 2014). Furthermore, pharmacological treatments for pain result in
significant reductions in agitated behaviors (Husebo, Ballard, Cohen-Mansfield, Seifert, &
Aarsland, 2014). The relationship between pain and agitated behavioral symptoms illustrate the
need to adequately assess and treat pain in people with AD.
Appetite and Nutrition. Dietary factors play an interesting role in the expression of
agitated behavioral symptoms in people with AD. Loss of appetite and poor nutritional status are
prevalent issues for persons with AD (Kimura, Sugimoto, Niida, Toba, & Sakurai, 2018; dos
Santos, Fonseca, Tedrus, & Delbue, 2018). Individuals may have reduced food consumption
while experiencing agitation or agitation may be triggered by mealtime routines (Milte, Bradley,
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Miller, Farrer & Crotty, 2018). Poor nutritional status is associated with worse cognitive status,
functional ability, and agitation in persons with AD (Yildiz, Pekel, Kilic, Tolgay, & Tufan,
2015). Importantly, dietary intake is a modifiable factor that may present an opportunity for
targeted interventions toward improving agitated behavioral symptoms.
Hearing loss. Hearing loss is common for all older adults. Estimates of age-related
hearing loss range between 2 (Sanders & Gillig, 2010) and 45 percent (Albers et al., 2015) of
people over the age of 65 years, and is thought to double in prevalence with every additional 10
years of age. Hearing loss is also known to be a correlate of agitated behavior in institutionalized
older adults (Cohen-Mansfield, Billig, Lipson, Rosenthal, & Pawlson, 1990; Vance et al., 2003).
Longitudinal studies have found that hearing loss that is caused by central auditory
dysfunction often precedes AD diagnosis (Gates, Anderson, McCurry, Feeney, & Larson, 2011).
This suggests the possibility of a shared neurodegenerative process between cognitive decline in
AD and impairments in hearing and the interpretation of sounds. Another large longitudinal
study found that hearing loss was in independent predictor for the development of dementia
when controlling for age, gender, education, APOE-ε4 allele, and cardiovascular risk factors
(Gurgel et al., 2014). Furthermore, adults with hearing loss and dementia experienced a faster
rate of cognitive decline than those with dementia and normal hearing (Gurgel et al., 2014).
These findings comport with analysis from a case-control analysis of population level
data in Taiwan. Hung et al. (2015) reported that the odds ratio of developing AD was 1.39 for
individuals with hearing loss compared to those with normal hearing. However, these analyses
did not distinguish central from peripheral hearing loss. The consensus that AD, central auditory
processing, executive function, attention and memory are inter-associated suggests that there
may be a common mechanism which impacts all of these cognitive domains.
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Besides serving as an early warning sign of AD, hearing loss may worsen cognitive
processing in AD due to the burden of increase cognitive load with diminished hearing. Because
hearing impairment requires the simultaneous use of several cognitive resources like attention
and interpretation to decipher speech, it may be more challenging to concurrently accomplish
other thought processes. This is clearly demonstrated in situations where noisy backgrounds
require more cognitive resources to understand speech, which results in impairments in other
cognitive functions such as working memory (Tun, McCoy, & Wingfield, 2009).
The concept of a cognitive resource-allocation framework comports with findings by
Wingfield and Grossman (2006). In a review of fMRI data, the authors propose a two-stage
hearing comprehension process: First, core elements of a sentence are deciphered and processed
sentence in the perisylvian region in cerebral hemisphere; Second, the recruitment of associated
brain regions involved in working memory and attention allow comprehension of sentence
salience (Wingfield & Grossman, 2006). As older adults lose function of central auditory
processing, other areas of the frontal and temporoparietal cortex are recruited to maintain
auditory processing and speech comprehension abilities. This model could explain the ability of
many older and demented patients to maintain language comprehension while other abilities fail.
To distinguish differences in hearing between normal older adults and those with AD, the
two groups were compared with physiological and functional hearing tests.

Using verbal

(phoneme identification test, word identification test) and nonverbal (environmental sound
identification test, identification of melodies from popular music) auditory tests for patients with
AD and age-matched controls, Eustache et al. (1995) found that both groups had similar levels of
moderate hearing loss. However, the AD group made significantly more errors on all functional
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hearing assessments than the controls.

The authors report that this discrepancy illustrates

problems with executive function and/or attention independent of hearing loss.
Hearing loss may contribute to obstacles in accomplishing activities of daily living, but
the effects on an individual’s lifestyle can be even farther reaching. One of the most burdensome
complications of hearing loss is the inability to understand speech, especially in the presence of
background noise. In patients with AD, vocal recognition, gender, and speaker discrimination
were impaired compared to healthy, age-matched controls (Hailstone et al., 2011). Hearing loss
may contribute to impairments in psychological health because difficulties understanding speech
may lead to social isolation, depression and reduced quality of life in some individuals
(Niemensivu, Manchaiah, Roine, Kentala, & Sintonen, 2015; Sanders & Gillig, 2010).

A

qualitative study from the United Kingdom described the social limitations of older adults with
hearing impairment. Common themes included the loss of identity, inability to communicate,
and social isolation (Bennion & Forshaw, 2013). Because social engagement supports healthy
cognitive function, (Freeman et al., 2017; Bennett, et al., 2006), and cognitive function is
inversely related to agitation, interventions to protect cognitive function by supporting social
engagement with optimized hearing should be explored to avoid agitation.
It is unclear whether sensory impairment from hearing loss directly causes the agitated
behavioral symptoms or if a common underlying cause (such as neurodegeneration) is
responsible for both the hearing loss as well as the agitated behavioral symptoms. Hearing loss
as a predictor of neurodegeneration and AD may be useful for increased surveillance of
cognition and early treatment interventions. Hearing loss as independent cause of agitation due
to sensory impairment suggests the possibility that interventions to improve communication and
optimize hearing ability may ultimately contribute to reduced agitation.
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Associated Outcomes
Quality of life for persons with Alzheimer Disease. Individuals with dementia have
decreased quality of life (as measured by proxy reports from caregivers and self-report) as levels
of agitation increase (Beerens, Zwakhalen, Verbeek, Ruwaard & Hamers, 2013; Hongisto et al.,
2015; Livingston et al., 2017). Unfortunately, there is no evidence that quality of life measures
improve with many of the interventions aimed at reducing agitation such as increased staffing
levels or increased family visits (Livingston et al., 2014; Livingston et al., 2017; Robertson et al.,
2017).

There is an urgent need to improve quality of life for these individuals, and the

possibility that reduced agitated behavioral symptoms can improve quality of life.
Functional status. Impaired functional ability, as measured by performance of activities
of daily living, is correlated with agitation (Cohen-Mansfield et al., 2012; Chen et al., 2014).
Functional status may also be impacted by the psychological issues such as depression, physical
problems such as declining cognition, and environmental considerations including living at home
(Martyr, Nelis, & Clare, 2014). The relationship between functional status and these antecedent
factors may be moderated by agitated behavior symptoms (Martyr et al., 2014). It has also been
suggested that functional ability has an indirect effect on agitation through depression, although a
direct effect of functional ability on agitation has not been demonstrated (Chen et al., 2014).
Risk for Admission to caregiving institutions.

Many individuals with AD are

eventually admitted to long-term care facilities. As agitation increases, the weekly hours of
supervision and assistance required also increases significantly (Okura et al., 2011). Caregiver
burnout or caregiver distress mediates the relationship between agitated behavioral symptoms
and admission to long-term care facilities (Gaugler et al., 2009). Admission to long-term care
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facilities is not only financially costly, it also reduces functional and cognitive ability as well as
quality of life for residents (Cobo 2014; Foebel et al., 2016).
Exposure to Psychopharmacologic treatment. Persons with AD may be treated with
psychoactive medications in an attempt to control or reduce agitated behavioral symptoms.
Atypical antipsychotic medications are widely prescribed to treat agitated behavior. As with all
medications, adverse effects are possible while taking these drugs. These adverse effects are in
especially problematic for older adults. The Food and Drug Administration (2005; 2008) has
issued public health advisories related to the increased risk of death when antipsychotic drugs are
used in a population of older adults with dementia. Despite guidelines designed to reduce the use
of these drugs, prevalence of their use remains between 40 and 68 percent of institutionalized
people with dementia (Mitka, 2012; Foebel et al., 2016).
While atypical antipsychotic medications such as aripiprazole, quetiapine, risperidone
and olanzapine significantly reduce agitated behavioral symptoms, they also have significant
risks of adverse effects (Ma et al., 2014). Adverse effects range from minor issues such as
edema and gait abnormalities to severe problems of somnolence, urinary tract infections,
extrapyramidal symptoms, adverse verebrovascular event and even death (Ma et al., 2014). The
risks of cardiovascular events and death were increased with medication dose and duration of use
(Schneider et al., 2006).
Besides the immediate adverse effects of antipsychotic drugs, long-term effects are also
seen. Individuals who are treated with antipsychotic medications were found to have declines in
functional ability and cognition compared to those who were not medicated (Foebel et al., 2016).
Since cognitive decline is associated with worsening agitated behavioral symptoms, the long-
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term use of antipsychotic medications and the associated cognitive decline may contribute to
worse agitation and the need for even more medication in long term use.
Other psychoactive medications have been tested to treat agitated behaviors in persons
with AD. Antidepressant drugs have been used for the treatment of agitated behavioral
symptoms in persons with AD even without depression. A Cochrane review found a significant
improvement in agitation after administration of selective serotonin reuptake inhibitors sertraline
and citalopram, although not all trials have confirmed this finding (Seitz et al., 2011). While
generally considered safer than antipsychotic medications, antidepressants increase the risk of
falls, electrolyte imbalances or gastrointestinal bleeding especially in older adults (Seitz et al.,
2011).
Anxiety is common in individuals with AD, and anxiety medication may be used to treat
agitated behavioral symptoms in these individuals (Borsje et al., 2015). Anxiolytic agents are
effective in treating agitation with short-term use, but can cause cognitive impairment, balance
problems, and short-term memory impairment (Antonsdottir, Smith, Keltz, & Porsteinsson,
2015). Furthermore, long-term use of benzodiazepines are strongly associated with increased
risk of development of dementia (Takada, Fujimoto, & Hosomi; 2016).
Exposure to Physical restraint. While not as prevalent as the use of antipsychotic
medications, physical restraints are widely used to control agitated behavioral symptoms in
persons with AD. It is estimated that physical restraints are used to manage agitated behavioral
symptoms in 20 to 31 percent of persons with AD and agitated behavioral symptoms in nursing
home settings (Foebel et al., 2016). The use of physical restraint is also likely to contribute to
additional psychological distress (Werner, Cohen‐Mansfield, Braun, & Marx, 1989).
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Following a similar trend to antipsychotic medication interventions, individuals who are
physically restrained were found to have declines in functional ability and cognition compared to
those who were not restrained, and also compared to those who received only antipsychotic
medications (Foebel et al., 2016). The functional and cognitive declines were the worst in
nursing home residents who were both physically restrained and medicated, suggesting an
additive effect (Foebel et al., 2016). It is possible, however, that cognitive and functional
declines were greater in this population due to the advancing disease process itself rather than as
a direct response to the physical restraint and medication interventions as no random assignment
to groups were made in Foebel’s retrospective observational study.
Caregiver Burden. Agitated behavioral symptoms are not only one of the most prevalent
symptoms in AD, they are also one of the most distressing symptoms to caregivers (Chiao et al.,
2015; Fauth & Gibbons, 2014). Caregiver burnout is a problem for family members who care
for persons with AD, and is associated with immune dysfunction, increased risk of stroke, and
increased pain (Fonareva & Oken, 2014; Hong et al., 2016; Ivey et al., 2017).
In the hospital setting, nurses and other professional caregivers may not respond
adequately to the care requirements of persons with AD and agitated behavioral symptoms. In
response to these challenging behaviors, nurses may react with avoidance or depersonalization,
ignoring these patients and providing only basic task-oriented care without compassion (Digby et
al., 2017). Healthcare Providers may respond to aggression or agitated behavioral symptoms
with physical force or chemical restraint (Nilsson, Rasmussen, & Edvardsson, 2015). When
patients with dementia are resistant to care, nurses may become angry or exasperated (Nilsson et
al., 2015). In some instances, nurses may even dehumanize these individuals resulting in the
patients being treated cruelly with shouting, mockery or with derogatory remarks (Griffiths et al.,
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2014; Digby et al., 2017). Digby and colleagues (2017) suggest that these unprofessional
caregiving behaviors are the result of nurses’ attempts to gain control of patient behaviors, a lack
of understanding or training about AD, and a lack of adequate time to look for reasons for
agitated behavioral symptoms.

In situations where nurses are unable to provide safe and

dignified care to persons with AD who have agitated behavioral symptoms, is not only unsafe for
patients but also dissatisfying to staff.
An extreme expression of caregiver burnout is the abuse or neglect of persons with AD.
Older people with dementia symptoms are at a greater risk for verbal and physical abuse in the
community and also in institutional settings compared to the elderly population in general (Boye
& Yan, 2016). Elder abuse was found to be predicted by caregiver factors such as depression or
stress, and patient factors including functional impairment, neuropsychiatric symptoms, and
dementia symptoms (Cooper et al., 2010; Pérez-Rojo et al., 2009; VandeWeerd et al., 2013).
Physical abuse of persons with AD is often triggered by disruptive behaviors such as agitation,
resistances to care, and aggression (Cooper et al., 2010; Pérez-Rojo et al., 2009; VandeWeerd et
al., 2013).
Gaps in the Literature
As a whole, the current body of evidence surrounding agitated behavioral symptoms in
AD provides evidence that (1) current interventions to improve agitated behavioral symptoms in
persons with AD are ineffective overall, (2) many possible risk factors for agitation have been
identified, and (3) outcomes for unresolved agitated behavioral symptoms are dire.
Interventions with some evidence of improvement to agitated behavioral symptoms
include environmental modifications and music therapy, communication training for caregivers,
physical exercise, and some medications.

Light therapy, staff training to encourage social
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interaction or exercise, and aromatherapy interventions are not efficacious.

Since

pharmacological interventions carry high risks of dangerous adverse events and the effects of
currently described nonpharmacological interventions are limited, there is a need to develop new
interventions to improve agitated behavioral symptoms in persons with AD through careful
evaluation of risks for and antecedents to agitated behaviors.
Cognitive decline is a key risk factor for agitation, and cognitive function may moderate
the effects of other protective factors such as social interaction and physical exercise. It is
unclear the extent to which worsening agitated behaviors and cognitive decline are both the
result of increasing neurodegeneration, or if agitated behavioral symptoms are a direct response
to increasingly impaired cognition. Furthermore, there is no evidence to determine if supporting
healthy cognition can improve cognitive behavioral symptoms or vice versa.
While many situational, psychological, and physiologic factors have been found to be
correlated with agitated behavioral symptoms, there is limited evidence to determine if these
factors are causative or simply correlated. Risk factors for agitation such as unidentified pain,
insufficient sleep, inappropriate level of stimulation, or untreated anxiety or depression merit
further exploration. Interventions to identify and treat pain, improve sleep cycles, and provide
appropriate stimulation may provide additional opportunities to improve agitated behavioral
symptoms.
Hearing loss is another important risk factor for agitated behavioral symptoms. While
some hearing loss may be an unavoidable result of neurodegeneration in AD, the effects of
hearing loss are immense.

Interventions to examine the possibility of improving agitation

directly through improvement of hearing are needed. Additionally, interventions to improve
communication for those with hearing impairment may improve agitation indirectly through
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avoidance of social isolation and improved cognition. More work is needed to investigate these
promising interventions.
The consequences of continuous agitated behavioral symptoms include diminished
quality of life, caregiver burnout, chemical or physical restraint, low quality hospital care, early
institutionalization, abuse or neglect, and adverse drug effects including death. To avoid these
outcomes, better interventions for agitated behavioral symptoms are urgently needed.

By

clarifying the relationship of antecedents and risk factors of agitated behavioral symptoms,
opportunities for effective interventions will become clear.
Conceptual Challenges
Dementia and Alzheimer disease. The first conceptual challenge in researching the
phenomenon of agitated behavioral symptoms in persons with AD is defining the population.
The definition of AD has undergone numerous revisions. In 1984, the National Institute of
Neurological and Communicative Disorders and Stroke (NINCDS) and the Alzheimer’s Disease
and Related Disorders Association (ADRDA) agreed on criteria to define the clinical diagnosis
of AD based on neuropsychiatric tests and medical history (McKhann et al., 1984).

As

knowledge about the AD neurodegenerative process and other pathophysiological processes with
similar symptom presentations grew, new diagnostic criteria for AD were created (McKhann et
al., 2011).
The currently accepted definition of AD, known as the NINCDS-ADRDA criteria
described by McKhann et al., 2011, includes a broad definition for dementia regardless of
etiology. This general definition of dementia includes cognitive or behavioral symptoms based
on five criteria: symptoms that impede usual activities; are a decline from an individual’s
baseline functioning; cannot be attributed to another psychiatric disorder; are observed through
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subjective report as well as objective measures; and involve at least two cognitive domains such
as memory, reasoning, visuaospatial abilities, language, or personality. When these symptoms
are present, but mild enough that they do not interfere with usual activities, Mild Cognitive
Impairment (MCI) is diagnosed. While MCI may be considered an early presentation of AD, it
is not definitive that MCI will progress to AD.
Dementia occurring secondary to AD is further categorized as probable, possible, and
“Probable or possible AD dementia with evidence of AD pathophysiological process” (McKhann
et al., 2011, p. 265). These further delineations depend on a patient history with insidious
symptom onset with initial presentation of memory deficits (amnestic presentation), or language,
visuospatial, and executive deficits (nonamnestic presentation). AD is not diagnosed if an
individual has a history of cerebrovascular disease or features of other types of dementia such as
Lewy body or frontotemporal dementia. The diagnosis of AD may be made with increased level
of certainty in the presence of biomarkers or genes.
With these stringent diagnostic criteria and the requirement of knowing each individual’s
history and presentation, it is not surprising that so much research with older adults who
experience cognitive decline does not attempt to differentiate dementia caused by AD from other
dementias. Even when Alzheimer diagnosis status is known for some participants, researchers
may combine all individuals with dementia symptoms in analysis.
Even the more general term, “dementia,” does not have a universally agreed upon
definition. The World Health Organization International Classification of Disease (ICD-10) has
categorized dementia as a mental and behavioral disorder (World Health Organization, 2004),
and further defines dementia on the basis of its etiology. The American Psychiatric Association
Diagnostic and Statistical Manual of Mental Disorders (DSM) removed the term dementia from
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its fifth edition, instead referring to these symptoms as a neurocognitive disorder (American
Psychiatric Association, 2013).
Some authors have argued that the distinction between different types of dementia in
older adults is futile.

There is a high prevalence of “mixed dementia” arising from a

combination of vascular and AD pathologies, with an increased risk of clinical dementia
symptoms with additional pathologies (Schneider, Arvanitakis, Bang, & Bennett, 2007). There
is also poor correlation between clinical diagnosis and neuropathological findings seen in
postmortem brain examinations (Schneider, Arvanitakis, Leurgans, & Bennett, 2009). Despite
these imperfections, distinctions between different etiologies causing dementia are important to
avoid extrapolating findings from one type of dementia to all types.
Operationalization of AD or other dementias has taken various forms in the literature. In
the absence of a formal diagnosis, scores on neuropsychological assessments are often used to
label dementia and quantify severity of cognitive impairment.
available makes comparisons across studies more difficult.

The wide variety of tools
While the benefit of these

assessments is that the numerical scores allow for easy analysis and they do not require lengthy
examination or expert input, tools are often limited in diagnostic accuracy in all populations and
may only represent the cognitive domain of dementia without regard to impact on functional
ability (Ritchie, Terrera, & Quinn, 2015).
Agitation. Lack of conceptual clarity is a problem in the literature describing agitation in
AD.

Cohen-Mansfield and Billig (1986) consider four components of agitation including

physically aggressive behavior, physically non-aggressive behavior, verbally agitated behavior,
and hiding or hoarding. The agitated behaviors are deemed socially inappropriate because: “It
may be abusive or aggressive toward self or others; it may be appropriate behavior performed
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with inappropriate frequency; and it may be inappropriate according to social standards for the
specific situation” (Cohen-Mansfield & Billig, 1986, p. 712). Aggression refers to destructive
behaviors directly at people, oneself, or objects (Cohen-Mansfield, Marx, & Rosenthal, 1989).
Cohen-Mansfield (2003) explains that agitated behavioral symptoms may be determined by an
observer, are not necessarily disruptive, and occur in individuals both with and without dementia.
Other definitions of agitation have been proposed. The DSM-5 defines psychomotor
agitation as excessive motor activity associated with a feeling of inner tension where the activity
is usually nonproductive and repetitious and consists of behaviors such as pacing, fidgeting,
wringing of the hands, pulling of clothes, and inability to sit still. (American Psychiatric
Association, 2013). This definition of agitation describes the non-aggressive behavioral aspect of
agitation described by Cohen-Mansfield and Billig (1986), but does not address aggressive or
verbal behaviors. The DSM-5 definition of agitation also presents research challenges because it
is not easy to observe feelings of inner tension, and may be difficult to ascertain these feelings in
persons with AD due to their communication limitations.
Agitation has also been described as a set of observable behaviors that demonstrate an
unpleasant state of excitement and do not respond to interventions to remove internal or external
stimuli (Hurley et al., 1999). Hurley and associates (1999) further explain that agitation is a state
that is experienced by an individual who is alone, while the same behaviors in the presence of
caregivers would be termed “resistance to care.” Examples of these behaviors include pacing
and repetitive movements or vocalizations. This definition is problematic because, by definition,
it cannot be improved through intervention. Hurley’s (1999) definition assumes that all agitated
behaviors that occur in the presence of caregivers represent a rejection of care, although the
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individual may not realize they are rejecting care.

This definition also omits aggressive

behaviors toward self, others or objects.
Kong (2005) describes a conceptual framework though which agitation can be
understood, and emphasizes that conditions preceding the agitation must be explored. While the
definition of agitation proposed by Cohen-Mansfield and Billig (1986) indicates that agitation is
the presence of inappropriate behavior in the absence of need, Kong (2005) emphasizes the
importance of assuring that physical needs are not the cause of the agitated behavioral
symptoms. Unmet physical or psychological needs such as pain or sleep deficits are likely to
cause a person with dementia to express this need through motor activity or verbalizations.
Although Cohen-Mansfield and Billig created the most widely-used definition of
agitation in 1986, there is no universal acceptance of this definition. Agitation describes such a
wide range of behavioral symptoms that it overlaps several related concepts. For example,
agitation includes aggressive behaviors but aggression is not always present in agitated behaviors
such as pacing (Cummings et al., 2015). Other concepts which are closely related to agitation
including restlessness, aggression, and disturbing behaviors are often included in the conceptual
definition of agitation (Kong, 2005). Concepts which may be considered as a part of agitation
such as aberrant motor behaviors including wandering or fighting (Fauth & Gibbons, 2014) and
inappropriate verbalizations such as screaming or ceaseless talking (von Gunten, Favre, Gurtner,
& Abderhalden, 2011) are often studied in isolation to other aspects of agitation.
The construct of agitation contains many different symptoms, making it a challenging
target to measure (Kolanowski et al., 2016). Lack of agreement on the conceptual definition of
agitation has resulted in the concept being operationalized with different tools in different
studies.

Commonly used tools include the Cohen-Mansfield Agitation Inventory (Cohen-
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Mansfield et al., 1989), Neuropsychiatric Inventory (NPI; Cummings et al.,1994), or Behavioral
Pathology in Alzheimer’s Disease (BEHAVE-AD; Reisberg et al., 1987; De Deyn & Wirshing,
2001). These different instruments make cross study comparisons difficult.
Because of a lack of agreement about the definition of agitation, an Agitation Definition
Work Group was formed by the International Psychogeriatric Association and 928 participants
responded to questionnaires to reach consensus. As a result, a standard definition of agitation
was created. “Agitation was defined broadly as: (1) occurring in patients with a cognitive
impairment or dementia syndrome; (2) exhibiting behavior consistent with emotional distress;
(3) manifesting excessive motor activity, verbal aggression, or physical aggression; and (4)
evidencing behaviors that cause excess disability and are not solely attributable to another
disorder (psychiatric, medical, or substance-related),” (Cummings et al., 2015, p. 7). This
definition adds to that which was proposed by Cohen-Mansfield (1986) by the explanation that
agitation in persons with cognitive impairment or dementia may differ in etiology and treatment
than agitation which is seen in other conditions. The “unmet needs” aspect of the definition is
reframed as “an excessive response.” This definition of agitation is also unique in its recognition
that the behavior interferes with normal or expected functioning.
While it is yet to be seen if this new definition will replace the traditional conceptual
definitions of agitated behavioral symptoms, its creation demonstrates the efforts that have gone
into creating conceptual clarity from the heterogeneity in previous definitions. Further work will
be needed to determine the extent to which extant tools are valid to measure agitation as it has
been conceptualized above.
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Nursing Theory: The Theory of Unpleasant Symptoms
Although the experience of agitated behavioral symptoms in persons with AD is very
common, interventions to reduce agitated behavioral symptoms are still unreliable.

The

consequences of untreated agitated behavioral symptoms are severe, ranging from diminished
quality of life to abuse and even death. To better understand agitated behavioral symptoms in
person with AD, the phenomenon has been conceptualized with theories like the Need-driven
Dementia-compromised Behavior (NDB) model (Algase et al., 1996) and the Progressively
Lowered Stress Threshold (PLST) model (Hall & Buckwalter, 1987).
The NDB model proposes that background factors (such as neurological status, health
status, premorbid characteristics) and proximal factors (including physical or psychosocial needs
and environment) result in disruptive behavioral symptoms related to dementia (Algase et al.,
1996). The PLST model is based on the idea that the disruptive behavioral symptoms seen in
persons with dementia are a response to overwhelming stress on the patient, and disease
progression results in lower doses of the triggering events resulting in the stress response (Hall &
Buckwalter, 1987). These models have been helpful in directing environment interventions to
minimize behavioral disruptions; however these two models are limited because they lack
explicit attention to functional performance as a secondary outcome beyond disruptive
behavioral symptoms.
To understand the relationship between these environmental stressors, needs, behavioral
symptoms, and their effects on an individual’s functional performance, another model is needed.
Numerous situational, psychological and physical risk factors for agitated behavioral symptoms
have been identified, but their relationship to agitation is complex and not fully understood. A
framework is needed to organize these risks, understand their relationship to agitated behavioral
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symptoms, and identify opportunities for future interventions. The TOUS is a good fit to model
these relationships.
The Theory of Unpleasant Symptoms
The middle-range TOUS was originally developed by Lenz and colleagues to better
understand the symptoms of fatigue and dyspnea in the populations of women in child birth and
individuals with lung disease (1995; Figure 1). Despite the differences in these symptoms and
populations, concepts that were common to both symptoms experiences were identified and
defined in a way that could be extrapolated to other unpleasant symptom experiences (Lenz et
al., 1995). The TOUS was later updated to recognize the coexistence and associations between
multiple symptoms (Lenz et al., 1997; Figure 2). The updated theory also considers the role of
performance outcomes in further influencing the symptom experience and antecedent factors
(Lenz et al., 1997).
Evaluation of TOUS
The TOUS can be critiqued through Fawcett and DeSanto-Madeya’s theory evaluation
criteria including theory scope, context, and content (2013).

The scope of the theory is

constrained to the middle-range nursing phenomenon since its theoretical concepts are more
concrete and specific than the abstract and broad concepts of grand theories. The TOUS was
developed with the goal of providing a guide for nursing theory and practice; the concepts and
relational statements of the TOUS are precisely defined (Lenz et al., 1995).
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Figure 1. Original Theory of Unpleasant Symptoms (Lenz et al., 1995)
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Figure 2. Updated Theory of Unpleasant Symptoms (Lenz et al., 1997)

The context of the nursing theory (its relation to nursing’s metaparadigm, philosophical
claims, conceptual model, and fit within previously developed nursing knowledge) places it
squarely within the nursing disciplinary perspective.

Nursing’s metaparadigm concepts of

nursing, human beings, health, and the environment are each represented (Fawcett & DeSantoMadeya, 2013). The concept of health is represented in the symptom experience, and antecedent
health factors which influence symptoms (Lenz et al., 1995). Human beings and environment
are represented through the antecedent factors of social and physical environment (Lenz et al.,
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1995). Nursing is indirectly related to the model itself, but Lenz et al. (1997) note that the TOUS
is useful in developing preventative (nursing) interventions to alleviate symptoms. Although
philosophical claims of the TOUS are not explicitly stated, the updated TOUS reflects the
reciprocal interaction world view (Lee, Vincent, & Finnegan, 2017). The patient is a holistic
being who presents symptoms which are influenced by environmental factors (Lenz et al., 1997).
The environment and multiple symptoms have a multiplicative effect on the symptom experience
and performance outcomes; these features create a feedback loop through which symptoms are
reinforced through performance factors (Lenz et al., 1997).
The content of the TOUS is evaluated on the basis of its significance, internal
consistency, parsimony, testability, and empirical and pragmatic adequacy (Fawcett & DeSantoMadeya, 2013). The theory is highly significant to nursing as demonstrated by its attention to
the metaparadigm concepts of interest to nursing and its development process through clinical
nursing observations and review of extant nursing literature (Lenz et al., 1995). The internal
consistency of the TOUS is demonstrated in the clear and concise definitions of theoretical
concepts and provision of examples of each (Lenz et al., 1995). There is a minor problem with
semantic consistency in the interchangeable use of the terms symptoms/symptom experience and
functional activities/functional performance/functional status, and performance/performance
outcomes (Lee, Vincent, & Finnegan, 2017). Overall, the interchangeable use of these terms
does not interfere with the understanding of relational concepts, and allows users of the TOUS
the flexibility to define these terms to provide the greatest utility to their own phenomena of
interest. The TOUS is testable; it has been used as the conceptual model in at least 152 different
studies many of which found evidence to support the TOUS empirical and pragmatic adequacy
(Lee, Vincent, & Finnegan, 2017).
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This model is particularly well-suited to the study of the determinants of agitated
behavioral symptoms in persons with AD because the TOUS was developed with the recognition
that multiple symptoms often occur together and may exacerbate one another. The theory
considers antecedents to symptoms such as physiological factors, psychological factors and
situational factors; describes the symptoms themselves in terms of distress, duration, quality, and
intensity; and considers the outcome of beyond just the presence or absence of symptoms
including functional abilities (activities of daily living, role performance) and cognitive
performance (concentration, problem solving). The inclusion of performance variables as an
outcome is consistent with the conceptual definition of agitation described by Cummings and
colleagues (2015).
Variables within Theory of Unpleasant Symptoms Framework
Symptom. The concept of agitation fits into the TOUS model as a symptom defined by
its distress, duration, intensity, and quality. In this study, agitation will be defined as behaviors
consistent with emotional distress, excessive motor activities, and verbal or physical aggression
which negatively impact an individual or others around them and which are not solely
attributable to another disorder (Cohen-Mansfield, 1986; Cummings et al., 2015).
Based on the model, the symptom of agitation will be impacted by the combined effects
of physiological, psychological, and situational factors. The agitated behavioral symptoms will
also have an effect on performance including quality of life and functional status.

The

relationship between agitation and other AD-related behavioral symptoms will be described.
Other behavioral symptoms often coincide with agitation in persons with AD. Symptoms
of apathy, delusions, disinhibition, elation, hallucinations, and sleep disorders will also be
examined. The TOUS predicts that these AD-related behavioral symptoms will also be impacted
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by physiological, psychological, and situational factors. The AD-related behavioral symptoms
will also have an effect on the performance outcomes of quality of life and functional status. The
relationship between AD-related behavioral symptoms and agitation will also be examined.
Antecedent factors.

The three categories of agitation-causing variables include

situational, psychological, and physical factors. Not only are these factors thought to influence
agitated behavioral symptoms, their relationships with each other are also considered.
Additionally, the antecedent factors will have an independent effect on performances outcomes.
Situational factors.

Situational factors influencing agitation include environmental

influences and interpersonal factors. In the proposed study, situational factors will include the
physical and social environment. The situational factor construct will be studied in terms of
three effects: its correlation with physical and psychological factors; its effect on agitation; and
its effect on performance outcomes.
Psychological factors. Psychological factors will be defined as anxiety and depression.
In the proposed study, the psychological factor construct will be studied in terms of three effects:
its correlation with physical and situational factors; its effect on agitation and other AD-related
behavioral symptoms; and its effect on performance outcomes.
Physiologic factors. Physical factors will be defined as comorbidities, pain, nutritional
status, hearing, cognitive impairment (as a marker of AD stage of progression), and fatigue. In
the proposed study, the physiologic factor construct will be studied in terms of three effects: its
correlation with physical and situational factors; its effect on agitation and other AD-related
behavioral symptoms; and its effect on performance outcomes.
Performance. For the purposes of the present study, the performance construct will be
defined as functional status and quality of life. As indicated in the TOUS, performance will be
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studied as a direct and indirect outcome of situational, psychological, and physical factors; it will
also be studied as a direct effect of agitation and other AD-related behavioral symptoms.
Model.

By considering the compounding effects of multiple symptoms that occur

simultaneously, it is clear how other symptoms which are common in aging such as depression,
social isolation, pain, hearing loss, or sleep difficulties may exacerbate the symptom of agitation
and ultimately diminish quality of life and functional performance. The TOUS model helps
clarify and organize the seemingly unpredictable nature of agitation by providing a clear
framework for understanding the symptom, its causes, and its effects on performance.
Performance is the outcome variable of this theory. Performance may include things like
role performance, activity level, or problem solving. These factors together may influence
quality of life overall. The resulting decrease in performance and function may act through a
feedback loop to perpetuate the cognitive decline symptom and exacerbate situational,
psychological, and physiological risk factors for even further cognitive decline.
From this model it can be deduced that if the symptoms of agitation and other AD-related
behavioral symptoms increase, then functional performance will decrease. The model also
visually depicts that a greater level of physiological impairment from AD or other dementias
contributes to an increased frequency of agitation and other AD-related behavioral symptoms
and ultimately further decrease functional performance.

Lastly, the resulting decrease in

functional performance may act through a feedback loop to perpetuate the agitation symptom
and exacerbate psychological, situational, and physiological risk factors for even further
agitation. The TOUS provides a framework of proposed relationships that can be empirically
tested.
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For the purposes of the present study, the simplified original version of the TOUS (Lenz
et al., 1995) will guide analyses. The correlations between antecedent factors will also be
considered as described in the updated TOUS (Lenz et al., 1997). Although it is clear that
feedback mechanisms described in the updated TOUS will cause iterative, reciprocal effects
from performance to symptoms and antecedent factors over time, only the direct paths will be
analyzed. Inclusion of reciprocal paths within a single model would preclude the possibility of
path analyses. Furthermore, cross sectional data provides only a snapshot in time: further study
of longitudinal changes over time is needed to evaluate the feedback mechanisms described in
the updated TOUS by reversing the model and considering functional performance and agitation
at an early time point the predictors of later declines in antecedent factors.
Chapter 2 Conclusion
All older adults should look forward to the experience of aging and the ability to live
their optimal quality of life in a safe and supportive environment. Unfortunately, persons with
AD who experience agitated behavioral symptoms may be unable to achieve their maximum
potential functional performance and quality of life (Beerens, et al., 2013; Hongisto et al., 2015;
VandeWeerd et al., 2013). Moreover, agitated behavioral symptoms may result in strained
relations with caregivers, early admission to residential institutions, administration of drugs with
dangerous side effects, physical restraint, and even elder abuse (Gaugler et al., 2009; Ma et al.,
2014; VandeWeerd et al., 2013). Current nonpharmacological interventions are unreliable or
unsafe (Livingston et al., 2017; Foebel et al., 2016). There is evidence that agitated behavioral
symptoms are related to a number of situational, psychological, and physiological factors,
however the nature of their relationship to agitation are still unclear. There is a critical need for
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research guided by theory such as the TOUS to organize these risks and outcomes, predict
relationships, and identify opportunities for intervention.
In conclusion, the TOUS provides a clear and comprehensive framework for
understanding the phenomenon of agitated behavioral symptoms in persons with AD.
Knowledge generated through the TOUS about agitation and cognitive decline has the potential
to improve care for older adults with cognitive impairments and also to contribute to nursing
knowledge. As long as a cure for AD is unattainable, a great need exists to improve the care of
agitated behavioral symptoms in persons with AD.
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CHAPTER 3: METHODS
Methods
Study Design
This dissertation’s purpose is to test a model of predictors and outcomes of agitated
behavioral symptoms in persons with AD. This study used a descriptive, correlational design
with cross-sectional data.

The specific aims of the study were tested theoretically and

empirically. Aim 1 seeks to describe the phenomenon of agitated behavioral symptoms in
persons with AD within the Theory of Unpleasant Symptoms. Aim 1 will be assessed by the
degree to which the path model calculated from the data matches the substructed model guided
by the TOUS, and adequately represents all of the expected theoretical concepts. Aims 2 and 3
seek to examine the relationships between situation, psychological state, and physical conditions
on agitation and functional status outcomes. These aims will be empirically tested to determine
the presences, strength and direction of relationships between variables of interest in the model
to evaluate the degree to which relationships hypothesized in the TOUS are supported by the
data.
Setting
This study analyzes data from previous studies of persons with AD. The original studies
examined genetic and environmental determinants of functional abilities, cognition and
behavioral symptoms in persons with AD. In the parent studies, participants were recruited from
community and nursing home settings in the Midwest (Schutte, Maas, & Buckwalter, 2003;
Schutte et al., 2011).
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Sample
Parent studies used convenience sampling to identify nursing home facilities and
community-dwelling individuals with AD from which all eligible participants were invited to
join the studies. Although some parent studies collected data from participants at multiple time
points, only baseline data for all participants were included in the present analysis. Data from
parent studies yielded a sample size of up to 110 participants. Some instruments were not used
across all studies, so sample sizes for individual measures varied between 5 and 110 participants.
A minimum sample of 48 participants was included in each variable in the model, with other
instruments evaluated separately. The G*Power analysis found that a sample of 48 participants
achieves a statistical power of 0.84 in detecting a moderate effect size (f2 = 0.15) for a one-tailed
 level of 0.05 in analyses of multiple regression with four predictors (Faul, Erdfelder, Lang, &
Buchner, 2007).
Inclusion criteria.

Subjects were eligible to participate if they met the NINCDS-

ADRDA criteria for possible or probable AD, were over the age of 21 years, were fluent in
English, and had the consent of a family member for participation.
Exclusion Criteria. Persons not meeting the inclusion criteria were excluded.
Procedures
All study procedures from the parent studies were approved by Institutional Review
Boards. Approval by the Institutional Review Board at Wayne State University was obtained
before data analysis began.

Since the data for the dissertation research had already been

collected, risks for participants were minimal. Risks included the loss of privacy if protected
health information was compromised. This risk was minimized by accessing only de-identified
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data safely stored in password protected electronics or hard copies of data assessment forms
stored in locked file cabinets in a locked office.
Recruitment. In the community, participants were recruited through their caregivers. In
nursing home settings, administrators at each facility mailed letters describing the study to
legally authorized representative of eligible participants (Schutte et al., 2011).

These

representatives were asked to indicate if they were interested in learning more about participation
in the study from the research team. Interested families were contacted by telephone to describe
the research and obtain informed consent. From the nursing home setting, an average of 51% of
eligible individuals chose to participate (Schutte et al., 2011).
Data Collection. Data were collected from chart review, questionnaires administered to
the participants, and family informant interview.

For some data, repeated measures were

collected for participants at various time points (Schutte et al., 2011). To assure interrater
reliability, functional ability and cognitive impairment assessments were measured by two
members of the research team simultaneously for the first three participants at each new facility,
with an intraclass correlation of greater than 0.75 for all measures (Schutte et al., 2011). Any
discrepancies that arose were discussed and resolved by consensus (Schutte et al., 2011).
Measures
In the following section, descriptions of instruments used to measure each theoretical
concept are described. The instruments are organized by the theoretical concept measured. In
cases where subscales of an instrument are used, the details of the instrument are described
within the first variable measured and the subscale is listed under the applicable theoretical
concept. The theoretical concept, variable, and measures are summarized in Table 1.
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Table 1. Theoretical Concepts, Definitions, and Measures
Theoretical
Term

Situational
antecedent
factors

Psychological
antecedent
factors

Definition

"Aspects of the
social and
physical
environment that
may … include
employment
status, marital and
family status,
social support…
noise, light, and
air quality" (Lenz
et al., p. 18-19)

An individual's
"mental state or
mood, affective
reaction to illness,
and degree of
uncertainty and
knowledge about
the symptoms"
(Lenz et al., 1997,
p. 18).

Conceptual
Term

Definition

Empirical measures

Social
Environment

Opportunities for
social engagement
and caregiver
perceptions of
burden.

Nursing Unit Rating Scale
Zarit Burden Interview
Score
MBPC Memory and
Behavior Caregiver
reaction subscale
MBPC ADL Caregiver
reaction
NPI Occupational
disruptiveness

Physical
Environment

The built
environment and
the degree to
which it supports
optimal
functioning.

Mood

The affective
presentation of
persons with AD.

Psychosis

Beliefs or sensory
experiences which
are not consistent
with reality.

Elevated
Behavior

Dysregulated
actions or
emotions.

Community or
Institutional Residence
Ambiance Scale
Therapeutic Environment
Screening Survey
NPI Depression subscale
NPI Anxiety subscale
NPI Apathy subscale
NPI Delusions subscale
NPI Hallucinations
subscale
NPI Elation subscale
NPI Disinhibition subscale
NPI Motor subscale
NPI Sleep subscale
NPI Irritability subscale
ADAS Non-cognitive
Behavioral
FAC Inappropriate
behavior subscale
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Table 1. Theoretical Concepts, Definitions, and Measures (continued)
Theoretical
Term

Physiologic
antecedent
factors

Symptom:
Agitation

Definition

Physiologic
factors include
the functioning of
body systems,
pathologies,
nutrition, and
energy level
(Lenz et al., 1997)

The "perceived
indicators of
change in normal
functioning... they
are the red flags
of threats to
health" (Lenz et
al., 1995, p. 146).

Conceptual
Term

Definition

Empirical measures

Comorbid
Diseases

Additional concurrent
disease states.

Cumulative Illness Rating
Scale-Geriatrics

Pain

Physical discomfort.

Pain Assessment in
Advanced Dementia

Nutritional
Status

Decreased nutritional
intake or decreased
desire for food.

Hearing
Impairment

Reduced hearing
ability.

AD-related
cognitive
impairment

Diminished cognition
in any domain of
memory, attention, or
problem-solving.

Agitation

Behaviors consistent
with emotional distress,
excessive motor
activities, and verbal or
physical aggression
which negatively
impact an individual or
others around them
and are not solely
attributable to another
disorder (CohenMansfield, 1986;
Cummings et al.,
2015).

Mini Nutritional
Assessment
NPI Appetite subscale
Hearing Inventory
Screening form
Long Term Care Minimum
Data Set
Mini Mental State Exam
Severe Impairment Battery
ADAS Cognitive subscale
MBPC Memory Behaviors
subscale
FAC Cognitive Status
subscale
Cohen-Mansfield Agitation
Inventory

FAC Agitation subscale

NPI Agitation subscale
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Table 1. Theoretical Concepts, Definitions, and Measures (continued)
Theoretical
Term

Definition

Conceptual
Term

Definition

Empirical measures
FAC Self-care subscale

Performance
outcomes

Performance is
conceptualized to
include functional
and cognitive
activities" (Lenz
et al., 1997, p.
19). Function
performance
includes physical
activity, ADL,
and role
performance or
quality of life.

Functional
status

Ability to engage in
activities to care for
oneself.

Global Deterioration
Scale/Functional Assessment
Staging Tool
MBPC ADL subscale
MDS 3.0
Alzheimer Disease Related
Quality of Life
Quality of Life in AD

Quality of
life

Degree to which one
can perform usual
roles and find
fulfillment in life.

Health Survey SF-36v2

NOTE: Memory and Behavior Problem Checklist-1987R (MBPC); Neuropsychiatric Inventory (NPI); AD
Assessment Scale (ADAS); Functional Abilities Checklist (FAC)
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Antecedent Situational Factors. Situational antecedent factors include measures of the
social and physical environments. Social environment is measured by Nursing Unit Rating Scale
(NURS) and in terms of caregiver burden as measured by the Zarit Burden Interview (ZBI), the
Memory and Behavior Problem Checklist-1987R (MBPC) Memory and Behavior Caregiver
reaction subscale, and the Occupational Disruptiveness subscale of the Neuropsychiatric
Inventory (NPI).

Physical environment is measured by the Ambiance Scale (AS) and the

Therapeutic Environment Screening Survey (TESS).
Nursing Unit Rating Scale (NURS).

NURS measures the social environment in

facilities which care for care for persons with dementia (Grant, 1994).

It assesses the

environment through interviews with staff describing six dimensions of the social environment
including separation, stability, stimulation, complexity, control/tolerance, and continuity (Grant,
1996). These items are measured on Likert scales and with estimated percent of residents with
dementia who share accommodations with cognitively intact residents (Grant, 1996). Higher
scores for separation indicate less intermingling between those with and without dementia
(Grant, 1996).

High scores in the stability subscale indicate consistent staff caregiver

assignments (Grant, 1996). High scores on the stimulation scale indicate more noise (Grant,
1996). Higher complexity scores indicate a lack of programs specifically designed for persons
with dementia (Grant, 1996). Higher scores in the control/tolerance scale indicate less tolerance
of behavioral symptoms that are problematic to others (Grant, 1996). Scores on the continuity
scale were higher when personal information was used in developing activities and individual
care plans (Grant, 1996).
Internal consistency of each subscale was acceptable to high with Cronbach α of .70-.95
(Grant, 1996). Scores between scales were weakly correlated (r = .03-.37, p < .05; Grant, 1996).
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Discriminate validity was demonstrated with significant differences between NURS scores on
dementia and non-dementia focused units for all subscales except continuity (Grant, 1996).
Zarit Burden Interview (ZBI). The ZBI measures a caregiver’s feelings of burden on a
personal level and in terms of role strain (Hérbert, Bravo,& Préville, 2000). It has been revised
from its original version to include 22 questions like “Overall, how burdened do you feel in
caring for your relative?” that are each scored between 0 (never) and 4 (nearly always; Zarit,
Reever & Bach-Peterson, 1980; Zarit, Orr, & Zarit, 1985). Scores range between 0 and 88 with
higher scores indicating greater burden.
The ZBI demonstrated good reliability and validity. Internal consistency is high with
Cronbach α of .92 (Hérbert et al., 2000; Al-Rawashdeh, Lennie, & Chung, 2016). Its convergent
validity with the Oberst Caregiving Burden Scale was good (r = .47, .58, p < .01; Al-Rawashdeh
et al., 2016; Oberst, 1990).
Memory and Behavior Problem Checklist 1987R (MBPC). The MBPC was developed
by Zarit and Zarit (1983) to measure memory deficits and challenging behaviors in individuals
with AD, as well as the responses of caregivers to these deficits. It was revised to include
separate subscales for ADL and Memory/Behaviors from the perspective of the person with AD
as well as their caregiver’s responses to the different types of behaviors (Zarit, Todd, & Zarit,
1986). The scale consists of 24 items with scores for frequency (0 never occurred to 5 occurs
daily or more often) and caregiver reaction (0 no bother to 4 extremely bothersome; Zarit et al.,
1986). In the sample included in this study, an additional frequency rating point was included
(Schutte et al., 2003). Nine of the items correspond to ADL, while the remaining 15 items
correspond to memory and behavior (Zarit, Todd, & Zarit, 1986).
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The MBPC has high internal consistency (Cronbach α = .84; Schutte et al., 2003). This
scale has a documented interrater reliability of 0.80 as well as test-retest reliability of 0.80
(Gerdner, Bckwalter, & Reed, 2002; Piccininni et al., 1998). The convergent validity of the
MBPC compared to other measures of cognition are low to moderate (r = .69 with the Mental
Status Questionnaire and .49 with the Mini Mental State Exam), but the discrepancy may be
partially attributed to the inclusion of behavioral problems measured in the MBPC which are not
measured in other cognitive tests (Gerdner et al., 2002; Kahn, Goldfarb, Pollack, & Peck, 1960;
Folstein, Folstein, & McHugh, 1975).
Neuropsychiatric Inventory- Nursing Home (NPI-NH).

The NPI Nursing Home

version was adapted from the original NPI to evaluate behavioral symptoms of AD (including
delusions, hallucinations, agitation/aggression, depression/dysphoria, anxiety, elation/euphoria,
apathy/indifference, disinhibition, irritability/lability, aberrant motor behavior, sleep and
nighttime behavior disorders, and appetite and eating disorders) for persons with AD living in
nursing homes (Cummings et al., 1994; Wood et al., 2000). Modifications include rephrasing of
questions to be more applicable to the nursing home setting. The NPI-NH includes an inventory
of whether or not each symptom has been present in the past month, and the frequency for those
that are present frequency (1 = Rarely to 4 = very often), severity (1 = mild distress to 3 = severe
distress), and disruption (0 = not at all to 5 = extremely disruptive) are measured through
caregiver or staff interview. The NPI-NH measures caregiver distress in response to these
symptoms with its occupational disruptiveness scale (Wood et al, 1999).
Internal consistency of the NPI-NH has been measured with Cronbach α of .67 (Lange,
Hopp, & Kang, 2004). Test-retest reliability at the 72-hour interval was good for each of the
symptoms measured (r = .55-.88; Iverson et al., 2002). When compared with other assessments
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of each item individually (for example, the CMAI for agitation and Cornell Depression scale for
depression), the NPI-NH subscales had moderate convergent and discriminant validity for each
individual symptoms (r = .26-.59; Lange et al., 2004).
Ambiance Scale (AS). The AS was developed to quantify the nature of the physical
environment of long term care facilities on persons with dementia (Algase et al., 2007). The AS
was adapted from a previous environmental assessment that evaluated how home-like a facility
appeared (Struble, 1995). The adapted AS evaluates the environment on the basis of its likely
soothing and engaging effects on persons with dementia (Algase et al., 2007). An observer uses
the AS to evaluate the environment on 13 criteria and score each between -2 and +2 resulting in
total scores between -26 to 26 (Algase et al., 2007). Examples of environmental criteria are
stimulating or custodial and personalized or regimented (Algase et al., 2007).
The AS has good psychometric properties.

Good reliability of the tool’s internal

consistency is demonstrated in Cronbach α of 0.89-0.91; interrater reliability was also good with
no significant differences between evaluators using the same tool (t = -0.537, df = 117, p > .05;
Algaese et al., 2007). Construct validity was demonstrated with significant correlations between
measures of engaging and soothing subscales (r = .49-.62, p < .01; Algase et al., 2007).
Therapeutic Environment Screening Survey (TESS). The TESS-NH was developed to
assess the degree to which a facility’s physical environment is equipped to meet the therapeutic
needs of persons with dementia (Sloane et al., 2002). The TESS-NH was developed as a result
of a NIA initiative to study special care units focused on dementia care, and was developed from
previous versions (Sloan et al., 2002, Sloane & Mathew, 1990). It measures exit control,
maintenance, cleanliness, safety, orientation cuing, privacy, unit autonomy, outdoor access,
lighting, noise, visual/tactile stimulation, space/seating, and familiarity or home-likeness with 84
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items; higher scores represent favorable attributes of the environment (Sloan et al., 2002). It is a
survey rather than a scale; each domain is score individually so no absolute score range is
available.
The TESS-NH has good psychometric properties. Cronbach α for each domain ranged
between .33 and .83 with the lowest performance on the noise domain. Interrater reliability was
high with an average agreement of 86.7%, and correlation of responses between .33 and 1.0; testretest reliability was .88 (Sloan et al., 2002).

Concurrent validity with Professional

Environmental Assessment Procedure was strong (r = .68, p < .01; Norris-Baker et al., 1999;
Sloan et al., 2002).
Antecedent Psychological Factors. Psychological antecedent factors of study include
mood, psychosis, and elevated behavioral symptoms. Mood is conceptualized as the affect
presentation of persons with AD, and specifically includes depression, anxiety and apathy
measured by the Depression, Anxiety, and Apathy subscales of the NPI. Psychological factors
of psychosis describe beliefs of sensory experiences that are not consistent with reality measured
by the Delusions and Hallucinations subscales of the NPI. Other elevated behavioral symptoms
are conceptualized as dysregulated actions or emotions, and are measured by the Elation,
Disinhibition, Aberrant Motor Behavior, Sleep, and Irritability subscales of the NPI, the
Noncognative Behavioral subscale of the AD Assessment Scale (ADAS), and the Inappropriate
behavior subscale of the Functional Abilities Checklist (FAC).
Alzheimer Disease Assessment Scale (ADAS). The ADAS was designed as a test that
could detect longitudinal changes in AD patients, and measures two aspects of AD: cognitive
and non-cognitive (emotional and behavioral) symptoms (Rosen, Mohs, & Davidson, 1984).
The maximum possible score is 115 points, and points are deducted throughout the interview as
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errors occur (Rosen et al., 1984). The cognitive subscale includes 70 of the total points, and
measures memory, language, praxis, and commands (Rosen et al., 1984). The remaining 45
points measure behavior.
Internal Consistency reliability was very high (Cronbach α = .97; Kørner, Lauritzen, &
Bech, 1996). Interrater reliability was high in initial testing (.65 - .99; p < .001; Rosen et al.,
1984).

ADAS was found to have very strong concurrent validity with other measures of

Alzheimer Disease symptoms (GDS, Clinical, Global Impressions, Cambridge Cognition
Examination, and MMSE; r = .89-.95, p < .001; Kørner et al., 1996).
Functional Abilities Checklist (FAC). FAC was developed by the University of Iowa
College of Nursing for Alzheimer’s Family Role studies. The FAC consists of 28 items to
measure four areas of functional ability including self-care, inappropriate behaviors, cognitive
status, and agitation (Swanson, Maas, & Buchwalter, 1994). These constructs are measured with
questions about activities of daily living such as dressing, eating, grooming, as well as questions
about behaviors such as resisting assistance for feeding, agitation at night, threatening others
(Swanson et al., 1994). Information is gathered by caregivers about behaviors from the past
week, and each item is scored between 1 (never) and 4 (multiple times per day) with high scores
indicating a high level of functional impairment (Swanson et al., 1994). Because two of the
items have a “not applicable” response, subscales are scored by averaging the given responses
resulting in scores of 1-4 for each subscale.
Internal consistency demonstrated moderate to high reliability (Cronbach α = .52-.89;
Swanson et al., 1994).

Test retest reliability was good (r = .77; Swanson et al., 1994).

Concurrent validity was demonstrated with a high correlation to the Geriatric Rating Scale which
also measures functional abilities (r = .84; Swanson et al., 1994).
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Antecedent Physiological Factors. Physical antecedent factors include comorbidities,
pain, nutritional status, hearing, cognitive impairment, and fatigue.

Comorbid physical

conditions are measured by the Cumulative Illness Rating Scale-Geriatrics (CIRS-G). Pain is
measured by the Pain Assessment in Advanced Dementia (PAIN-AD). Nutritional Status is
measured by the Mini Nutritional Assessment-Short Form (MNA-SF) and NPI Appetite
subscale. Hearing loss is measured by the Hearing Handicap Inventory for Elderly Screening
(HHIE-S), and by hearing data in the Long Term Care Minimum Data Set (MDS 3.0). Cognitive
Impairment is measured by the Mini Mental State Exam (MMSE), Severe Impairment Battery
(SIB), the cognitive subscale of the ADAS, the memory behaviors frequency of the MBPC, and
the cognitive status subscale of the FAC.
Cumulative Illness Rating Scale-Geriatrics (CIRS-G). The CIRS-G was developed
from the original CIRS to reflect the health concerns that are important to Geriatric populations
(Lin, Lin, & Gurel, 1968, Miller & Towers, 1991). The assessment is administered by a health
care provider who identifies which body systems have issues and rates the severity of each issue.
Scores are calculated by the total number of health systems with illnesses, the severity rating for
each illness from 0 (no problem) to 4 (extremely severe), the severity index (ratio of the total
score to the number of systems with problems), and the number of categories with a rating of 3
or 4 (Miller & Towers, 1991).
Interrater reliability was good; correlations were found between .78-.85 for total score
and .81-.83 for number of categories for outpatients and inpatients respectively (Miller et al.,
1992).

Convergent validity was measured against a physician’s rating of a patient’s overall

health on a scale of 0-50 with moderate agreement (r = .48, p < .05; Miller et al., 1992).
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Pain Assessment in Advance Dementia (PAIN-AD). Pain-AD was developed as an
observational scale to quantify severity of pain symptoms in persons with advanced dementia
(Warden, Hurley, & Volicer, 2003).

Categories (including breathing, vocalizations, facial

expression, body language, and consolability) are scored from 0 (normal) to 2 (severe symptoms
such as noisy labored breathing, hyperventilation etc.); total scores range from 0 to 10 with
higher scores indicating more severe pain (Warden et al., 2003).
Internal consistency is very reliable (Cronbach α = .85; DeWaters et al., 2008). Interrater
reliability is also very high with a correlation of .98 when vignette videos were assessed
(DeWaters et al., 2008). Concurrent validity was high when the PAINAD was measured against
the 0-10 numeric rating scale in populations of cognitively intact and impaired patients (r = .735,
.915, p <.001; DeWaters et al., 2008) Convergent validity was also tested by comparing PAINAD scores with nurse and physician ratings of pain. Pain ratings from health providers were
significantly correlated with PAIN-AD scores, but with less agreement than self-reported
measures (r = .44 - .69; Zwakhalen, 2012).
Mini Nutritional Assessment-Short Form (MNA-SF).

The MNA-SF is a six-item

assessment of nutritional status (Rubenstein, Harker, Salvà, Guigoz, & Vellas, 2001). The
MNA-SF is an abbreviated version of the original 18-item MNA (Guigoz, Jensen, Thomas, &
Vellas, 2006; Rubenstein et al., 2001). The six items include questions about intake of food,
weight changes, mobility, stress or diseases, dementia or depression, and body mass index yield
total scores of 0-14 points with lower scores indicating a greater risk for malnutrition
(Rubenstein et al., 2001).
Reliability of the MNA-SF internal consistency was good with Cronbach α = .65
(Guigoz, et al., 2006). Interrater reliability was good with a kappa = .78 for assessments of
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institutionalized elderly (Guigoz, et al., 2006).

Convergent and Divergent validity were

demonstrated by MNA-SF’s strong sensitivity of 97.9% and specificity of 100% to detect
malnutrition compared to a clinical nutritional status assessment (Rubenstein et al., 2001).
Hearing Handicap Inventory for Elderly Screening (HHIE-S). The HHIE-S was
developed as an assessment to identify hearing loss in older adults (Ventry & Weinstein, 1982).
The HHIE-S includes 25 items which correspond to emotional and social/situational subscales
(Ventry & Weinstein, 1982). An example of a social/situational example is “Does a hearing
problem cause you to attend parties less often than you would like?” ((Ventry & Weinstein,
1982, p. 129). Each question is answered with a yes (4 points), sometimes (2 points), or never (0
points) (Ventry & Weinstein, 1982). Total scores range from 0-100, and higher scores indicate
greater impairment (Ventry & Weinstein, 1982).
Cronbach α of the HHIE-S was .95, .93. and .88 for the total score and emotional and
social/situational subscales respectively (Ventry & Weinstein, 1982).

Using pure-tone

audiometry to evaluate hearing loss in the better ear, the HHIE-S was found to have good
convergent validity with a significant correlation (r = .61; Weinstein & Ventry 1983). The
assessment was found have good to great construct validity (53-72% sensitivity, 70-84%
specificity), with some variation depending on the type and degree of hearing loss used as a cut
point to define hearing loss (Lichtenstien,Bess, & Logan, 1988).
Long Term Care Minimum Data Set (MDS 3.0). The MDS 3.0 is a standardized
assessment of physical, clinical, psychological, psycho-social, and life care wishes of older
adults who live in long term care facilities (Saliba & Buchanan, 2012). All long-term care
facilities that participate in Medicare or Medicaid programs are required to maintain these data
for their residents (Saliba & Buchanan, 2012). The goal of the wide collection of these data is to
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report quality indicators, decide Medicare payments, and to assure appropriate care plans are
developed (Morris et al., 2003). It takes just over one hour to complete on average (Saliba &
Buchanan, 2012).
Development testing revealed that interrater reliability between research nurses and
facility staff was good to excellent (.85-.90; Saliba & Buchanan, 2012). Validity on the basis of
agreement between with diagnoses from hospital claims compared to MDS data found a positive
predictive value above .7 for major diagnoses (Mor, Intrator, Unruh, & Cai, 2010). Because of
the wide range of categories covered, the performance of each individual assessment must be
assessed individually. The greatest threat to the reliability and validity of the MDS is known as
“paper compliance,” where documentation in the form is completed to appease quality indicator
standards, but does not accurately reflect the clinical reality of higher rates of delirium,
depression, pain, and low oral intake (Rahman & Applebaum, 2009).
Mini Mental State Exam (MMSE).

The Mini Mental State Examination (MMSE;

Folstein et al., 1975) was originally developed as a brief evaluation of the cognitive state of
psychiatric patients including those with affective disorders, psychoses, and dementia syndromes
excluding mood and abnormal though processes. Scores on the MMSE range from 0-30 with
higher scores indicating better cognition (Folstein et al., 1975). The MMSE contains two
sections. The first section assesses registration of three words, short-term memory used to recall
the words, orientation to time and place, and attention to calculation through verbal responses
(Folstein et al., 1975). The second section assesses language through naming objects, the ability
to follow verbal and written commands, and writing. The second section also assesses visual
spatial skills through the participant’s ability to copy a complex polygon shape (Folstein et al.,
1975).
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Reliability of internal consistency has been demonstrated in a population of hospitalized
individuals (Cronbach α = 0.96; Tombaugh & McIntyre, 1992). Interrater reliability of the
MMSE was demonstrated by Folstein et al., (1975) with a high correlation of scores obtained by
two examiners in hospitalized and community-dwelling individuals (.83, p < .001). The MMSE
demonstrated test-retest reliability with no significant differences between scores obtained 24
hours apart for acute psychiatric conditions, or 28 days apart for dementia syndromes (as
measured by non-significant Wilcoxon T = 45, 42, p > 0.05), and high correlations between first
and second test scores for both groups (r =.89, .98 p < .0001; Folstein et al., 1975). Concurrent
validity is demonstrated with the agreement between MMSE scores and the expert clinical
diagnosis of cognitive difficulty (Mann-Whitney U 4, p < .001; Folstein et al., 1975). The
MMSE scores are similar to the Wechsler Adult Intelligence Scale (WAIS-I; Wechsler, 1955),
with strong correlations demonstrated between MMSE and WAIS-I Verbal IQ and Performance
IQ domains (r = .78, .66, p < .001; Folstein et al., 1975).
Construct validity is supported by observations that MMSE scores improve when acute
cognitive conditions are treated (including acute depression, metabolically induced delirium, and
head trauma; Folstein et al., 1975), and with diminished scores reflecting cognitive decline over
time in longitudinal studies of persons with AD (Tombaugh & McIntyre, 1992). Construct
validity of the MMSE is also supported by its high sensitivity to correctly identify those with
cognitive impairment as well as it specificity to correctly identify those who are cognitively
intact. The MMSE’s specificity for dementia is usually moderate to high (66-100%), but MMSE
may overestimate cognitive impairment in African Americans, individuals with lower than 8 th
grade educational attainment, and those with sensory impairment (Foreman, Fletcher, Mion,
Simon, & Faculty, 1996; Leveille et al., 1998; Tombaugh & McIntyre, 1992). The differential
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performance of these groups on the MMSE threatens the validity of the MMSE as a tool to
identify dementia. However, the MMSE is a screening tool for cognitive impairment; it is not
intended to provide a definitive diagnosis of AD and not valid for that purpose (Monroe &
Carter, 2012).
Severe Impairment Battery (SIB). SIB is designed to measure cognition in those with
severe cognitive limitations such as advanced AD for whom other tests of cognition are
impractical or result in a floor effect (Saxton, McGonigle-Gibson, Swihart, Miller, & Boller,
1993). The SIB includes 40 items yielding scores between 0-100 with low scores indicating
impairment in cognition (Saxton et al., 1993). The scale can be divided into nine subscales
measuring social interaction, memory, orientation, language, attention, praxis, visuospatial
ability, and construction through writing and verbal responses (Saxton et al., 1993). For an
example of items used to assess memory, participants are asked to recall a sentence and the name
of the examiner (Saxton et al., 1993).
Internal consistency of the SIB is very high (Cronbach α = .97; Ahn, Kim, Ku, Saxton, &
Kim, 2006).

In its development testing, interrater reliability was very high with a perfect

correlation of overall scores (r = 1.0), and good correlations between scores on each subscale (r
= .87 – 1.0, p < .001; Saxton et al., 1993). Test-retest reliability was also high at the 14 day
retest interval (r = .85, p <.001; Saxton et al., 1993). Concurrent validity was measured against
the MMSE, and good correlations between scores on the two tools were found (r = .74, p < .001;
Saxton et al., 1993).
Symptom: Agitation. The symptom of interest is Agitation. Agitation is the primary
outcome of interest in this study. Agitation is measured by the Cohen-Mansfield Agitation
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Inventor (CMAI), the agitation subscale of the FAC, and the agitation/aggression subscale of the
NPI.
Cohen-Mansfield Agitation Inventory (CMAI). The CMAI was developed to quantify
agitated behaviors in nursing home residents, and has also been used in community and acutecare hospital settings (Cohen-Mansfield et al., 1989; Koss et al., 1997; Kupeli et al., 2017). The
CMAI a questionnaire composed of 29 agitated behaviors (Cohen-Mansfield et al., 1989).
Examples of agitated behaviors include: “Pace, aimless wandering; inappropriate dress or
disrobing; and screaming” (Cohen-Mansfield, 1991, p. 22). Each behavior is given a frequency
score on a seven-point rating scale (1 = never, 7 = several times per hour; Cohen-Mansfield,
1991). Behaviors are reported by caregivers, and scores pertain to activities occurring over the
past two weeks (Cohen-Mansfield, 1991). Later versions of the CMAI include a five-point
disruptiveness scale, with a scores ranging between 1 (never) and five (extremely disruptive;
Cohen-Mansfield, 1991).
Total scores range from 29 to 203; however the use of subscales for the different factors
of agitation is preferred (Cohen-Mansfield 1991). Some versions of the CMAI include two
additional ratings: a score of eight indicating that the behavior would have occurred if not
prevented (for example, the individual would have been pacing, but could not due to being
physically restrained), or a score of nine if the behavior is not applicable (such as an amputee
being physically unable to kick; Cohen-Mansfield, 1991). Originally, three factors of agitated
behaviors were identified including physical aggression, verbal aggression, and nonaggressive
behaviors (Cohen-Mansfield et al., 1989; Finkel, Lyons & Anderson, 1992). Later studies
identified four factors by separating nonaggressive behaviors into verbal and physical
nonaggressive factors (Rabinowitz et al., 2005). More recently, the scale was found to be
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described by only two factors categorized as aggressive and nonaggressive behaviors (Kupeli et
al, 2017). Cohen-Mansfield (1991) recognizes that the factors contributing to agitated behavior
differ based on population and circumstances, and suggests that researchers conduct their own
factor analysis.
Criteria for identifying agitated or not agitated status involves dividing the responses into
factors (such as aggressive, physically nonaggressive behavior, and verbally nonaggressive
behavior) and examining the frequency of behaviors. For example, someone who demonstrated
agitated and aggressive behavior with at least one aggressive behavior occurring at a frequency
of several times a week, or at least two aggressive behaviors occurring at a frequency of once or
twice a week, or at least three aggressive behaviors occurring at a frequency of less than once a
week, or two aggressive behaviors occurring at a frequency of less than once a week but still
occurring and one at a frequency of once or twice a week would be characterized as
demonstrating an aggressively agitated status (Cohen-Mansfield 1991). Alternatively, CohenMansfield (1991) suggests that behaviors could be weighted based on level of disruptiveness and
combined accordingly. While these methods are useful for categorizing agitation versus not
agitation, total scores from each factor subscale are most commonly used in analysis of research
data.
The internal consistency reliability of the CMAI has generally been high. For the scale
overall and aggressive, physically-nonaggressive, verbally agitated, and hiding or hording
behaviors, Cronbach α are all .62 to .91 (Finkel et al., 1992; Rabinowitz et al., 2005). Due to the
subjective nature of this rating, interrater reliability of the disruptiveness scale is indeterminate.
Concurrent validity has been demonstrated by comparing the CMAI to the Behavioral
Syndromes Scale for Dementia (BSSD; Devanand et al., 1992), the Behavioral Pathology in
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Alzheimer’s Disease (Behave-AD; Reisberg et al., 1987), and the Ryden Aggression Scale’s
physically aggressive behavior subscale (RAS-PABS; Ryden, 1988). Moderate correlations
were found between the CMAI and BSSD (.40-.52, p < .05) as well as the Behave-AD (.27-.43,
p < .05), although correlations were nonsignificant on night shifts (Finkel et al., 1992). The
CMAI had moderate agreement with the RAS-PABS (Cohen’s κ = .544, p < .001), and the
agreement increased substantially when only the physically aggressive behavior subscale of the
CMAI was compared to the RAS-PABS (Cohen’s κ = .733, p < .001; Whall et al., 2013).
In the development of the CMAI, Cohen-Mansfield and coworkers (1989) found high
interrater reliability between three assessors in a population of nursing home residents.
Discrepancies of one point or less was considered agreement on scores, and correlations
averaged .88-.92 (Cohen-Mansfield et al., 1989). Zuidema et al., (2010) reported interrater
reliabilities of .61 to .73 on the three agitation subscales in a population of Dutch nursing home
residents. Conversely, Finkel and others (1992) found lower interrater reliability of only .41,
with the lowest agreement of only .26 on the physically nonaggressive behaviors subscale in a
population of institutionalized elderly adults.

In the community, interrater reliability (as

measured by discrepancies of zero or one point) was high at .92 (Koss et al., 1997).
Performance outcome: Functional status and quality of life. Functional Status and
quality of life are secondary outcome variables. Functional Status is conceptualized as the
ability to engage in activities to care for oneself, and is measured by the self-care subscale of the
FAC, Global Deterioration Scale (GDS), Functional Assessment Staging Tool (FAST), MBPC
ADL subscale, and information about functional abilities status from the MDS 3.0. Quality of
Life conceptualized as the degree to which one can perform usual roles and find fulfillment in
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life. Quality of life is measured by the Quality of Life in AD (QOL-AD), AD Related Quality of
Life (ADRQL), and the Health Survey 36 Short Form (SF-36).
Global Deterioration Scale (GDS). GDS is used to evaluate the stage of severity in AD
symptoms from 1 (no cognitive decline) to 7 (very severe cognitive decline) through a 50-point
assessment measuring memory, executive function, and social function (Reisburg, Ferris, de
Leon, & Crook, 1982). Each stage is described with associated clinical characteristics including
functional status, behavioral and psychiatric problems (Reisberg et al., 1982). It was designed to
help caregivers or families understand the disease course of AD, and set realistic expectations for
the performance abilities and care needs of individuals with AD (Reisberg et al., 1982).
The authors state that they developed the GDS with a conceptual approach rather than
through psychometric and statistical methods; therefore internal consistency was not measured
(Eisdorfer et al., 1992). Good interrater reliability has been found using the GDS (r = .82;
Foster, Sclan, Welkowitz, Boksay, & Seeland; 1988). Convergent validity was found between
GDS stage and PET scans of brain regions affected by AD lesions which utilize less glucose (r =
.69-.83, p < .05; Ferris et al., 1980).
Functional Assessment Staging (FAST). The FAST is a functional assessment
questionnaire for individuals with AD.

It was developed by Reisberg (1986) through an

expansion of the functional components of the GDS to describe progressive functional changes
in AD.

Like the GDS, the FAST corresponds to the seven stages of AD with decreased

functional ability at higher levels (Reisberg, 1986). The FAST further divides the late stages of
AD with eleven sub-stages describing the functional considerations of GDS stage 6 and 7 in
greater detail (for a total of 16 FAST levels; Reisberg, 1986).
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Interrater reliability for the FAST was high (ICC 0.87, p < .01; Sclan & Reisberg, 1992).
Concurrent validity between the FAST and ten other psychometric measures of AD were highly
correlated (r = .59-.73; p < .01, Reisberg et al., 1984). Concurrent validity with the Ordinal
Scales of Psychological Development (used as a measure of AD severity stage) was correlated
with FAST (r = -.79, p < .01; Sclan & Reisberg, 1992).
Quality of Life in AD (QOL-AD). QOL-AD was designed as a tool to measure quality of
life specifically in persons with dementia (Logsdon, Gibbons, McCurry, & Teri, 1999). It
contains 13 questions covering physical health, mood, memory, social relationships, participation
in meaningful activities, financial situation, overall assessment of self, and quality of life
(Logsdon et al., 1999). Each item is rated by the individual on a four-point Likert scale from 1
(poor) to 4 (excellent; Logsdon et al., 1999). Total scores range from 13 to 52 with higher scores
indicating a higher quality of life (Logsdon et al., 1999). This assessment includes one version
for participants to self-report their QOL, and another version for caregivers to report each
question as a proxy for the participant. Composite scores are calculated by doubling the selfreported score, adding in the proxy reported score, and then dividing by three (Logsdon et al.,
1999).
The QOL-AD has good internal consistency Cronbach α for self-reported, proxyreported, and composite scales (.88, .87, .90, Geschke et al., 2013; Logsdon et al., 1999). Testtest reliability was acceptable for both patients and caregiver reports (ICC = .76, .92; Logsdon et
al., 1999). Divergent validity was noted with lower correlations to MMSE scores (r = .12, .02, p
> .05 for patient and caregiver responses), and convergent validity was noted with significant
correlations to other measures of each domain such as reports of engagement in activities,
psychological status, and physical functions with higher correlations between caregiver reports
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of these items (Logsdon, Gibbons, McCurry, & Teri, 2002). Generally, self-rated scores are
higher than proxies, but this phenomenon is addressed by the increased weighting of the selfrated score in the calculation of composite score (Geschke et al., 2013; Huang et al., 2009;
Logsdon et al., 2002; Logsdon et al., 1999).
AD Related Quality of Life (ADRQL). ADRQL is another measure of Quality of Life for
individuals with AD. It was developed through focus groups with caregivers of individuals with
AD and expert panels (Rabins, Kasper, Kleinman, Black, & Patrick, 1999). It measures five
domains (social interaction, awareness of self, feelings/mood, enjoyment of activities, and
response to surroundings) through observations of actions and assessments of subjective states.
Scores are calculated with quality of life indicators weighted by the importance of each domain
(as ranked by caregiver input during tool development). Responses are recorded from the
caregiver of the person with AD as a proxy in a structured interview format. Questions pertain to
behaviors observed in the past 2 weeks; respondents are asked to agree or disagree if a statement
describes the person with AD (for example “He/She smiles or laughs when around other people;”
Rabins et al., 1999, p. 42). The total score is obtained by determining the percent of affirmative
points scored in each domain; higher scores indicate a higher quality of life.
Cronbach α was .86 for the total scale; subscales ranged from .56 to .86 indicating
acceptable to good reliability of internal consistency (Kasper, Black, Shore, & Rabins, 2009).
Content validity is supported by the development of the scale through qualitative methods of data
collection from patients, experts, and the literature (Rabins et al., 1999).
Health Survey 36 short form (SF-36). The SF-36 questionnaire measures health-related
quality of life (Ware & Sherbourne, 1992). It was designed to measure health status in the large
Medical Outcomes Study (Ware & Sherbourne, 1992).

It can be divided into subscales
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describing physical function, role limitations related to health problems, pain, social function,
emotional well-being, role limitations related to emotional problems, energy/fatigue, and
perceived general health (Ware & Sherbourne, 1992). Scores from each domain are transformed
to a range of 0 (poor health) to 100 (excellent health; McHorney, Ware, & Raczek, 1993).
Internal consistency has been demonstrated with high Cronbach α (.81-.88; Steward,
Hays, & Ware, 1988). Convergent and discriminant validity tested well against comorbid
disease burden and other measures of these factors (McHorney et al., 1993). In persons with
dementia, Cronbach α was good for most subscales (.64-.92 on each subscale), but slightly lower
for individuals whose MMSE scores were below 16 (.51-.90; Geschke, Fellgiebel, Laux,
Schermuly, & Scheurich, 2013). Concurrent validity with the QOL-AD has been demonstrated
with significant correlations between self-rated scores and QOL-AD composite scores (r = .29.62; p < .05; Geschke et al., 2013).
Other Participant Information:

In addition to the formal instruments, further

individual information was collected including: demographic data (age, sex, racial/ethnic
background, level of education, and type of career); age at time of AD diagnosis; years since
initial diagnosis; type of residence (community or institutional dwelling).
Data Analysis
Data Management
Original data were stored in an electronic database. Data were managed and analyzed
using the Statistical Package for the Social Sciences (SPSS) version 25.0. Path analyses were
calculated with the Analysis of a Moment Structures (AMOS) graphics module of SPSS. First,
data were converted into SPSS format. Next, individual data files from specific instruments and
studies were matched by participant identification numbers and added to a new SPSS file.
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Duplicate observations and time points were removed, as well as variables that were not
pertinent to the current study.
Missing Data
Missing data is present in most large datasets (Kline, 2011). This study is no exception.
As this secondary analysis pulled data from multiple sources of data, there were frequent
occurrences of missing data. Not all studies used the same instruments to measure data, and
there were also isolated cases of item-level missing data. Missing data assessed for pattern and
frequency. Variables measured in only a single study with fewer than 20 responses were
removed. Remaining variables were tested for significant differences between participants with
missing data and those with measured data. Little’s Test for Missing Completely at Random
found significant patterns of missing data, indicating that imputation techniques are inappropriate
for this sample (χ2 = 167.9, p < .001; Little, 1988). Missing Value Analysis in SPSS was then
used to identify the maximum subset of data with complete responses for main analyses. Other
variables were analyzed individually with missing cases removed list wise as secondary
outcomes.
Sample Summary Analysis
All variables were individually summarized through descriptive statistics.

Central

tendency (measured with mean, median, and/or mode) and dispersion (measured by standard
deviation, range and/or interpercentile measures) were calculated to define the data within the
sample.
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Data Analysis for each Specific Aim
Aim 1: Describe the phenomenon of agitated behavioral symptoms in persons with AD
within the Theory of Unpleasant Symptoms.
Hypothesis: The Theory of Unpleasant Symptoms will adequately describe the antecedents and
consequences of agitated behavioral symptoms in persons with AD.
Aim 1 is evaluated by the degree to which the final path analysis model represents all theoretical
constructs predicted in the TOUS. First, an exploratory factor analysis is used to reduce the
empirical measures into factors that represent each of the theoretical concepts suggested by the
TOUS (Munro, 2005). A large number of variables are present in the existing data set (8
demographic measures and 40 instruments). One of the greatest conceptual strengths held by the
TOUS is its extremely broad scope in considering all possible antecedents and consequences
relevant to an individual’s experience of symptoms (Lee, Vincent, and Finnegan, 2017). From
the pragmatic perspective of theory testing however, it is not feasible to include variables that
fully capture each possible dimension of the concepts described in the TOUS into a single
testable model. To reconcile this challenge, the data were reduced and summarized through an
exploratory factor analysis.
Next, the relationships between theoretical constructs were tested with path analysis.
Variables that describe each of the three main concepts within the TOUS (antecedents,
symptoms, and performance outcomes) are analyzed through exploratory factor analysis. The
resultant factors then take the place of measured data within the path model as proxy variables
for the indicators which they represent. The path analysis is used to test the main relationships in
TOUS and determine the degree to which the composition of model matches the variables
described in TOUS.
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Path analysis calculates regressions between each factor, and examines direct effects of
independent (exogenous) variables on dependent (endogenous) variables as well as indirect
mediator effects of independent variables (Munro, 2005). Path analyses provide evidence about
whether or not the hypothesized model fits the observed data (Munro, 2005). The hypothesized
model substructed from the TOUS is shown in figure 3.

Figure 3. Proposed path model of predictors and outcomes of agitation.

Aim 2: Determine the effect of situational (physical and social environment),
psychological (anxiety and depression), and physiological factors (comorbidities, pain,
nutritional status, hearing, cognitive impairment, and fatigue) on agitation in persons
with AD.
Hypothesis:
(1) Supportive and stimulating physical and social environments will have a negative direct
effect on agitation.
(2) Comorbid psychological states will have a positive direct effect on agitation.
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(3) Comorbid physical conditions, pain, inadequate nutritional status, hearing loss, cognitive
impairment, and fatigue will have a direct positive effect on agitation.
Aim 2 was tested with the examining the regression coefficients in the path analysis model
best fitting the data. The magnitude, direction, and significance of the path coefficients from
situational, psychological, and physical factors to agitation were evaluated.

Bivariate

relationships (Pearson’s correlation) between individual measures and the agitation outcome
were also used to test these hypotheses.
Aim 3: Determine the effect of situational, psychological, physical antecedent factors
and agitation on performance outcomes (functional status and quality of life) in
persons with AD.
Hypothesis:
(1) Supportive and stimulating physical and social environments will have an indirect
positive effect on functional status and quality of life through reduced agitation.
(2) Comorbid psychological states will have an indirect negative effect on functional status
and quality of life through increased agitation.
(3) Comorbid physical conditions, pain, nutritional status, hearing loss, cognitive
impairment, and fatigue will have an indirect negative effect on functional status through
increased agitation.
(4) Agitation will have a negative direct effect on functional status and quality of life.
Aim 3 was tested by examining the regression coefficients in the path analysis model best
fitting the data.

The magnitude, direction, and significance of the path coefficients from

situational, psychological, and physical factors to functional ability were evaluated. The paths
from agitation to functional ability were also examined. Bivariate relationships (Pearson’s
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correlations) between individual measures and the functional performance outcome are also used
to test these hypotheses.
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CHAPTER 4: RESULTS
The results chapter is divided into five sections. This chapter begins with a description of
the study sample.

In this descriptive statistics section, demographic data and descriptive

information for all study instruments is summarized. In the second section, preliminary analyses
of correlations between instruments measuring each study variable are presented. The final three
sections report results of analyses for each of the three specific aims. The first aim is evaluated
by first performing an exploratory factor analysis. Next the path analysis results relating the
factors are presented.

The second aim is tested by evaluating relationships between the

independent variables and outcome of agitation with an examination of path coefficients. The
third aim is tested by evaluating relationships between the independent variables and the
performance outcomes. The final 2 sections concerning aims 2 and 3 conclude with results of
bivariate Pearson’s correlation analyses to explore relationships between key variables that were
not captured in the path analysis.
Description of Sample and Key Variables
Study Sample Characteristics
Data from a sample of 110 individuals with AD were analyzed in this study. A summary
of demographic data is presented in Table 2. Most participants were female (72.9%, n = 72).
Nearly all of the participants identified as white (96.3%, n = 103). Participants had most
commonly had attained a high school diploma (27.2%, n = 22), with more reporting higher
educational attainment than lower (45.7%, n = 37 above high school diploma). Participants most
commonly reported blue-collar work experience (22.4%, n = 19). Ages of participants ranged
from 59 to 101 years with a mean of 83.3 years (SD = 8.3). The time since AD diagnosis ranged
from 0 to 23.7 years with a mean of 9.2 years (SD = 5.2).
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Table 2. Demographic Characteristics of the Sample
Sample Demographics
n
Percentage
Gender
107
Male
29
27.1
Female
78
72.9
Ethnicity
White
African American
Hispanic
Native American
Other

107
103
1
1
1
1

96.3
0.9
0.9
0.9
0.9

Level of Education
Attended grade school
Completed 8th grade
Attended high school
High school diploma
Attended college
Associate degree
Bachelor’s degree
Postgraduate courses
Master’s degree
Ph.D.

81
2
13
7
22
16
9
6
2
3
1

2.5
16.0
8.6
27.2
19.8
11.2
7.4
2.5
3.7
1.2

Occupation
Professional
White-collar
Blue-collar
Farmer
Homemaker
Other
None

85
12
13
19
6
17
17
1

14.1
15.3
22.4
7.1
20.0
20.0
1.2

Residence
Community dwelling
Institutional care residence

110
27
83

24.5
75.5

Sample Continuous Demographics
Age in years
Years since AD diagnosis

Mean ± SD
83.3 ± 8.3
9.2 ± 5.2

Range
59.0 – 101.6
0 – 23.7
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Descriptive Results for Key Variables
All instruments used to collect data were examined for central tendency and dispersion of
scores with means, standard deviation, and range of reported scores. The possible range of
scores is also reported. The sample size of each instrument is also reported. Results are
summarized in Table 3. Data for some measures were not available (Nursing Unit Rating Scale,
Ambiance Scale, Therapeutic Environment Screening Survey, and Long Term Care Minimum
Data Set 3.0). Results are discussed by study variable below.
Instruments measuring situation. Four instruments measured data about situation related
to caregiver reactions. All scales were scored with higher scores indicating more caregiver
burden. The ZBI had only five respondents, the two MBPC subscales had 28 respondents each,
and the NPI Occupational disruption scale had 48 responses.

All scales indicated low to

moderate levels of caregiver burden with maximum scores of less than 61% of possible points.
Mean scores all fell between 10% (MBPC ADL Caregiver Reaction subscale) and 28% (MBPC
Memory and Behavioral Caregiver Reaction subscale) of the maximum possible points.

82
Table 3. Descriptive Results by Instrument
Instrument
Situational Antecedents
Zarit Burden Interview score
MBPC Memory and behavior
caregiver subscale
MBPC ADL Caregiver reaction
subscale
NPI Occupational disruptiveness
subscale
Psychological Antecedents

n

Possible Observed Mean
Range
Range

Standard
Deviation

5
28

0-88
0-96

5-38
4-58

18.20
26.54

12.19
14.63

28

0-36

0-12

3.64

3.63

48

0-60

0-24

6.42

6.54

48
48
48
48
48
48

0-12
0-12
0-12
0-12
0-12
0-12

0-8
0-12
0-12
0-12
0-12
0-4

0.94
0.73
5.35
1.08
0.56
0.23

1.83
2.56
4.97
2.60
1.99
0.91

NPI Disinhibition subscale
NPI Motor subscale
NPI Sleep subscale
NPI Irritability subscale
ADAS Non-cognitive behavioral
subscale
FAC Inappropriate behavior subscale
Physical Antecedents
Cumulative Illness Rating ScaleGeriatrics
Pain Assessment in Advanced
Dementia
Mini Nutritional Assessment

48
48
48
48
52

0-12
0-12
0-12
0-12
0-45

0-9
0-12
0-12
0-12
0-28

0.58
2.21
0.40
3.10
6.31

1.90
3.97
1.85
3.78
5.52
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1-4

1-4

2.92

0.90

18

0-56

3-31

18.56

6.91

18

0-10

0-7

0.89

1.64

18

0-14

4-13

7.78

2.46

NPI Appetite subscale
HHIE-S
Mini Mental State Exam
Severe Impairment Battery
ADAS Cognitive subscale
MBPC Memory Behaviors Subscale
FAC Cognitive Status subscale
Table 3. Descriptive Results by

48
5
5
72
15
31
82

0-12
0-100
0-30
0-100
0-70
0-120
1-4

0-12
6-22
14-30
0-100
10-48
19-111
1.00-3.80

1.94
13.60
22.80
51.45
33.27
56.03
1.75

4.10
5.90
6.30
36.68
13.23
25.15
0.83

NPI Depression subscale
NPI Anxiety subscale
NPI Apathy subscale
NPI Delusions subscale
NPI Hallucinations subscale
NPI Elation subscale
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Instrument (Continued)
Instrument

n

Possible Observed Mean
Range
Range

Agitation
Cohen-Mansfield Agitation Inventory

66

29-203

29-86

43.27

12.65

83
48

1-4
0-12

1.00-4.00
0-12

1.88
3.56

0.77
4.18

83
91
31

1-4
1-11
0-45

1.13-4.00
3-9
0-21

3.01
5.56
8.65

0.64
1.27
5.93

FAC Agitation subscale
NPI Agitation subscale
Functional Performance
FAC Self-care subscale
GDS/FAST
MBPC ADL subscale

Standard
Deviation

ADRQL
5
0-100
83.6-100 95.36
6.84
QOL-AD
5
13-52
36-43
39.40
2.61
SF-36
5
0-100
84-100 92.60
6.12
NOTE: Memory and Behavior Problem Checklist-1987 (MBPC); Neuropsychiatric Inventory
(NPI); Activities of Daily Living (ADL); Alzheimer Disease (AD); Alzheimer Disease
Assessment Scale (ADAS); Functional Abilities Checklist (FAC), Hearing Handicap Inventory
for Elderly Screening (HHIE-S); Global Deterioration Scale (GDS); Functional Assessment
Staging Tool (FAST); Alzheimer Disease Related Quality of Life (ADRQL); Quality of Life in
Alzheimer
Disease
(QOL-AD);
Health
Survey
36
Short
Form
(SF-36)
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Instruments measuring psychological states. Twelve scales measured psychological states
and behaviors.

All scales were scored with higher scores indicating more symptoms or

behavioral difficulties.

Ten subscales of the NPI (depression, anxiety, apathy, delusions

hallucinations, elation, disinhibition, aberrant motor behaviors, sleep, and irritability) each had
48 responses.

The ADAS non-cognitive behavioral subscale included responses from 52

individuals, and the FAC inappropriate behavior subscale included responses from 81
individuals.
Overall, a variety of responses were observed on most of the subscales, with the exception of
the elation, depression, and disinhibition subscales with highest recorded responses of only 4, 8,
and 9 out of 12 possible points. Apathy was the NPI subscale with the highest average score (M
= 5.35, SD = 4.97), whereas elation was reported the least (M = 0.23, SD = 0.91). ADAS noncognitive behavioral subscale responses fell to the lower end of the possible range, with a
maximum reported score of 28 out of 45 possible points, and a mean score of 6.31 (SD = 5.52).
FAC inappropriate behavior scores represented the entire possible range of responses, with a
mean score of 2.92 out of 4 (SD = 0.90).
Instruments measuring physical comorbidities.

Ten instruments measured several

dimensions of physical factors including: CIRS-G quantifying comorbid disease burden; Pain in
AD; nutrition and eating behaviors measured by the MNA and NPI appetite subscale; Hearing
measured by the HHIE-S; Cognition measured by the MMSE, SIB, ADAS Cognitive subscale,
MBPC memory-behaviors subscale, and FAC cognitive status subscale. Scales were interpreted
with higher scores indicating greater impairment, except for the MNA, MMSE, and SIB in which
lower scores indicated more impairment.
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The largest samples were obtained with the FAC cognitive subscale and SIB (n = 82 and 72
respectively). The NPI appetite and MBPC memory behaviors subscales had samples of 48 and
31 participants respectively. Samples of 15 to 18 responses were returned in the CIRS-G, Pain in
AD, MNA, and ADAS Cognitive Subscale. Small samples (n = 5) were returned for the HHIE-S
and MMSE. Most samples included scores representing the full spectrum of possible responses.
The least variety of responses was observed with the HHIE-S (observed scores ranged from 622; possible scores ranged from 0-100), the CIRS-G (observed scores ranged from 3-31; possible
scores ranged from 0-56) and the MMSE (observed scores ranged from 14-30; possible scores
ranged from 0-30). All of the scores with limited ranges of reported scores also had few
responses.
The greatest levels of impairment were compared across scales with the percent of possible
points (or inverse in the case of MNA, MMSE, and SIB). Overall, participants had moderate
levels of cognitive impairment on average as measured by the SIB and ADAS cognitive
subscales. The highest average levels of impairment were recorded by the SIB (M = 51.45, SD =
36.68; lower scores indicate greater impairment), ADAS cognitive subscale (M = 33.27, SD =
13.23), MBPC memory behaviors subscale (M = 56.03, SD = 25.15), and the MNA (M = 7.78,
SD = 2.46; lower scores indicate greater risk for malnutrition). The lowest average level of
impairment was measured by the Pain-AD with mean response of 0.89 (SD = 1.64).
Instruments measuring agitation. The three instruments measuring agitation were the
CMAI, FAC agitation subscale, and NPI agitation subscale. Sample sizes were 66, 83, and 48
respectively. All three instruments were scored with higher values indicating more agitated
behavioral symptoms. The NPI agitation and FAC agitation scales returned responses from the
entire range of possible scores; the CMAI returned a maximum of only 86 out of 203 possible
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points. On average, the scales indicated low to moderate levels of agitation. The CMAI had the
lowest mean score compared to total possible points (M = 43.27; SD = 12.65) and the FAC
agitation subscale had the highest mean score compared to total possible points (M = 1.88, SD =
0.77).
Instruments measuring functional performance.

Seven instruments measured the

functional ability and quality of life dimensions of functional performance. Functional ability
was measured by the FAC self-care subscale, GDS/FAST, and the MBPC ADL subscale.
Higher scores indicated greater functional impairment. Measures of functional ability had 91,
83, and 31 responses for the GDS/FAST, FAC self-care, and MBPC ADL subscales. Quality of
life was measured by the ADRQL, QOLAD, and HS-36. High scores indicated higher quality of
life. Quality of life measures each had 5 responses.
The measures of functional ability had good representation of the full range of possible
scores. The mean scores of the FAC self-care subscale and GDS/FAST were high (M = 3.01,
8.65; SD = 0.64, 1.27), indicating a high degree of difficulty with functional ability. The mean
score of the MBPC ADL subscale was lower (M = 8.65, SD = 5.9), indicating less difficulty with
functional ability measured by this instrument and within this community-dwelling subset of the
sample. The measures of quality of life all measured relatively high quality of life, with a
highest percent of possible points obtained on the ADRQL (M = 95.36, SD = 6.84).
Preliminary Statistical Analysis
Correlations Between Measures of Concepts
Situational factors. Correlations between measures of situation were calculated. For the
concept of situational factors, correlations between caregiver measures were only available for
the two subscales of the MBPC because different tools were used in each different parent study
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sample. Moderate Pearson’s correlations were found between the MBPC memory behavior and
MBPC ADL caregiver reaction subscales (r = .59, p < .001).
Psychological states.

Correlations between measures of psychological states and

behaviors are presented in Table 4. Low correlations were found between depression and
anxiety (r = .31, p = .034), delusions (r = .36, p = .012), and disinhibition (r = .35, p = .014),
with a low inverse correlation to the FAC inappropriate behavior (r = -.39, p = .007). Low to
moderate correlations were also found between anxiety and delusions (r = .49, p < .001),
disinhibition (r = .45, p = .001), aberrant motor behavior (r = .39, p = .006), and irritability (r =
.35, p = .016). A low inverse correlation was found between apathy and disinhibition (r = -.34, p
= .019). Delusions were moderately correlated with hallucinations (r = .51, p < .001),
disinhibition (r = .47, p = .001), aberrant motor behavior (r = .42, p = .003), and irritability (r =
.38, p = .007). Low correlations were observed between hallucinations and aberrant motor
behavior (r = .45, p = .001) and irritability (r = .37, p = .009). Elation was correlated with no
other psychological instruments. Disinhibition was moderately correlated with aberrant motor
behavior (r = .47, p = .001), and ADAS non cognitive behavior (r = .51, p = .004). Aberrant
motor behavior was weakly correlated with irritability (r = .39, p = .007). Sleep disturbances
were not significantly correlated with other factors.
Physical factors. Correlations between physical factors are presented in Table 5. A very
strong inverse correlation was seen between the CIRS-G and MMSE scores (r = -.96, p = .011).
A moderately strong correlation was seen between MNA and SIB (r = .62, p < .006). SIB scores
had a low inverse correlation with FAC cognition scores (r = -.30, p = .015). The ADAS
cognitive scale was strongly correlated with the FAC cognition scores (r = .88, p < .001). The
MBPC memory scale was moderately correlated with FAC cognition scores (r = .65, p = .030).
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The NPI appetite subscale, HHEI-S, and Pain Scores were not correlated with other measures.
Comparisons were not possible between ADAS cognitive subscale, MBPC memory behaviors
subscale, and HHIE-S and other scales because of small sample sizes of these tools.
Agitation.

Correlations between measures of agitation are presented in Table 6.

Significant low correlations were found between the CMAI and FAC agitation subscale (r = .39,
p = .002). Correlations between CMAI and NPI agitation subscale or FAC and NPI agitation
subscales were not significant.
Performance outcomes. Correlations between measures of quality of life and functional
ability performance outcomes are presented in Table 7. Significant low correlations were found
between the FAC self-care and GDS/FAST scores (r = .43, p < .001). Scores for GDS/FAST
had low correlations with MBPC ADL (r = .40, p = .025), and strong inverse correlations to
ADRQL (r = -.96, p = .010). Scores of instruments measuring quality of life were not correlated
with each other, although sample sizes were small. Correlations between measures of quality of
life and the FAC self-care subscale or MBPC ADL subscale could not be calculated because
these tools were not used in the same studies.
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Table 4. Pearson Correlations: Psychological Measures
NPI HLNs

NPI Elation

NPI Dis-inhibit

NPI Motor

NPI Sleep

NPI Irritability

ADAS Non cog

FAC Inapp.
behav.

.360*

0.098

0.189

.354*

0.228

0.114

0.161

0.215

-0.022 1

.493** -0.221 1

-0.082 -0.001 .505**

-0.074 -0.089 -0.108

.454** -.338* .472**

.391** 0.1

0.207

.346*

0.096 .382**

-0.182 -0.224 0.094

-.385** 0.006

0.172 0.068

1

-0.07 1

-0.02 -0.079 1

.449** -0.091 .469** 1

-0.06 -0.055 0.096

.374** 0.049

-0.05 0.085

0.047 0.036

0.169

.387** .361* 1

.509** 0.165 -0.17 0.058

-0.039

0.075 1

1

-0.005

0.194 0.112 0.14

NPI Delusion
-0.274

1

0.196 -0.037

NPI Apathy

.306*

NPI
NPI
NPI
NPI
NPI
NPI NPI
NPI NPI NPI
ADAS
DisDepress Anxiety Apathy Delusion HLNs Elation
Motor Sleep Irritabilit non cog
inhibit

.423**

NPI Anxiety

1
r

NPI Depress
Results:

NOTE: Neuropsychiatric Inventory (NPI); Depression (Depress); Hallucinations (HLNs);
Alzheimer Disease Assessment Scale (ADAS); Non-cognitive (non cog); Functional Abilities
Checklist (FAC), Inappropriate Behavior (inapp. behav.)
*. Correlation is significant at the 0.05 level (2-tailed).
**. Correlation is significant at the 0.01 level (2-tailed).
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FAC
Cognitive
Status

MBPC
Memory
Behavior
s
ADAS
Cognitive

SIB

SIB

MMSE

MMSE

NPI
Appetite
HHIE-S

HHIE-S

MNA

NPI
Appetite

PainAD

1

MNA

CIRS-G

PainAD

CIRS-G

Table 5. Pearson Correlations: Physiological Measures.
Results:
r

.006 -.338

.171

-.218 -.955* -.443

.a

.a

-.047

1

.052

-.157

-.062 .406

-.029

.a

.a

.056

1

-.505

-.423 -.295

.624**

.a

.a

-.233

1

.a

.a

.029

.a

.a

-.075

1

.387

.130

.a

.a

.a

1

.783

.a

.a

.a

1

.a

.a

-.298*

ADAS
1
.397
.882**
Cognitive
MBPC
1
.651*
Memory
Behaviors
NOTE: Cumulative Illness Rating Scale–Geriatrics (CIRS-G); Mini Nutritional Assessment
(MNA); Severe Impairment Battery (SIB); Memory and Behavior Problem Checklist-1987
(MBPC); Alzheimer Disease (AD); Alzheimer Disease Assessment Scale (ADAS);
Functional Abilities Checklist (FAC), Hearing Handicap Inventory for Elderly Screening
(HHIE-S).
* Correlation is significant at the 0.05 level (2-tailed).
** Correlation is significant at the 0.01 level (2-tailed).
.a = No comparative sample was available.
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Table 6. Pearson Correlations: Agitation Measures.
Results: r Cohen-Mansfield
FAC Agitation
NPI Agitation
Agitation Inventory
subscale
subscale
Cohen-Mansfield
1
.389**
.229
Agitation Inventory
FAC Agitation
1
.211
subscale
NPI Agitation
1
subscale
NOTE: Functional Abilities Checklist (FAC); Neuropsychiatric Inventory (NPI).
** Correlation is significant at the 0.01 level (2-tailed).

Table 7. Pearson Correlations: Performance Outcome Measures.
Results: r FAC
GDS/FAST MBPC ADL ADRQOL QOL-AD
Self-care
FAC Selfcare
GDS/FAST
MBPC
ADL
ADRQOL
QOLAD

1

SF-36v2

.425**

.186

.a

.a

.a

1

.402*

-.959*

-.160

-.224

1

.a

.a

.a

1

.075

.324

1

-.674

NOTE: Functional Abilities Checklist (FAC); Global Deterioration Scale (GDS); Functional
Assessment Staging Tool (FAST); Memory and Behavior Problem Checklist-1987 (MBPC);
Activities of Daily Living (ADL); AD related quality of life (ADRQL); Quality of life in AD
(QOL-AD); Health Survey Short Form (SF-36)
** Correlation is significant at the 0.01 level (2-tailed).
* Correlation is significant at the 0.05 level (2-tailed).
.a = Cannot be calculated because no comparative sample was available.
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Aim 1: Results of Statistical Analysis
Aim 1: Describe the phenomenon of agitated behavioral symptoms in persons with AD within
the Theory of Unpleasant Symptoms.
Hypothesis: The Theory of Unpleasant Symptoms will adequately describe the antecedents and
consequences of agitated behavioral symptoms in persons with AD as determined by the bestfitting path analysis.
The first aim sought to describe the phenomenon of agitated behavioral symptoms in
person with AD within the Theory of Unpleasant Symptoms (TOUS) by constructing a path
model based on the theory, and then determining if the model that best fits the data contains all
important concepts described in the theory. To test the hypothesis that the TOUS adequately
describes all aspects of agitated behavioral symptoms, instruments that best describe the
theoretical concepts were first identified through exploratory factor analysis. Then, a path
analysis of these factors was calculated to identify the model that best fits the data.
Exploratory Factor Analysis
Antecedent Factors.

The TOUS indicates that predictors of symptoms fall into three

categories: situational, psychological, and physiological predictors. Exploratory Factor Analysis
was used to determine which of the instruments measured related concepts. The Missing Values
Analysis identified the instruments which had been used most consistently to provide a complete
sample of 48 participants. The NPI subscales, FAC subscales, and SIB were included in the
analysis. Because the SIB instrument is scored with higher values indicating less impairment,
scores were recoded to inverse scoring to match the scoring scheme for other instruments and aid
in ease of comparison. MBPC subscales, ADAS subscales, ZBI, CIRS-G, Pain Assessment in
AD, MNA, HHEI-S, and MMSE were not included in this analysis.
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The remaining data were suitable for Exploratory Factor. The sample of 48 participants
measured across all 15 instruments is sufficient for the minimum of two observations per
variable, and approaching the preferred ratio of 5-6 observations per variable after further
variables were removed from the analysis pool later in the process (Kim & Mueller, 1978;
Tabachnick & Fidell, 2013). As demonstrated in the correlation matrix previously presented in
Tables 4 and 5, numerous variables had correlations above .30 to further support the use of
exploratory factor analysis for these data.

The Kaiser-Meyer-Olkin Measure of Sampling

Adequacy was above the recommended value of .50 at .632 (Kaiser, 1974). Finally, statistical
significance found in Bartlett’s Test of Sphericity indicates that the correlation matrix provided
by the data is appropriate for factor analysis (Munro, 2005; χ2 = 240.6, p < .001).
The first iteration of the factor analysis revealed that the NPI elation measure did not load
strongly on any factors. This matches findings from the correlation Table 4, and NPI elation was
removed from further analysis. On the next analysis, NPI sleep and apathy subscales were not
loaded strongly on any factors with eigenvalues above 1, and these were also eliminated from
further analysis.
Principal components method of extraction was used to identify factors from SIB scores,
FAC inappropriate behavior and cognitive status subscales, and NPI occupational disruption,
depression, anxiety, delusions, hallucinations, disinhibition, aberrant motor behavior, and
irritability subscales. The percentage of the variance in each variable which is explained by all
extracted factors, or extracted communalities of each factor, is illustrated in Table 8.
The Scree Plot was examine to determine the number of factors that best describe the data
(see figure 4). The scree plot illustrates a marked change in slope after component number 3.
This “elbow” point in the graph illustrates that three factors should be extracted, as further
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factors explain less and less additional variance. The three factor solution is further supported by
the criteria of extracting only factors with eigenvalues greater than 1, as well as matching the
three factors suggested by the TOUS.
Table 8. Communalities between predictor variables
Instrument
Initial
Extraction
NPI Occupational disruptiveness
1.000
0.809
NPI Depression subscale
1.000
0.564
NPI Anxiety subscale
1.000
0.695
NPI Delusions subscale
1.000
0.646
NPI Hallucinations subscale
1.000
0.885
NPI Disinhibition subscale
1.000
0.670
FAC Inappropriate behavior
1.000
0.795
FAC Cognitive Status subscale
1.000
0.432
SIB (Inverse)
1.000
0.671
NPI Aberrant Motor Behavior
1.000
0.549
NPI Irritability subscale
1.000
0.539
NOTE: Neuropsychiatric Inventory (NPI), Functional Abilities Checklist (FAC), Severe
Impairment Battery (SIB).
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Table 9. Total Variance Explained: Predictor Variables
Initial Eigenvalues

2.683 24.388
2.469 22.447
2.104 19.123

Cumulative
%

% of
Variance

3.84 34.946 34.946
2.22 20.134 55.08
1.2 10.877 65.958

Rotation Sums of Squared
Loadings

Total

0.131 1.19

Cumulative
%

11

34.946
55.08
65.958
74.163
82.318
87.802
92.616
95.392
97.54
98.81

% of
Variance

34.946
20.134
10.877
8.205
8.156
5.484
4.813
2.776
2.147
1.27

Extraction Sums of
Squared Loadings

Total

% of
Variance

3.844
2.215
1.197
0.903
0.897
0.603
0.529
0.305
0.236
0.14

Cumulative
%

Total

Component
1
2
3
4
5
6
7
8
9
10

_

24.388
46.835
65.958

100

NOTE: Extraction Method: Principal Component Analysis.

The eigenvalues and percent of explained variance for all possible factors is illustrated in
Table 9. Only the first three factors (components) demonstrated eigenvalues greater than 1.
Together, these three factors explained 65.96% of the total variance. Only rotational calculations
for these three factors were calculated.
Because the factor scores will be used in other analyses, it was important to use orthogonal
rotation methods to assure that the resulting factor scores are not correlated with other factors;
thus avoiding problems with multicollinearity assumptions in multivariate statistical procedures.
Varimax rotation was calculated to simplify interpretation of the factors. As shown in Table 9,
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the rotation procedure does not change the percent of explained variance; it only affects the
distribution of the variance on each factor.
Next, the rotated component matrix was examined to evaluate and name the extracted factors
(Table 10). Factor loadings represent the correlation between scores of individual measures and
each of the factors. The first factor was named “Situation-Caregiver” because it represented the
largest loading for the NPI Occupational disruptiveness subscale. It also contained high loadings
of the FAC cognitive status, and NPI delusions, hallucinations, motor behavior, and irritability
subscales. The second factor was named “Psychological” and contained high loadings for NPI
depression, anxiety, delusions, disinhibition, motor behavior, irritability, and occupational
disruptiveness subscales. The third factor was named “Physical-Cognitive” and contained high
loadings for the inverse SIB scores, FAC cognitive status and inappropriate behavior subscales,
and NPI depression subscale. Because several variables were significantly loaded onto more
than one factor, a simple structural solution was not achieved.
Table 10. Rotated Component Matrix: Predictor Variables
Component
Variable
1
2
NPI Occupational disruptiveness
0.652
0.614
NPI Depression
0.370
NPI Anxiety
0.820
NPI Delusions
0.667
0.444
NPI Hallucinations
0.901
NPI Disinhibition
0.805
FAC Inappropriate behavior
NPI Motor Behavior
0.570
0.455
NPI Irritability
0.665
0.304
FAC Cognitive Status
0.358
SIB (Inverse)

3
-0.598

0.887

0.520
0.801

NOTE: Neuropsychiatric Inventory (NPI); Functional Assessment Checklist (FAC); Severe
Impairment Battery (SIB). Extraction Method: Principal Component Analysis; Rotation
Method: Varimax with Kaiser Normalization.
Small factor loadings >0.3 are suppressed.
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The magnitude of the rotation applied to the original factors to obtain the rotated factor
solution was surveyed in the Component Transformation Matrix. By examining the scores
outside of the center diagonal (scores 1, 1; 2, 2; 3, 3) it was determined that the rotation for
components one and two were large with all rotations above 0.5. Component 3 was calculated
with a small rotation because all transformations in column 3 were below 0.5.
Agitation. Agitation was measured by the CMAI, FAC agitation subscale, and NPI agitation
subscale. There were 48 complete cases available for analysis. The KMO Measure of sampling
adequacy was at the low, but acceptable (KMO = .59).

Bartlett’s Test of Sphericity was

significant only at the .05 level (χ2 = 10.146, p = .017), indicating that the data may not be
perfectly suited for exploratory factor analysis, but still acceptable. There was also a moderate
correlation between FAC agitation and CMAI scores (Table 6: r = .39, p < .01), further
supporting the application of exploratory factor analysis.
The communalities of extracted variance shown in Table 11 indicate that the NPI agitation
subscale had the least variance explained by the factor analysis (37.6%). The FAC agitation
subscale and CMAI had similar percentages of variance explained by the extracted factor. Table
12 illustrates that only one factor was extracted. This factor explained only 51.69% of the total
variance of all three measures.

Factor rotation was not possible as only one factor was

calculated.
Table 11. Communalities between Agitation Measures

FAC Agitation subscale
NPI Agitation subscale
CMAI

Initial
1.000
1.000
1.000

Extraction
.578
.376
.596

NOTE: Functional Abilities Checklist (FAC); Neuropsychiatric Inventory (NPI); CohenMansfield Agitation Inventory (CMAI).
Extraction Method: Principal Component Analysis.
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Table 12. Total Variance Explained: Agitation Factor
Initial Eigenvalues
_
Extraction Sums of Squared Loadings
Component
Total
% of
Cumulative
Total
% of
Cumulative
Variance
%
Variance
%
1
1.551
51.694
51.694
1.551
51.694
51.694
2
0.824
27.477
79.171
3
0.625
20.829
100.000
NOTE: Extraction Method: Principal Component Analysis.

The factor loading of each of the three agitation measures on the single extracted factor is
shown in Table 13. The correlation of the NPI agitation subscale and the extracted factor was
.61. The FAC agitation subscale and CMAI each had higher factor loadings, indicating a higher
correlation between these measures and the factor score.
Table 13. Agitation Component Matrix
Component 1
FAC Agitation subscale
0.761
NPI Agitation subscale
0.613
CMAI
0.772
NOTE: Functional Abilities Checklist (FAC); Neuropsychiatric Inventory (NPI); CohenMansfield Agitation Inventory (CMAI).
Extraction Method: Principal Component Analysis. One component extracted.

Performance Outcomes.

The functional abilities aspect of the performance outcome

theoretical concept was measured by the FAC self-care subscale and GDS/FAST scale. There
were 48 complete cases available for analysis. Other measures of functional performance were
not included in the analysis because of the lack of overlapping cases. The KMO Measure of
sampling adequacy was at the lowest range of acceptable values (KMO = .50). Bartlett’s Test of
Sphericity was significant (χ2 = 12.25, p < .001), indicating that the data are acceptable for
exploratory factor analysis.

There was a moderate correlation between FAC self-care and

GDS/FAST scores (Table 7: r = .43, p < .001).
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The communalities of extracted variance indicate that both measures of functional ability had
71% of their variances explained by the extracted factor (named Functional Performance factor).
Table 14 illustrates that the single factor describing both measures accounted for 71% of the total
explained variance. Factor rotation was not possible as only one factor was calculated. Finally,
the component matrix indicated that both the FAC self-care subscale and GDS/FAST scores had
a factor loading of .844. This factor loading shows that the correlation between original FAC
self-care and GDS/FAST scores had a correlation of .84 with the extracted factor.
Table 14. Total Variance Explained: Performance Outcome Factor
Initial Eigenvalues
Extraction Sums of Squared Loadings
Component
1
2

Total
1.425
0.575

% of
Variance
71.251
28.749

Cumulative
%
71.251
100.000

Total
1.425

% of
Variance
71.251

Cumulative
%
71.251

NOTE: Extraction Method: Principal Component Analysis.
Path Analysis
Before analyzing the path analysis, the data were checked against the assumptions for path
analysis. Path analysis has several assumptions in common with multiple regression, as well as
unique assumptions for path analysis. Theoretically-based assumptions that are unique to this
method include the assumption that the independent and dependent variables are correlated,
independent variables occur before dependent variables in time, and that the relationship
between independent and dependent variables is nonspurious and does not disappear when
effects of additional variables are controlled (Munro, 2005). The first two assumptions are met
through the theory that guided the construction of the model; the third assumption is difficult to
confirm with certainty because all possible confounding variables cannot be measured with
certainty.
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Statistically-based assumptions for path analysis also assume that correlated, independent
variables have a relationship that is represented by the size of their correlation coefficients, since
these relationships cannot be directly measure with this method (Munro, 2005).

Since

independent variables were rotated factors, their correlation was zero and the assumption was
met. The model is assumed to be recursive: it moves only in one direction (Munro, 2005). This
assumption was met by all proposed relationships moving from the independent variables toward
the dependent variables. Variables should include interval level data, although occasionally
dummy-coded data can be acceptable (Munro, 2005).

In this analysis, all variables were

measured on ratio and interval level scales. Finally, path analysis assumes that all variables are
measured without error (Munro, 2005). The data included in this model approached a lack of
measurement error as no outliers were observed and all measures had good psychometric
properties.
Statistical assumptions are identical to assumptions of regression analysis (Munro, 2005). It
is assumed that relationships between the exogenous and endogenous variables are linear, and
other patterns of relationships are not interpreted. Residual differences between observed values
and values predicted by the line of regression are not correlated with other residual values and
also not correlated with exogenous variables in the model.
Using the factors calculated above, the path model following the TOUS was constructed and
tested (see Figure 5). The goodness-of-fit between the model and the data was evaluated with a
chi-square test. The null hypothesis stated that the model was consistent with the data. The chisquare of Model A was statistically significant and the null hypothesis was rejected; the model
was not a good fit for the data (χ2= 24.68, df = 3, p <.001).
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To identify a better fitting model, the analysis was modified to include direct paths between
predictors and Functional Performance. A strong relationship was found between the predictor
Physical: Cognitive factor and Functional Performance outcome factor. The fit of Model A was
improved upon by adding the direct effects of the predictor Physical: Cognitive factor to the
Functional Performance factor as the outcome (see Figure 6). The chi-square results of this
model indicate that the null hypothesis could not be rejected and Model B is consistent with the
data (χ2= 2.418, df = 2, p =.299).

Figure 5. Path Model A
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Figure 6. Path Model B

According to Pedhazur (1982), larger probabilities for the chi-square goodness-of-fit test
indicate the best fitting model. To explore if the model could be further optimized to fit the data,
two additional paths were investigated. Since the only statistically nonsignificant path calculated
in Model B was the path from Agitation to the Functional performance outcome, this path was
removed. The resulting model, labeled Model C, is displayed in Figure 7. The removal of the
path between Agitation and Functional Performance did increase p value of the statistical
significance of the model compared to the first two iterations (χ2 = 2.518, df = 3, p =.472).
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Figure 7. Path Model C

The model indices were then modified a final time to reverse the direction of the relationship
between Agitation and Functional Performance. The final model, labeled Model D, is illustrated
in Figure 8. Model D provided the best fit to the data (χ2 = 1.049, df = 2, p =.592). Further
modifications resulted in no further improvements in model fit.
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Figure 8. Path Model D
This final model partially supports the hypothesis of Aim 1. All three of the predicted
antecedents to agitation are present in the final model, and have been assigned as interrelated
predictors of agitation as described in the TOUS. The symptom of agitation is influenced by the
situational, psychological, and physical antecedent factors, which is consistent with the
relationship predicted by the TOUS. The outcome of function performance is present in the final
model; however the model best fitting the data suggests that the relationship flows in the
opposite direction as predicted by the TOUS. Rather than functional performance being the
result of agitation, the model suggests that agitation is generally the result of greater functional
impairment, although the exact relationship was not statistically significant. The regression
coefficients derived from Model D are examined in detail in the following sections describing
statistics for Aims 2 and 3.
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Aim 2: Results of Statistical Analyses
Aim 2: Determine the effect of situational (physical and social environment), psychological
(anxiety and depression), and physiological factors (comorbidities, pain, nutritional status,
hearing, cognitive impairment, and fatigue) on agitation in persons with AD.
Hypothesis:
(1) Supportive and stimulating physical and social environments will have a negative direct
effect on agitation.
(2) Comorbid psychological states will have a positive direct effect on agitation.
(3) Comorbid physical conditions, pain, inadequate nutritional status, hearing loss, cognitive
impairment, and fatigue will have a direct positive effect on agitation.
Aim 2 was tested with the examining the regression coefficients in the path analysis model
best fitting the data. The magnitude, direction, and significance of the path coefficients from the
situational, psychological, and physical factors to agitation are evaluated. Bivariate relationships
(Pearson’s correlation) between individual situational, psychological, and physical measures and
the agitation measures are also examined to support these hypotheses.
Regression results from Path Analysis
The regression coefficients from the exogenous predictor variables (Situation-Caregiver,
Psychological, and Physical-Cognitive factors) to Agitation and Agitation to Functional
Performance are given in Table 15. Standardized path coefficients are used to allow for direct
comparisons between different paths. All three of the exogenous predictor variables (SituationCaregiver, Psychological, and Physical-Cognitive factors) have statistically-significant, positive
effects on Agitation, supporting hypotheses 1, 2, and 3 of aim 1. Taken together, the predictors
explain approximately 63% of the variance in Agitation (R2 = .628).
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Table 15. Path Coefficients for Predictors of Agitation
Variables
Unstandardized
Coefficients
Outcome
Predictor
B
S.E.
P
Agitation
<--Situation- Caregiver
0.509 0.09 < .001
Agitation
<--Psychological
0.446 0.09 < .001
Agitation
<--Physical- Cognitive
0.583 0.179 0.001
Agitation
<--- Functional- Outcome -0.207 0.18 0.251
Functional
<--Physical- Cognitive
0.858 0.097 < .001
Outcome
NOTE: Standard Error = S.E.;
R2 = Squared Multiple correlation for dependent variables.

Standardized R2
Coefficients
ß
0.504
0.442
0.579
-0.217
.628
0.812
.660

Next, the paths were evaluated for direct, indirect, total, and spurious effects on agitation.
The effects in table 16 were calculated with the decomposition of path correlations method
(Smyth & Yarandi, 1992).

Taking into consideration the indirect effect of the Physical-

Cognitive factor on Agitation, it was determined that the strongest relationship was demonstrated
in the effect of the Situation-Caregiver factor to the Agitation factor (B = .509, p <.001). Of note
was the spurious component calculated from the product of the direct effects of PhysicalCognitive to Agitation and Physical-Cognitive to Functional Performance paths, added to the
direct effect of Functional Performance on Agitation. This finding suggests that Functional
Performance and Agitation have the Physical-Cognitive factor as a common cause.

Table 16. Direct, Indirect, and Total Effects on Agitation
Effect
Variable
Direct
Indirect
Total
Spurious
Situation-Caregiver
0.504
0
0.504
0
Psychological
0.442
0
0.442
0
Physical-Cognitive
0.579
-0.176
0.403
0
Functional Outcome
-0.217
0
-0.217
0.470
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Other Analyses for Aim 2
Hypothesis 1. To further examine the hypothesis that supportive and stimulating physical
and social environments will have a negative direct relationship with agitation, correlations
between agitation measures (FAC agitation subscale, CMAI, and NPI agitation subscale) and
individual measures of situation were examined in Table 17. For the 5 participants with both
ZBI and CMAI scores measured, there was a very strong correlation between caregiver burden
and cognitive impairment (r = .96, p = .006). The NPI occupational disruptiveness subscale was
moderately correlated with both CMAI (r = .55, p < .001) and NPI agitation measures (r = .58, p
< .001). Agitation as measured by the FAC was not correlated with any measures of the social
environment. Caregiver reactions as measured by the MPBC subscales were not correlated with
measures of agitation.

This exploratory evidence from individual correlation calculations

partially supported hypothesis 1 of aim 2: additional individual measures of caregiver burden
were correlated with measures of agitation with the exception of the FAC agitation subscale and
MBPC caregiver subscales in a small community sample.
Table 17. Pearson Correlation of Agitation and Social Environment Measures
Results: r
Agitation Measures
Social Environment Measures
CMAI
FAC Agitation
NPI Agitation
Zarit Burden Interview Score .956**
.a
.a
n=5
MBPC .a
.274
.a
Memory and Behavior Caregiver reaction
n = 11
MBPC .a
.283
.a
ADL Caregiver reaction
n = 11
NPI Occupational disruptiveness .552**
.119
.583**
n = 48
n = 48
n = 48
NOTE: Memory and Behavior Problem Checklist-1987 (MBPC); Activities of Daily Living
(ADL); Neuropsychiatric Inventory (NPI); Cohen Mansfield Agitation Inventory (CMAI);
Functional Abilities Checklist (FAC), Hearing Handicap Inventory for Elderly Screening
(HHIE-S).
** Correlation is significant at the 0.01 level (1-tailed).
.a = No comparative sample available.
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Hypothesis 2. To further examine the hypothesis that the comorbid psychological states
will have a positive direct relationship with agitation, correlations between psychological
measures and agitation measures were examined in Table 18. The NPI depression (r = .39, p =
.007) and anxiety (r = .41, p = .004) subscales had a weak association with CMAI. A moderate
correlation was observed between the NPI delusion subscale and the CMAI (r =.52, p < .001); it
also demonstrated a weak correlation with the NPI agitation subscale (r =.36, p = .011). NPI
hallucinations subscale was weakly correlated with the NPI agitation subscale (r =.40, p = .004).
The NPI disinhibition (r = .59, p < .001) and aberrant motor behavior subscales (r = .50, p <
.001) both demonstrated a moderate relationship with the CMAI; NPI aberrant motor behavior
was also weakly correlated with NPI agitation (r = .29, p = .048). NPI sleep subscale was
weakly correlated with the FAC agitation subscale (r =.31, p = .035). The NPI irritability
subscale demonstrated moderate correlation with both the CMAI (r = .51, p < .001) and the NPI
agitation subscales (r = .68; p < .001). The ADAS non-cognitive behavioral subscale had a weak
correlation with the FAC agitation subscale (r =.47, p = .001). The FAC inappropriate behavior
subscale was weakly correlated with the NPI agitation subscale (r =.29, p = .048).

No

correlations were observed between NPI apathy or elation subscales and any measures of
agitation.
Overall, the FAC agitation subscale had the fewest correlations with psychological
measures. The CMAI and NPI agitation subscales were similarly correlated with psychological
measures. Only the NPI delusions, aberrant motor behavior, and irritability subscales were
correlated with more than one measure of agitation. This exploratory evidence from individual
correlation calculations partially supported hypothesis 2 of aim 2: most individual measures of
comorbid psychological states were correlated with at least one measure of agitation.
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Table 18. Pearson Correlations of Agitation and Psychological Measures
Results: r
Psychological
Measures
NPI Depression
NPI Anxiety
NPI Apathy
NPI Delusions
NPI
Hallucinations
NPI Elation
NPI
Disinhibition
NPI Aberrant
Motor Behavior
NPI Sleep
NPI Irritability

CMAI
.385**
n = 48
.410**
n = 48
-.222
n = 48
.518**
n = 48
.213
n = 48
-.057
n = 48
.588**
n = 48
.503**
n = 48
.241
n = 48
.508**
n = 48
.251
n = 30

Agitation Measures
FAC Agitation
-.098
n = 48
.064
n = 48
-.076
n = 48
.134
n = 48
-.015
n = 48
.144
n = 48
.267
n = 48
.171
n = 48
.305*
n = 48
.176
n = 48
.465**
n = 51

NPI Agitation
-.051
n = 48
.110
n = 48
.114
n = 48
.362*
n = 48
.404**
n = 48
.095
n = 48
.062
n = 48
.287*
n = 48
.116
n = 48
.676**
n = 48
.205
n = 30

ADAS Noncognitive
Behavioral
FAC
.135
.210
.287*
Inappropriate
n = 59
n = 81
n = 48
behavior
NOTE: Cohen-Mansfield Agitation Inventory (CMAI); Functional Abilities
Checklist (FAC); Neuropsychiatric Inventory (NPI); Alzheimer Disease
Assessment Scale (ADAS).
* Correlation is significant at the 0.05 level (1-tailed).
** Correlation is significant at the 0.01 level (1-tailed).

Hypothesis 3. Correlations between physical measures and agitation measures were
examined in Table 19 to further examine the hypothesis that physical aspects of health including
comorbid physical conditions, pain, inadequate nutritional status, hearing loss, cognitive
impairment, and fatigue have a direct, positive relationship with agitation.

There was a
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moderately strong correlation between scores on Pain in Advanced Dementia measure and the
CMAI (r =.69, p = .001). A strong inverse correlation was observed between MMSE and CMAI
scores (r = -.82, p = .045). A weak inverse correlation was observed between and SIB scores
and NPI agitation (r = -.28; p = .028). No correlations were observed between the FAC agitation
subscale and any physical measures. No correlations were observed between agitation and
CIRS-G, MNA, NPI appetite subscale, or the HHIE-S measures.
This exploratory evidence from individual correlation calculations partially supported
hypothesis 3 of aim 2: few additional individual measures of comorbid physical conditions were
correlated with measures of agitation. Individual measures of physical conditions were not
correlated with more than one measure of agitation. Measures of cognitive impairment (MMSE
and SIB) were correlated with agitation measures as identified in the path model. Additionally,
only pain was identified as a physical measure correlated with agitation.
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Table 19. Pearson Correlations of Agitation and Physical Measures
Results: r
Physical
Measures
Cumulative
Illness Rating
Scale-Geriatrics
Pain AD
Mini Nutritional
Assessment
NPI Appetite
subscale
HHIE-S

Cohen-Mansfield
Agitation
Inventory
.199
n = 18
.689**
n = 18
-.104
n = 18
-.066
n = 48
.030
n=5
-.818*
n=5

Agitation Measures
a
FAC Agitation
NPI Agitation subscale
subscale
-.150
n = 13

.006
n = 13

.263
n = 13
-.021
n = 13
-.187
n = 48
.a

.334
n = 13
.107
n = 13
.058
n = 48
.a

Mini Mental
.a
.a
State Exam
Composite
Severe
-.102
-.173
-.279*
Impairment
n = 66
n = 67
n = 48
Battery
NOTE: Cohen-Mansfield Agitation Inventory (CMAI); Functional Abilities Checklist
(FAC); Neuropsychiatric Inventory (NPI); Hearing Handicap Inventory for the
Elderly – Short Form (HHIE-S); Alzheimer Disease Assessment Scale (ADAS).
* Correlation is significant at the 0.05 level (1-tailed).
** Correlation is significant at the 0.01 level (1-tailed).
.a = No comparative sample available.

Aim 3:
Aim 3: Determine the effect of situational, psychological, physical antecedent factors and
agitation on performance outcomes (functional status and quality of life) in persons with AD.
Hypothesis:
(1) Supportive and stimulating physical and social environments will have an indirect
positive effect on functional status and quality of life through reduced agitation.
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(2) Comorbid psychological states will have an indirect negative effect on functional status
and quality of life through increased agitation.
(3) Comorbid physical conditions, pain, nutritional status, hearing loss, cognitive
impairment, and fatigue will have an indirect negative effect on functional status through
increased agitation.
(4) Agitation will have a negative direct effect on functional status and quality of life.
Aim 3 is tested by examining the regression coefficients in the path analysis model best
fitting the data.

The magnitude, direction, and significance of the path coefficients from

situational, psychological, and physical factors to functional ability are evaluated. The paths
from agitation to functional ability are also examined.

Bivariate relationships (Pearson’s

correlation) between individual measures and the functional performance outcome were also
examined to test these hypotheses.
Regression results from Path Analysis
The regression coefficients from the exogenous predictor Physical-Cognitive factor to the
Functional Performance factor and from the Functional Performance Factor to Agitation are
given in Table 15. This model indicated that only the Physical-Cognitive exogenous predictor
factor had a significant effect on the Functional Performance factor (B = 0.858, p < .001). The
direct effect of the Physical-Cognition factor on the Functional Performance factor explained
about 66% of the variance in Functional Performance (R2 = .660).

This finding supports

hypothesis 3 to the extent that the Physical-Cognition factor has an effect on Functional
Performance, but provides evidence against hypothesis 1 and 2 as no relationships between
Situation-Caregiver or Psychological factors and the Functional Performance factor were found.
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The path model suggests that there is no important relationship between agitation and
functional performance (B = -0.207, p = .47; Table 15). Rather, the path model indicates that
both agitation and functional performance are the result of the Physical-Cognitive factor
(spurious effect B = .470; Table 16). Hypothesis 4 is not supported by these data.
Additional Analyses to test Aim 3:
Hypothesis 1. Correlations were calculated between situational measures and measures
of functional outcomes to explore the hypothesis that supportive and stimulating physical and
social environments will have a positive relationship with functional status and quality of life
(Table 20). Zarit Burden Inventory was strongly correlated with GDS/FAST scores (r = .83, p =
.042), and also had a strong negative correlation with ADRQL scores (r = -.93; p = .013) in the 5
participants who had all measures. The MBPC caregiver reaction to ADL subscale was weakly
correlated with the MBPC ADL subscale (r = .34, p = .028). No correlations were observed
between MBPC or NPI occupational disruptiveness scales and measures of functional
performance outcomes. Overall, exploratory evidence from individual correlation calculations
partially supported hypothesis 1 of aim 3: additional individual measures of caregiver burden
were correlated with measures of functional status and quality of life.
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Table 20. Pearson Correlations of Functional Performance and Situational Measures
Results: r
Functional Status Measures
Quality of Life Measures
FAC
GDS/FAST MBPC ADRQL QOL AD
Health
Self-care
ADL
Survey
SF-36v2
Zarit Burden
.a
.a
-.310
-.100
.828*
-.923*
Interview Score
n=5
n=5
n=5
n=5
MBPC Memory
-.031
.303
.143
.a
.a
.a
and Behavior
n = 11
n = 28
n = 28
Caregiver reaction
subscale
MBPC ADL
-.059
.284
.a
.a
.a
.341*
Caregiver reaction n = 11
n = 28
n = 28
subscale
NPI Occupational
disruptiveness
subscale

.023
n = 48

.111
n = 30

.a

.a

.a

.a

NOTE: Memory and Behavior Problem Checklist-1987 (MBPC); Activities of Daily Living
(ADL); Neuropsychiatric Inventory (NPI); Cohen Mansfield Agitation Inventory (CMAI);
Functional Abilities Checklist (FAC), Global Deterioration Scale/Functional Assessment
Staging Tool (GDS/FAST). Alzheimer Disease Related Quality of Life (ADRQL), Quality
of Life in Alzheimer Disease (QOLAD)
* Correlation is significant at the 0.05 level (1-tailed).
** Correlation is significant at the 0.01 level (1-tailed).
.a = No comparative sample available.

Hypothesis 2. Correlations were calculated between psychological measures and measures
of functional outcomes to explore the hypothesis that comorbid psychological states will have a
negative relationship with functional status and quality of life (Table 21). A weak correlation
was measured between NPI apathy and FAC self-care subscales (r = .30, p =.018). A weak
correlation was also measured between the ADAS non-cognitive behavioral and FAC self-care
subscale (r = .32, p =.010). The FAC inappropriate behavior subscale was moderately correlated
with both the FAC self-care subscale (r = .41, p <.001) and GDS/FAST scores (r = .49, p <.001).
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Table 21. Pearson Correlations of Functional Performance and Psychological Measures
Results: r
Functional Status Measures
Quality of Life Measures
Psychological
FAC
GDS/FAST MBPC ADRQL
QOLHealth
Measures
Self-care
ADL
AD
Survey
SF-36v2
NPI Depression
-.126
-.062
.a
.a
.a
.a
n = 48
n = 30
NPI Anxiety
.021
-.051
.a
.a
.a
.a
n = 48
n = 30
NPI Apathy
.303*
.241
.a
.a
.a
.a
n = 48
n = 30
NPI Delusions
-.001
.024
.a
.a
.a
.a
n = 48
n = 30
NPI Hallucinations
.021
.007
.a
.a
.a
.a
n = 48
n = 30
NPI Elation
.201
-.046
.a
.a
.a
.a
n = 48
n = 30
NPI Disinhibition
-.084
-.058
.a
.a
.a
.a
n = 48
n = 30
NPI Aberrant motor
.095
.208
.a
.a
.a
.a
behavior
n = 48
n = 30
NPI Sleep
.043
-.032
.a
.a
.a
.a
n = 48
n = 30
NPI Irritability
.129
.036
.a
.a
.a
.a
n = 48
n = 30
ADAS Non-cognitive .324*
.133
.271
.a
.a
.a
behavioral
n = 51
n = 52
n = 10
FAC Inappropriate
.485**
-.083
.a
.a
.a
.408**
behavior
n = 81
n = 62
n = 11
NOTE: Cohen-Mansfield Agitation Inventory (CMAI); Functional Abilities Checklist
(FAC); Neuropsychiatric Inventory (NPI); Alzheimer Disease Assessment Scale (ADAS)
Memory and Behavior Problem Checklist-1987 (MBPC); Activities of Daily Living (ADL);
Neuropsychiatric Inventory (NPI); Global Deterioration Scale/Functional Assessment
Staging Tool (GDS/FAST). Alzheimer Disease Related Quality of Life (ADRQL), Quality of
Life in Alzheimer Disease (QOL-AD).
* Correlation is significant at the 0.05 level (1-tailed).
** Correlation is significant at the 0.01 level (1-tailed).
.a = No comparative sample available

No correlations were found between functional status measures and NPI depression, anxiety,
delusions, hallucinations, elation, disinhibition, aberrant motor behavior, sleep, or irritability
subscales. Comparative samples were not available to calculate correlations for measures of
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quality of life. MBPC ADL scores could only be compared to ADAS non-cognitive behavioral
and FAC inappropriate behavior subscales, though no correlations were found. In general, this
exploratory evidence from individual correlation calculations demonstrates further evidence
against hypothesis 2 of aim 3: additional individual psychological measures were not well
correlated with measures of functional status with the exception correlations between functional
status and general measures of AD-related behavioral symptoms (ADAS non-cognitive
behavioral subscale and FAC Inappropriate behavior subscale) and the NPI apathy subscale.
Hypothesis 3. Correlations were calculated between physical measures and measures of
functional outcomes to explore the hypothesis that comorbid physical conditions, pain,
nutritional status, hearing loss, cognitive impairment, and fatigue will have a negative
relationship functional status and quality of life (Table 22). CIRS-G scores were moderately to
highly correlated with FAC self-care (r = .60, p =.015), and GDS/FAST functional status
measures (r = .93; p = .011). CIRS-G scores had a strong inverse correlation with the ADRQL
measure of quality of life (r = -.93, p = .011) for the 5-13 participants with measurements.
Nutritional status measured by the MNA was strongly correlated with QOLAD measures (r =
.90, p = .019, n = 5). Hearing scores were strongly correlated with quality of life measured on
the SF-36 (r = .83, p = .042, n = 5). Mini mental state exam scores had a strong inverse
correlation with GDS/FAST measures of functional status (r = -.84, p = .036, n = 5), and were
strongly correlated with quality of life as measured by the ADRQL (r = .91, p = .017, n = 5).
Cognition as measured by the SIB had a moderate inverse correlation with FAC self-care (r = .57, p < .001, n = 67) and GDS/FAST functional status measures (r = -.54, p = .015, n = 53), and
a very strong positive relationship with ADRQL (r = .97, p = .004, n = 5).
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Correlations between Pain AD and the NPI appetite subscale with measures of functional
performance outcomes and were not observed. Correlations between physical measures and the
MBPC ADL subscale could not be calculated due to lack of overlapping participants. Many of
the correlations that were observed were based on small samples of less than 15 participants and
should be interpreted with caution. The results of these exploratory analyses provided evidence
that partially supported hypothesis 3 of aim 3: some individual measures of comorbid physical
conditions were correlated with measures of functional status and quality of life.
Table 22. Pearson Correlations of Functional Performance and Physical Measures
Results: r
Functional Status Measures
Quality of Life Measures
(p)
Physical
FAC SelfGDS/FAST
MBPC
ADRQL QOL AD Health
Measures
care
ADL
Survey
SF-36v2
CIRS-G
.a
-.931*
.192
-.395
.603*
.931*
n = 13
n=5
n=5
n=5
n=5
PainAD
.210
-.691
.a
.475
.140
-.155
n = 13
n=5
n=5
n=5
n=5
MNA
-.441
-.085
.a
.113
-.694
.899*
n = 13
n=5
n=5
n=5
n=5
NPI Appetite
.010
-.025
.a
.a
.a
.a
subscale
n = 48
n = 30
HHIE-S
.a
-.250
.a
.255
-.215
.826*
n=5
n=5
n=5
n=5
Mini Mental
.a
.a
-.344
.617
-.844*
.908*
State Exam
n=5
n=5
n=5
n=5
Severe
.a
.300
.098
-.572**
-.543**
.967**
Impairment
n = 67
n = 53
n=5
n=5
n=5
Battery
NOTE: Cumulative Illness Rating Scale-Geriatrics (CIRS-G); Mini Nutritional Assessment
(MNA); Neuropsychiatric Inventory (NPI); Hearing Handicap Inventory for the Elderly –
Short Form (HHIE-S); Severe Impairment Battery (SIB); Functional Abilities Checklist
(FAC); Global Deterioration Scale/Functional Assessment Staging Tool (GDS/FAST);
Memory and Behavioral Problems Checklist, Activities of Daily Living (MBPC ADL);
Alzheimer Disease Related Quality of Life (ADRQL), Quality of Life in Alzheimer Disease
(QOLAD).
* Correlation is significant at the 0.05 level (1-tailed).
** Correlation is significant at the 0.01 level (1-tailed).
.a = No comparative sample available.
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Hypothesis 4. Correlations were calculated between agitation measures and measures of
functional performance to explore the hypothesis that agitation will have a negative relationship
functional status and quality of life (Table 23). Weak correlations were found between the
CMAI and GDS/FAST measure of functional status (r = .31; p = .018, n = 47), as well as a
strong inverse relationship between the CMAI and ADRQL (r = -.96, p = .006, n = 5). The FAC
agitation subscale had a weak correlation with the FAC self-care subscale (r = .19, p = .040, n =
83). Agitation measured by the NPI agitation subscale had no significant correlations with
functional status measures, although the weak correlation with the FAC self-care subscale
approached significance (r = .23, p = .057, n = 5). Correlation calculations were limited by small
sample size for quality of life measures with little overlap in observed participants.

This

evidence from individual correlation calculations partially supported hypothesis 4 of aim 1: some
individual measures of agitation were correlated with individual measures of functional status
and quality of life.
Table 23. Pearson Correlations of Functional Performance and Physical Measures
Results: r
Functional Status Measures
Quality of Life Measures
(p)
Physical
FAC SelfGDS/FAST
MBPC
ADRQL QOL- Health Survey
Measures
care
ADL
AD
SF-36v2
CMAI
.042
.a
.192
-.106
.306*
-. 955**
n = 61
n = 47
n=5
n=5
n=5
FAC
-.165
.250
.a
.a
.a
.193*
Agitation
n = 83
n = 64
n = 11
NPI Agitation
.231
.131
.a
.a
.a
.a
n = 48
n = 30
NOTE: Cohen-Mansfield Agitation Inventory (CMAI); Functional Abilities Checklist (FAC);
Neuropsychiatric Inventory (NPI); Hearing Handicap Inventory for the Elderly – Short Form
(HHIE-S); Alzheimer Disease Assessment Scale (ADAS), Global Deterioration
Scale/Functional Assessment Staging Tool (GDS/FAST). Alzheimer Disease Related Quality of
Life (ADRQL), Quality of Life in Alzheimer Disease (QOLAD).
*. Correlation is significant at the 0.05 level (1-tailed).
**. Correlation is significant at the 0.01 level (1-tailed).
.a = No comparative sample available.
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CHAPTER 5: DISCUSSION
The central purpose of this dissertation was to test a model of agitated behavioral
symptoms in persons with Alzheimer disease within the framework defined by the Theory of
Unpleasant Symptoms (TOUS; Lenz et al., 1995). Specifically, this dissertation sought to (1)
describe the phenomenon of agitated behavioral symptoms in persons with AD within the
constructs predicted in the TOUS; (2) to investigate the relationships between situational,
psychological, and physiological factors on agitated behavioral symptoms in persons with AD;
and (3) to investigate the relationships between functional performance outcomes and situational,
psychological, and physiological factors and agitated behavioral symptoms. To a large extent,
the TOUS was found to accurately predict most (though not all) of the observed relationships.
This discussion is divided into three main sections. The first section describes the
conclusions drawn from study results and compares them to expected findings from extant
literature. Second, limitations of the results interpretation and study methods are discussed. The
chapter concludes with recommendations for future research.
Research Conclusions
Support for the Theory of Unpleasant Symptoms
The TOUS is a middle-range theory developed to guide research and practice around a
variety of unpleasant symptom experiences (Lenz et al., 1997). It was originally developed to
describe linear relationships between influential factors, symptoms, and outcomes (Lenz & Gift,
1998). Later, authors expanded the TOUS to more broadly consider interrelationships between
predictors and reciprocal interactions between symptoms, outcomes and predictors. Therefore,
the original version of the TOUS was selected to guide the hypotheses and path model in the
present study.

The TOUS defined variables of interest by category and relationship to
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symptoms. Main study results pertaining to the variables and relationships hypothesized by the
TOUS are discussed first, followed by a discussion of results by individual variables.
Variables.

Overall, the TOUS provided a good framework for identifying and

categorizing variables that may affect agitation. The antecedent category contained three types
of variables (physiologic, psychologic, and situational) that are thought to influence a single
symptom (agitation) that is measured by its distress, duration, intensity, and quality.

The

performance outcome category includes functional status, and was theorized to be affected by the
symptom. These variables were all represented to some extent within the final path model.
Situation-Caregiver. This study measured the antecedent concepts with eleven
instruments.

The exploratory factor analysis identified three factors summarizing the

instruments that corresponded to the three antecedent categories proposed by the TOUS. The
concept of situational antecedents paralleled to the factor named Situation-Caregiver.

The

Situation-Caregiver factor included occupational disruption measured on the NPI as well as
measures of delusions, and partially measured hallucinations, aberrant motor behavior,
irritability, and cognitive status measured by the FAC.
The NPI occupational disruptiveness scale has previously been applied to the
measurement of caregiver burden, especially for professionals caring for those with AD in
institutional settings (Tan, Wong, & Allen, 2005). In such environments, the NPI Occupational
Disruptiveness (OD) subscale measures staff burnout that results in added costs, staff turnover,
and impedes optimal care (Tan et al., 2005). Outward expressions of hallucinations, delusions,
irritability, and aberrant motor behaviors rather than inward depression, anxiety or cognitive
decline aggravate caregiver burden, which supports the identification of these outward and
inward variables into separate factors (Hiyoshi-Taniguchi, Becker, & Kinoshita, 2018; Reed et
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al., 2020; Tan, 2005). The FAC cognitive status subscale was not expected to be loaded onto the
caregiver burden factor as previous studies have found cognition to be unrelated to caregiver
burden (Reed et al., 2020). Although the FAC cognitive status scale loaded minimally onto the
Situation-Caregiver factor, it loaded more strongly onto the Physical-Cognitive factor.
Psychological. The Psychological factor was primarily defined by NPI anxiety,
depression, and disinhibition with minor loadings of occupational disruptiveness, delusions,
motor behavior, and irritability. This factor structure is generally consistent with symptom
cluster “emotion and disinhibition” which includes depression and disinhibition identified by
Nagata and colleagues (2016).

The variables describing the Psychological factor are also

consistent with AD-related impairments of the neural networks connecting with the angular
cingulate cortex which is thought to cause deficits in emotional regulation and impulse control
(dos Santos Tascone & Bottino, 2013).
Physical-Cognitive. The final predictor factor was named Physical-Cognitive and was
defined by the SIB scores, FAC cognitive status, FAC inappropriate behaviors, and had a
negative factor load for NPI depression. It is possible that some of the items on the FAC
inappropriate behavior subscale measure such a broad range of behaviors that many overlap with
signs of diminished cognition. Because depression is a risk factor for developing AD as well as
an early sign of the disease, the negative loading of depression on the Cognitive-Physical factor
was surprising (Defrancesco et al., 2017). An explanation for the negative loading of depression
on the cognition factor is that individuals with very advanced AD no longer express depression
in a way that is immediately recognizable as their capacity for complex communication declines,
and therefore less depression may be reported during late-stage disease when impaired cognition
is most pronounced.
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Although the TOUS originally conceptualized cognitive functioning as a component of
performance outcome, its position was modified in this study. Because diminishing cognition is
an expected consequence of the physical neurodegeneration in AD, it was conceptualized here as
an indicator of the physiologic antecedent concept. Hutchinson and Wilson (1998) reached a
similar conclusion about blurred theory components when applying the TOUS to interpreting
qualitative data about behavioral symptoms in AD. Despite these minor conceptual challenges,
work by Hutchinson and Wilson (1998) and this present study ultimately concluded that the
TOUS remains useful in this population because of its emphasis on the complexity of
interactions among symptoms.
Although the exploratory factor analysis of all of the variables measuring antecedent
concepts did not achieve a simple structure with each measured indicator corresponding to a
single factor, this is consistent with the description of the original TOUS model. For example,
the TOUS identifies that social support contributes to both the psychological and situational
concept (Lenz et al., 1995).
Agitation. The symptom of agitation was measured with three tools that considered each
of the proposed aspects of the symptom experience: duration (frequency), distress, intensity
(severity) and quality (specific agitated behaviors).

The tools included the FAC agitation

subscale, the NPI agitation subscale, and the CMAI. Although the term “symptom” is normally
reserved for self-reported subjective experiences by individuals, the diminished cognition in AD
reduces the reporting capability of individuals with AD.

Therefore, symptoms in AD are

generally reported by proxy observation of discernible behavioral signs of suspected symptoms
(Hutchinson & Wilson, 1998).
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Performance Outcome. Performance outcomes were measured by a factor containing
the FAC self-care subscale and the FAST/GDS scores. The use of both tools was useful as the
FAST/GDS scores individuals along an expected trajectory of the loss of ADLs over the disease
course, while the FAC self-care subscale allowed more individualization of scores with questions
about specific tasks that were difficult for participants and the frequency of these challenges
(Reisberg, 1986; Swanson, Maas, & Buchwalter, 1994).
Relationships. The original TOUS defined simple, direct relationships between the three
categories of antecedents (physiologic, psychologic, and situational) to a single symptom with
one final direct relationship between the symptom and performance outcomes (Lenz et al., 1995).
The first major finding from this study was that the path model guided by the TOUS was a good
fit to the relationships in the observed data with one notable exception.

The predicted

relationship of a direct positive effect of agitation on functional impairment was not supported by
the model.

When the relationship between agitated behavioral symptoms and function

performance outcomes were reversed, the optimal model for the data was produced. Although
this arrangement produced the best-fitting model overall, the specific relationship between
agitation and function was not statistically significant.
As predicted by the TOUS, the final model showed strong support for the relationships
between situation and agitation, psychological symptoms and agitation, and physical health on
agitated behavioral symptoms-. The model found no support for the effects of situational and
psychological predictors on functional performance or the relationship between agitated
behavioral symptoms and functional outcome. A relationship between physical predictors and
functional outcome was supported. The spurious relationship calculated between agitation,
functional outcome, and physical factors indicated that agitation and functional outcomes were
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both the result of physical factors as opposed to any direct relationship between agitation and
functional outcome.
One explanation for the lack of a significant relationship observed between agitated
behavioral symptoms and performance outcomes could be attributed to an incomplete
measurement of the performance outcome concept. While this study thoroughly measured
functional ability with two distinct instruments, adequate sample was not available to consider
quality of life indicators in the model. Functional status decline with AD progression is a
consistent and expected finding, even with the most supportive care interventions (Reuben et al.,
2019). It is possible that measurements of quality of life would provide a more stable measure of
a modifiable performance outcome that is less directly tied to disease progression.
The consideration of important performance outcomes such as functional status and
quality of life was seen as a major strength of the TOUS compared to other similar theories such
as the needs-driven dementia-compromised behavior (NDB) framework (Algase et al., 1996), the
unmet needs model (Cohen-Mansfield, 2000), and the Progressively Lowered Stress Threshold
(PLST) model (Hall & Buckwalter, 1987).

It may be possible that because of the all-

encompassing nature of the AD degenerative process, a theory that is tailored to the experiences
of this specific population would be more effective in conceptualizing relationships than a theory
like TOUS which describes symptom experience regardless of specific population. Lenz and
Gift (1998) report that the development of the TOUS was from a theory primacy approach
starting with the clinical problem of symptom complaints across diverse clinical populations.
Theories developed from the perspective of substantive area primacy are centered on the specific
needs of unique patient populations, such as AD patients, and may be better tailored to
describing the phenomenon of agitated behavioral symptoms in AD patients (Kim, 1996).
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A path model to describe agitated behavioral symptoms in AD was previously reported
by Chen and colleagues (2014). Chen’s model was developed from the NDB framework and
unmet needs model. There are several similarities between these models and the TOUS. All of
the theoretical models include physical health, pain, psychological health, depression and
environmental predictors that affect agitated behaviors (Algase et al., 1996, Cohen-Mansfield,
2000; Lenz et al., 1995). The biggest difference between the models is the conceptualization of
cognitive impairment as a predictor of problematic behavioral symptoms in AD in the NDB and
unmet needs models while the TOUS does not explicitly conceptualize AD-related cognitive
decline as a predictor.

The models also differ in the relationships between agitation and

functional ability with NBD and unmet needs model categorizing functional ability as a predictor
of agitation and TOUS considers it an outcome.
The path model identified by Chen et al. (2014), found that agitation was directly affected
by cognitive function and depression. Indirect effects on agitation were found from pain and
functional ability through depression. Functional ability was found to be affected by cognitive
function and pain. The model identified in this study agreed with Chen’s model to a large extent.
Both models found agitation to be influenced by cognitive factors and psychological factors
(including depression). Both models failed to find a direct relationship between functional
ability and agitation (regardless of its hypothesized causative or outcome placement). Both
models found that cognitive factors influenced both agitation and functional ability.
Key differences between the two models include the measured variables, study sample
characteristics, explained variance, and the overall model fit. The model identified in the current
study included additional measures of psychological states, caregiver-related situational factors,
and multiple measures of agitation, but did not measure pain. Chen et al., (2014) included in
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their study sample 405 older adults with dementia (not specifically AD), who resided in nursing
homes in Taiwan. The sample from which this study’s model was generated included 48
participants from community and institutional settings in Midwestern United States. The model
generated in the present study explained nearly 63% of the variance in agitation while Chen’s
model explained only 11%. The model in this study also found that 66% of the variance in
functional ability was explained by the cognitive factor while Chen’s model found 52% of the
variance in functional ability was explained by cognitive function and pain. Overall, both
models fit their datasets, although the model generated in the present study had a better fit
compared to Chen et al., (2014). Taken together, these models confirm the important impact of
cognitive function and psychological factors on agitation. Our study adds the importance of the
impact of caregiver burden on agitation.
With all of the strengths and weaknesses of the TOUS taken together, the fit between the
data in this study and the TOUS is satisfactory in explaining the phenomenon of agitated
behavioral symptoms in AD. When testing a theory to explain research data, the theory should
aid the researcher in expanding knowledge and exploring a small part of the larger phenomenon
of interest in depth (Artinian, 1988). It is not necessary that the theory explain all of the data but
is more useful in the interpretation of some aspects. Especially when approaching a secondary
analysis of data, the model is not expected to perfectly match the data since the theory was not
used to guide instrument selection or to plan research methods (Lenz & Gift 1998). Regardless
of these barriers, the TOUS provided a useful framework for formulating hypotheses and
organizing the variables and relationships in the phenomenon of agitated behavioral symptoms in
AD. The TOUS provided valuable insight to guide research exploration and to illuminate key
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nursing interventions to improve care for this population. Further exploratory evidence within
each variable category is discussed below.
Support for individual relationships
Situation. The effect of situational caregiver burden was found to have the greatest
impact on agitation in the path model. This finding is consistent with previously reported
research that negative interactions between overburdened caregivers and individuals with AD
can worsen agitation severity in this population (de Mauléon et al., 2019; de Vugt et al., 2004;
Ragneskog et al., 1998). The direction of the relationship is called into question by other
findings that conceptualized caregiver burden as a result of agitation (Chiao, Wu, & Hsiao, 2015;
Hiyoshi-Taniguchi et al., 2018). When viewed from a reciprocal-interactive perspective as
outlined in the updated TOUS (Lenz et al., 1997), the direction of the interaction is
inconsequential because caregiver burden and agitation are constantly interacting and creating
feedback within each other.
Findings from the path analysis were further supported with exploratory data from
subsets of participants. Correlations between a specific measure of situation (the Zarit Burden
Interview and NPI occupational disruption scale) and measures of agitation (the CMAI and NPI
agitation subscale) were found. A nearly perfect correlation was found between the ZBI and
CMAI for the 5 participants with both measures, and the NPI occupational disruptiveness scale
was moderately correlated with both CMAI and NPI agitation.
Psychological states. The final path model showed strong support for the relationships
between psychological symptoms and agitation. It was previously demonstrated that
psychological disturbances often co-occur with agitated behavioral symptoms in persons with
AD (Borsje et al., 2015; Chen et al., 2014; Van der Mussele et al., 2015). This research further
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confirms co-occurrences of psychological disturbances and agitation, and suggests that states of
psychological distress may exacerbate agitated behavioral symptoms in persons with AD.
In addition to the evidence supporting the relationship between increased psychological
disturbances and agitation discovered through the path analysis, additional exploratory evidence
further supports these findings. The ADAS non-cognitive behavioral scale was correlated with
the FAC agitation scale. While not measured in the path analysis, this provides further evidence
supporting the relationship between agitation and other neuropsychiatric symptoms in AD across
different instruments of measurement.
Physical Health. The path analysis found a strong relationship between the cognitive
aspect of physical health and agitated behavioral symptoms. This relationship is consistent with
previously reported findings of increasing agitation with diminishing cognition (Chen et al.,
2014; Livingston et al., 2017; Ryu et al., 2005; Veldwijk-Rouwenhourst et al., 2017).
Contradictory evidence was reported by Lovheim et al., (2008) who reported that agitation
increased with cognitive decline only to the point of moderate dementia impairment, and then
subsided. Disagreements in previous reports of the relationship between agitated behavioral
symptoms and cognitive measures may be attributable to definition of dementia with agitation
being more prevalent in dementia related to AD than other types of dementia (Apostlova et al.,
2014; Steinberg et al., 2006).
Although other measures of physical comorbidities were not measured in the path
analysis, exploratory evidence suggested the existence of correlations between pain and
agitation. The relationship between pain and agitation has been demonstrated in many previous
studies (Pelletier & Landreville, 2007; Volicer et al., 2012). Volicer and collegues (2012) only
found a relationship between agitation and pain when dementia severity and functional disability
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were controlled, and Chen (2014) found an indirect relationship between pain and agitation
through the effect of pain on depression and functional disability suggesting that the relationship
between agitation and pain is sometimes complex. Findings that the treatment of pain reduces
agitated behaviors suggest that agitated behavioral symptoms can be a response to untreated pain
(Husebo, Ballard, Cohen-Mansfield, Seifert, & Aarsland, 2014). The modifiable relationship
between pain and agitation demonstrates the need to assess and treat pain in persons with AD.
Surprisingly, exploratory evidence did not identify relationships between cumulative
disease burden (CIRS-G), nutritional measures (MNA, NPI Appetite), or hearing (HHIE-S) and
agitation. Sample sizes for these exploratory comparisons were small (n = 5-18), which may
have contributed to the lack of observed relationships. Although correlations cannot determine
cause and effect relationships, these are interesting findings that could be explored further in
future analyses.
Agitation. Agitation was measured with three different tools concurrently: CMAI, FAC
agitation subscale, and NPI agitation subscale.

Surprisingly, these measures demonstrated

minimal intercorrelation among measures (only CMAI and FAC agitation subscale were
significantly correlated). There were, however, strong correlations between CMAI and NPI
disinhibition, aberrant motor behavior, and irritability subscales, between the FAC agitation
subscale and the ADAS non-cognitive behavioral subscale, and also between the NPI agitation
subscale and NPI aberrant motor behavior and NPI irritability subscales.
This clearly demonstrates the inconsistencies with which AD-related agitation is
described by different authors and is measured by different tools. With the broadest definition of
agitation, Cohen-Mansfield and Billing (1986) consider verbal aggression, physical aggressive
and non-aggressive behaviors, as well as hording to all measure different aspects of the broader
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construct of agitation. This overlaps with related concepts that others describe as restlessness,
aggression, aberrant motor behaviors, or inappropriate behaviors (Cummings et al., 2015, Kong,
2005). While some researchers narrow the conceptual definition of agitation to exclude related
factors, others measure agitation broadly and may simply explain the broad construct as
“agitation and aggression” (de Mauleon et al., 2019). This broad approach seems to be the most
effective since the reported consequences of agitation-related challenging behavioral symptoms
in AD are similar, including increased caregiver burden and institutionalization (de Mauleon et
al., 2019; Dufournet et al., 2019). No evidence was found to support different patient outcomes
for different types of agitation, but if future evidence suggests that different types of agitation do
impact different outcomes, then the narrow definition of agitation would be appropriate.
Functional Outcomes. In the present study, functional outcomes were conceptualized
both as functional abilities and quality of life.

Only measures of functional ability were

measured in the path analysis due to sample size constraints. The model found no support for the
effects of situational and psychological predictors on functional performance or the relationship
between agitated behavioral symptoms and functional outcome. This may be attributable to
caregiver perceptions of functional deficits as less burdensome that other AD-related symptoms
(Dufournet et al., 2019). Many caregivers report less psychological burden from physical and
cognitive AD-related deficits than from agitation. However, these three factors are directly tied
to over 84% of nursing home admissions for persons with AD and all merit in-depth exploration
(de Mauleon, 2019; Dufournet et al., 2019).
A relationship between physical predictors and functional outcome was supported by the
path model. The spurious relationship calculated between agitation, functional outcome, and
physical factors indicated that agitation and functional outcomes were both the result of physical
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factors as opposed to a direct relationship between agitation and functional outcome. This is
consistent with the disease course of AD causing both functional and cognitive decline and
worsening neuropsychiatric symptoms as neuropathological changes worsen (Braak & Braak,
1991; Tward et al., 2017; Maas et al., 2015; Serrano-Pozo et al, 2011; Tam & Pasternak, 2017).
No other factors measured in this analysis contributed any noticeable effect on this relationship.
Exploratory evidence based on small samples indicated that caregivers felt more
burdened when individuals with AD had later-staged illness (ZBI was correlated with
GDS/FAST stage, n = 5), and that burdened caregivers rated lower quality of life for individuals
with AD (ZBI was correlated with ADRQL, n = 5). Previous findings have also indicated that
caregiver-reported quality of life for individuals with dementia diminished as the disease
progresses, and that these changes are often accompanied by increasing levels of agitation
(Livingston et al., 2017). Quality of life is an important outcome that should be measured in
additional research.
Functional performance outcomes and psychological factors were not found to be related
in the path analysis, and no additional significant findings were uncovered through individual
analyses.

There were no participants with concurrent measures of quality of life and

psychological indicators, so no conclusions can be drawn.
Exploratory evidence was found to support the relationship between increased comorbid
disease burden and worsening function status as well as quality of life (CIRS-G correlations to
FAC self-care, n = 13; GDS/FAST scores, n = 5; and ADRQL, n = 5). Other authors examining
quality of life from the perception of both caregivers and patients have also found lower quality
of life and functional status in individuals with high comorbid disease burden in AD, and
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attributed lower quality of life ratings to issues pertaining to dignity, disease development, health
and function, and safety issues (Verloo, Salina, Fiorentino, & Cohen, 2018).
Further initial evidence suggests a correlation between worsening nutritional status and
lower quality of life, although the sample was small (MNA was correlated with QOL-AD, n = 5).
These findings are consistent with previous research that nutrition, weight, and quality of life
declined over a one-year study of persons with AD (Suominen et al., 2015). Suominen and
collegues (2015) also reported that tailored nutritional interventions resulted in little change in
quality of life and no change in nutritional status. As reduced oral intake is an expected outcome
of advanced-stage AD, it is important to evaluate the stage of AD when considering aggressive
dietary interventions (Ferrell, Twaddle, Melnick, & Meier, 2018). Avoidance of forced feeding
can be part of compassionate end of life care (Post, 2001).
Limitations
Limitations of methods
This dissertation was a secondary analysis of cross-sectional, descriptive data from
multiple parent studies. Cross-sectional studies are limited by their snapshot perspective on
study variables.

In contrast, longitudinal studies are particularly important to studying

degenerative diseases like AD by examining the declining trajectory over time rather than
instantaneous observations. Individual variations between baseline features can complicate the
separation of signal from noise in the analysis of differences. To help clarify differences
between individuals which are attributable to AD-related decline and differences between
individuals at baseline, longitudinal measurements are the gold standard for all aspects of AD
research from neuroimaging, to biomarkers to cognition (Jack et al., 2014; Raz & Kennedy,
2009; Xu et al., 2014).
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Original parent studies employed a convenience sample for enrollment of participants.
Eligible participants and their caregivers voluntarily enrolled in the study without random
selection. Without random sampling, there may have been systematic error introduced to the
data due to unmeasured similarities between participants which limits the ability of results to be
generalized.
Secondary analysis provides unique limitations as well as benefits compared to original
research. In secondary analysis, the researcher is committed to measuring study variables with
the instruments that have already been used. Therefore, careful evaluation of psychometric
properties was necessary. It was also important to assure that research questions could be
adequately addressed by the existing data set. Benefits of secondary analysis include accessing
larger pools of participants than would otherwise be possible and that secondary analysis can be
used to answer new research questions without further burdening vulnerable populations
(Wickham, 2019). Despite its limitations, secondary analysis is a useful and appropriate method
for answering the observational and theory-based research questions examined in this research
study.
Limitations of results
There are limits to generalization of these research findings to wider populations. The
individuals in this sample were mostly females and almost entirely white. Male gender is has
previously been associated with agitation and aggression in AD (Kolanowski, 2016).
Conversely, female gender has been associated with higher levels of psychosis (delusions and
hallucinations) in AD (Nagata et al., 2017).

It has been suggested that caregiver burden

experienced by female family members caring for agitated males with AD may be related to
traditional gender roles causing some females to perceive helplessness or inappropriateness in
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controlling these challenging behaviors (Tan et al., 2005). It is unclear if females who suffer
from AD have a different presentation, experience, or consequences to agitated behavioral
symptoms or if their symptoms are interpreted differently than males. The lack of individuals
from non-white backgrounds in this sample presents a barrier to wide generalization of these
results as individuals with racial or ethnic minority backgrounds may have unique
socioeconomic circumstances, physical comorbidities, or social environments impacting
agitation.
Traditionally, symptoms are characterized as subjective experiences known only to the
individual, whereas signs are observable by others (MacBryde & Blacklow, 1983). In AD,
diminishing mental ability caused by the disease interferes with an individual’s ability to
recognize and express their symptom experience. For this reason, AD symptoms are usually
considered to include any manifestation of AD as observed by individuals or their caregivers
(Hutchinson & Wilson, 1998). It is not known how accurately these observable signs represent
the internal symptom experience of individuals (Lenz & Gift, 1998). The extent to which signs
are recognized by outside observers presents a barrier to understanding the true symptom
experience in this population.
Although many of the hypothesized relationships surrounding the symptom experience of
agitation were supported through the analysis of the data, agitation and other background factors
did not demonstrate the expected relationships with functional performance outcomes and
quality of life measures.

Many potentially important variables like stability of place of

residence, family support, social isolation, hearing loss, comorbid disease burden, pain, and
quality of life were not measured in the model. These factors could affect the results.
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There is still not enough evidence to definitively determine a comprehensive list of
antecedents and consequences to agitation, and more evidence is needed to decide for certain if
the TOUS is the best model for understanding this phenomenon. The original version of the
TOUS provided a simple and straightforward model from which the symptom experience could
be understood. The updated version of the TOUS introduced more complexity. It may provide a
better understanding of the symptom experience from a longer term view, but also created a less
specific, recursive model of the symptoms where every variable essentially impacts every other
variable concurrently. This type of relationship does not lend itself well for cross sectional
analysis, and so little support for the updated TOUS can be determined by the present analysis.
Although limitations in this research are acknowledged, the results do contribute to a
wider body of knowledge to improve the care of individuals with AD and their family members.
Importantly, it demonstrates a unique application of the Nursing TOUS to guide a model of
agitated behavioral symptoms in individuals with AD.

From this theory-guided model,

predictors of agitated behavioral symptoms were identified, and limitations to the application of
TOUS in persons with AD were suggested.
Recommendations for Future Research
This study has partially validated the utility of the TOUS in describing and predicting
agitated behavioral symptoms in persons with AD.

Further research into other possible

antecedents to agitated behavioral symptoms as well as consequences of agitation are necessary
to provide further guidance to the utility of the TOUS in the population, and to identify
opportunities for interventions to improve life individuals with AD and for caregivers.

136
Theory testing
More testing of the TOUS is necessary to determine its utility in understanding
behavioral symptoms in persons with Alzheimer Disease.

The qualitative research by

Hutchinson & Wilson provides an excellent example of how the TOUS can be applied to
systematically understanding the symptoms of AD through real-world episodic cases. Rather
than asking participants about experiences from the prior week or month, specific instances of
problematic behaviors were examined within the TOUS framework. From these examples,
antecedents can be identified to reduce future recurrences of the problematic symptoms or
performance outcomes.

The same approach could be applied to the development of an

intervention support caregivers in managing episodes of agitated behaviors.

Because the

application of the TOUS to populations with AD has been mixed, future studies should also
compare results to other available nursing theories like the NDB (Algase et al., 1996), unmet
needs framework (Cohen-Mansfield, 2000), and PLST (Hall & Buckwalter, 1987) models of
behavior in AD.
The TOUS should be tested over longer time frames to determine if the updates made in
the second version of the TOUS mitigate some of the deficiencies in the original version.
French, Crawford, Bova, and Irwin (2017) found that many of the antecedent factors identified in
their understanding of chronic cough were improved by managing the symptoms itself,
supporting the hypothesized feedback loop proposed in the updated model of the TOUS. A
similar analysis could be examined within the phenomenon of agitated behavioral symptoms in
AD through an analysis of data collected at multiple time points.
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Antecedents
Other environmental factors (such as the physical surroundings, changes to daily
routines, level of stimulation, noise, social engagement) have previously demonstrated a
relationship with agitated behavioral symptoms (Corcoran & Gitlin, 1992; Kolanowski et al.,
2017; Livingston et al., 2014; Ragneskog et al., 1998; Smith et al., 2006). These specific
environmental variables were not tested within the situational theoretical construct of the TOUS
in the current study. Testing the effects of these factors on agitated behavioral symptoms and
functional performance outcomes would add evidence to the extent and importance of
environmental variables that may impact outcomes within the TOUS, and also potentially
provide evidence for interventions to improve these outcomes.
Because depression and anxiety are themselves symptoms of Alzheimer disease, future
studies could consider premorbid psychiatric illness rather than only comorbid psychiatric states.
This follows the method suggested by Kolanowski and colleagues (2017). This method could
further elucidate the independent effects of premorbid psychiatric concerns rather than
neuropsychiatric symptoms that occur as a direct result of the course of AD symptoms.
This research found that the role of caregiver burden is very important in explaining
agitated behavioral symptoms. As this is one of the few modifiable antecedents of agitated
behavioral symptoms in AD, this area should be prioritized for future intervention research. In
an initial trial of a comprehensive dementia care program, Rueben and colleagues (2019) found
that individualized dementia care plans, dementia management skills training, and caregiver
support groups helped improve neuropsychiatric symptoms and caregiver burden after one year,
although functional ability continued to decline. Programs like this should be optimized through
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continued research and targeted to improve support for caregivers throughout the disease
progression. Similar programs should be tested to determine efficacy for professional caregivers.
Finally, future research should focus on diverse populations and include participants from
racial and ethnic minority backgrounds.

Interpreted within the TOUS, racial or ethnic

experiences could potentially contribute to differential expressions of agitation through physical
or situational antecedent risks. Physical risks such as cardiovascular disease and other comorbid
health conditions are more prevalent African American and Hispanic populations (Chin, Negash,
& Hamilton, 2011).

Social risks for minority populations are extensive and may include

environment, educational background, stigmatization, and access to care (Dilworth-Anderson,
Pierre, & Hilliard, 2012; Weuve et al., 2017). More research is necessary to validate the degree
to which the TOUS adequately describes the impact of these risk factors on agitated behavioral
symptoms in AD. Future research should focus on modifiable risk factors to target future
interventions.
Agitation
Greater conceptual clarity is still a major concern in defining and describing this
phenomenon. Although some work to clarify the concept has been made through efforts such as
the Agitation Definition Work Group of the International Psychogeriatric Association, its
definition of agitation has not been fully translated into research as evidenced by the continued
use of tools that operationalize agitation narrowly.

This research emphasizes the close

association of agitation and related concepts like irritability or aberrant motor behaviors. Future
research may consider combining closely related concepts into a single “agitation/aggression”
factor (de Mauleon et al., 2019). This is especially important with the recognition that different
individuals may have different expressions of “behaviors consistent with emotional distress”
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(Cummings et al., 2015, p. 7). To definitively end the disagreements over which behaviors
should and should not be included in the conceptualization of agitation, research into specific
components of agitation should seek to understand if these behaviors occur independently of one
another, and if their causes or consequences are different. If no differences are found, then the
broad definition of agitation and related behaviors should prevail.
Functional outcomes
Quality of life measures are of utmost importance in evaluating care decisions made on
behalf of older adults with AD. While treatment for AD remains elusive, AD is a terminal
illness. As such, principles of palliative care, such as maximization of comfort and quality of
life, are paramount outcomes in caring for this population (Volicer & Simard, 2015). Although
these outcomes were not fully investigated in the present study, they warrant thorough research
in the future.
Implications for Nursing Practice
Agitation is a common but distressing behavioral symptom in persons with AD.
Agitation is unpleasant for both individuals as well as their professional and family caregivers
(Chiao et al., 2015, Hongisto et al., 2015, Tan et al., 2005). The model of agitated behavioral
symptoms in AD described in this research is useful for nursing practice in the assessment of
patient needs, planning for long term care needs, and implementing nursing interventions.
Persons with AD are often unable to fully communicate their needs, especially as the
disease progresses. For this reason, it is especially important for nurses to assess any possible
physical, psychological or situational cause of agitation. This research suggests that untreated
pain may be expressed as agitation, and should be carefully assessed. Psychological states may
be resultant of the AD process (Borsje et al., 2015; Chen et al., 2014; Van der Mussele et al.,

140
2015), but should also be assessed as possible contributing factors to expressions of agitation (de
Mauleon et al., 2019).
As AD is a long-lasting illness, long-term needs should be assessed and discussed with
caregivers. When individuals with AD are cared for in the home, their situation should be
monitored and needs for additional services should be frequently reassessed as their situation
changes over time (Reuben et al., 2019). Although the impact of agitation and its antecedents on
quality of life was not fully investigated in this study, it remains an important outcome as
identified in the TOUS. While planning the for the long-term care needs of individuals with AD,
end of life plans should be discussed at the earliest opportunity to assure that quality of life
remains a priority in all care planning decisions (Ferrell et al., 2018).
This model, as well as previous evidence, has clearly demonstrated the close relationship
between caregiver distress and agitated behavioral symptoms in AD (de Mauleon et al., 2019).
Nursing interventions to prevent or relieve the distress in both professional and family caregivers
are necessary for the wellbeing of the caregivers as well as a means of improving the agitated
behavioral symptoms directly.

Interventions that have demonstrated improvements in the

caregiver experience include respite care for family members, communication training, and
support groups (Barbosa, Nolan, Sousa, & Figueiredo, 2015; Reuben et al., 2019).

These

interventions should be implemented for both professional and informal caregivers of persons
with AD.
Conclusion
As the United States and much of the world consider ways to confront the impending
surge of older adults who are likely to require care for AD and its related symptoms, research
into mitigating the most challenging symptoms of this devastating disease are critically

141
important. This research found that the TOUS can provide a valid and important conceptual map
for understanding, predicting, and potentially controlling agitated behavioral symptoms in older
adults with AD. Until treatment or prevention of AD is possible, more work is necessary to
minimize symptoms and maximize functional performance to enable older adults with AD and
those who provide care to live with the most independence and dignity as possible. This
research supports the use of the TOUS as a framework to guide this effort, and provides evidence
of the TOUS’s pragmatic utility in nursing research and practice.
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Background: Worldwide population trends are shifting with the population of Elders
expected to dramatically increase in absolute and relative numbers in coming years. Alzheimer
Disease (AD) is a common and costly disease of aging with agitation being the most poorly
managed and detrimental behavioral symptom of the condition.

The Nursing Theory of

Unpleasant Symptoms provides a conceptual basis for understanding agitated behavioral
symptoms associated with AD in the context of its antecedent causes and outcomes of the
symptoms.
Purpose: The purpose of this dissertation was to model the predictors and outcomes of
agitated behavioral symptoms in persons with AD. The specific aims were: (1) Describe the
phenomenon of agitated behavioral symptoms in persons with AD within the Theory of
Unpleasant Symptoms; (2) Determine the effect of situational, psychological, and physiological
factors on agitation in persons with AD; (3) Determine the effect of situational, psychological,
and physical antecedent factors and agitation on performance outcomes.
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Methods:

A descriptive, correlational, cross-sectional, secondary analysis research

design will be employed. The original data were collected in communities and in Nursing
Homes settings in the Midwestern US.

A convenience sampling of facilities yielded 120

participants.
Results:

Exploratory factor analysis identified three antecedent factors to agitated

behavioral symptoms: Situation-Caregiver, Psychological, and Physical-Cognitive. The path
analysis model closely represented all variables and relationships predicted in the TOUS (χ2 =
1.049, df = 2, p = .592). Significant relationships between situation and agitation (B = 0.51, p <
.001), psychological symptoms and agitation (B = 0.446, p < .001), and physical health on
agitated behavioral symptoms (B = 0.58, p = .001) were found, and explained 63% of the
variance in agitation. The model found no support for the effects of any measured factors on
performance outcomes, except the effects of the Physical: Cognitive factor (B = 0.86, p < .001)
which explained 66% of the variance in functional performance.
Implications: The TOUS provides a good model to identify causes of agitated behaviors
in AD. This study emphasizes the need for greater support of caregivers of persons with AD
because caregiver burden is an important modifiable antecedent to agitated behavioral
symptoms. Future research should investigate interventions to reduce professional and informal
caregiver burnout and study the effects of reduced caregiver burnout on improvements in
agitated behavioral symptoms in persons with AD. Future research should also evaluate quality
of life outcomes to better determine if the relationships between symptoms and performance
outcomes predicted in the TOUS remain valid in persons with AD.
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